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1. Summary 
Protein-protein interactions within the plane of cellular membranes play a key role 
for many biological processes and in particular for transmembrane signaling. A 
prominent example is the ligand-induced crosslinking of cytokine receptors, where 3-
dimensional cytokine binding followed by 2-dimensional interaction between the 
receptor subunits have been recognized to be important for regulating signaling 
specificity. The fundamental importance of such coupled interactions for cell-surface 
receptor activation has stimulated numerous theoretical studies, which have hardly 
been confirmed experimentally. An experimental approach to measure interactions 
and real time kinetics of type I interferon (IFN) induced assembly between interferon 
receptor subunits ifnar2 and ifnar1 on membrane was developed and determinants of 
the 2-dimensional interactions, such as dimensionality, size, valency, orientation, 
membrane fluidity and receptor density were quantitatively addressed  
The C-terminal decahistidine tagged extracellular domains (EC) of ifnar1 and 
ifnar2 were site- specifically tethered onto solid-supported fluid lipid membrane, 
which carried covalently attached chelator bis-nitrilotriacetic acid (bis-NTA) groups. 
Interactions on the lipid bilayer were detected with a novel solid phase detection 
technique, which allows simultaneous detection of ligand binding to a membrane 
anchored receptors and lateral interaction between them in the real time. This was 
achieved by combining two optical techniques: label-free reflectance interferometry 
(RIf) and total internal reflection fluorescence spectroscopy (TIRFS). Fluorescence 
signals, in the order of 10  fluorophores/µm
2, were detected without substantial 
photobleaching. The sensitivity of the label-free interferometric detection was in the 
range of 10 pg/mm
2. The crosstalk between the two signals was eliminated by means 
of spectral separation. Fluorescence was detected in the visible region and RIf was 
performed at 800  nm in the near infrared. Flow through conditions allowed to 
automate experiments and measure binding events as fast as ~ 5 s
-1.  
Using this technique we have dissected the interactions involved in IFN-induced 
ifnar crosslinking. 2-dimensional association and dissociation rate constants were 
independently determined by tethering high stoichiometric excess of one of the 
receptor subunits and comparing dissociation of the labelled ligand away from the 
membrane in the absence and presence of the non-labelled high affinity competitor. 
Dissociation traces were fitted with the two-step dissociation model: the first step   7
being the 2-dimensional separation of the ternary complex followed by the 3-
dimensional ligand dissociation into solution. Label-free RIf detection allowed 
absolute parameterization of the 2-dimensional concentrations of the ifnar subunits 
on the membrane. The TIRFS signal provided high sensitivity of the ligand 
dissociation and was correlated against the RIf signal before fitting. These features of 
the detection system allowed us to parameterize the model, and the 2-dimensional 
association or dissociation rate constants were the only variables during the fitting.  
Another FRET based binding assay was developed to determine the 2-
dimensional dissociation rate constant using a pulse-chase approach. The donor 
fluorescence from ifnar2-EC was quenched upon the ternary complex formation with 
the acceptor-labelled IFN and the nonlabelled ifnar1-EC. The equilibrium was 
perturbed by rapid tethering of substantial excess of the nonlabelled ifnar2-EC onto 
the membrane. The exchange of the labelled ifnar2-EC with the nonlabelled one was 
monitored as the decrease in the FRET signal with the 2-dimensional dissociation of 
ifnar2-EC from the ternary complex being the rate limiting step.  
Based on the several mutants and variants of the interacting proteins, the effect 
of different rate constants and receptor orientation on the 2-dimensional crosslinking 
dynamics was studied. We have identified several critical features of the 2-
dimensional interactions on membranes, which cannot be readily concluded from the 
solution binding assays. The restricted rotation and the increased lifetime of the 
encounter complex due to high membrane viscosity are the main determinants of the 
2-dimensional association. Tethering ifnar1-EC to the membrane via N-terminal 
decahistidine tag decreased the 2-dimensional association rate constant 4-5 fold. 
Electrostatic attraction and steering, the important mechanism to enhance 
association rate constant between the soluble proteins, are not pronounced for 
interactions on the membrane. Protein orientation due to membrane anchoring 
dominates over electrostatic effects and together with the increased lifetime of the 
encounter complex consequence that 2-dimensional association rate constants are 
quite similar and do not correlate with association rate constants in solution. The 2-
dimensional dissociation rate constants were generally 2-5-fold lower compared to 
the corresponding 3-dimensional dissociation rate constants in solution. Possible 
explanations for this are that long lifetime of the encounter complex stabilizes the 
ternary complex or that membrane tethering affects the interaction diagram. In 
conclusion, combined TIRFS-RIf detection turn to be powerful and versatile 
technique to characterize protein-protein interactions on membranes.   8
2. Zusammenfassung 
Inter-zelluläre Kommunikation basiert häufig auf Liganden, welche selektiv von 
Rezeptoren auf der Plasmamembran erkannt werden, und durch Wechselwirkung mit 
diesen Rezeptoren Signaltransduktion im Zytoplasma aktivieren. Die molekularen 
Mechanismen der Signalvermittlung durch die Membran sind noch wenig verstanden. 
Die wichtigen Klassen der Zytokinrezeptoren und der Rezeptortyrosinkinasen werden 
durch Liganden aktiviert, die zu einer Di- oder Oligomerisierung von 
Rezeptoruntereinheiten führt, welche offenbar für die Aktivierung zytoplasmatischer 
Effektoren notwendig ist. Diese laterale Interaktion zwischen Rezeptoruntereinheiten 
lässt sich aus mehreren Gründen nicht mit der Interaktion der Proteine in Lösung 
vergleichen. Zum einen handelt es sich um eine Wechselwirkung in 2 anstatt von 3 
Dimensionen, d.h. die Interaktionspartner haben durch die Verankerung auf der 
Membrane weniger Freiheitsgrade als in Lösung. Dabei spielt die eingeschränkte 
Rotation ein besondere Rolle, da sie zu einer Vor-Orientierung der 
Interaktionspartner führt. Ein weiterer wichtiger Unterschied ist die dramatisch 
langsamere Diffusion von Membran-verankerten Proteinen im Vergleich zu Proteinen 
in Lösung. Über die Einflüsse dieser Faktoren auf die Bildung von Proteinkomplexen 
an der Membran wurde sehr viel spekuliert, aber es liegen bis dato kaum 
systematische experimentelle Untersuchungen vor. 
In der vorliegenden Arbeit sollten Detektionsmethoden und Bindungsassays 
etabliert werden, mit welchen die Gleichgewichtskonstanten und die 
Ratenkonstanten von Ligand-Rezeptor Interaktionen auf Membranen in vitro 
bestimmt werden können. Als biologisches Testsystem wurde der Typ I 
Interferonrezeptor gewählt. Typ I Interferone (IFN) sind wichtige Zytokine in der 
angeborenen Immunabwehr von viralen Infektionen, und haben weitere wichtige 
Funktionen für die Aktivierung des adaptiven Immunsystems. Interessanterweise 
binden verschiedene IFN an den gleichen Rezeptor, aber führen zu 
unterschiedlichen Wirkungsmustern. Diese Unterschiede müssen in der 
Wechselwirkung mit den Rezeptoruntereinheiten ifnar1 und ifnar2 kodiert sein. 
Intensive Struktur-Funktions-Untersuchungen konnten keine Unterschiede in der 
Struktur oder Stöchiometrie der Ligand-Rezeptor Komplexen identifizieren, die durch 
verschiedene IFN rekrutiert werden. Allerdings unterscheiden sich für verschiedene 
IFN die Bindungskonstanten und die Ratenkonstanten der Wechselwirkung mit den 
Rezeptoruntereinheiten außerordentlich. Daher sind vermutlich die Effinzienz der   9
Rekrutierung der Rezeptoruntereinheiten und die Dynamik des ternären Komplexes 
von zentraler Bedeutung für die differentielle Wirkung verschiedener IFN. Da der 
Ligand die beiden Untereinheiten auf der Membran verbrückt, sind hier 2-
dimensionale Wechselwirkungen Membran-verankerter Proteine vermutlich die 
Grundlage unterschiedlicher Wirkung. Um diese Szenario zu emulieren, wurden die 
extrazellulären Domänen von ifnar1 (ifnar1-EC) und ifnar2 (ifnar2-EC) über C-
terminale Histidin-tags an Festkörper-unterstützten Membranen mit Chelatorlipiden 
angebunden. FRAP-Experimente haben gezeigt, dass die so angebundenen 
Proteine lateral mit einer Geschwindigkeit von ca. 1 µm²/s diffundieren, also ähnlich 
der (lokalen) Diffusion auf der Plasmamembran. 
Zur Untersuchung der Ligand-induzierten Hetero-Dimerisierung von ifnar1-EC 
und ifnar2-EC auf Festkörper-unterstützten Membranen wurde ein Versuchsaufbau 
zur simultanen Detektion von Fluoreszenz und von Massenänderungen an 
Oberflächen implementiert. Dazu wurde die totalinterne Reflexions-Fluoreszenz 
Spektroskopie (TIRFS) mit der reflektometrischen Interferenzspektroskopie (RIf) 
kombiniert. TIRFS basiert auf der selektiven Anregung von Oberflächen-nahen 
Fluorophoren durch das evaneszente Feld, welches bei Totalreflexion an 
Grenzflächen wenige 100  nm mit dem benachbarten Medium wechselwirkt. Über 
Faseroptik wurde zusätzlich eine Illuminierung senkrecht zur Transducer-Oberfläche 
implementiert, über welche die Dicke einer Interferenzschicht reflektometrisch 
gemessen werden kann. Durch diese Methode können Bindungsereignisse an 
Oberflächen markierungsfrei quantifiziert werden. Da die Schichtdickenmessung bei 
800 nm im NIR Bereich erfolgt, ist sie von der Fluoreszenzmessung im sichtbaren 
Bereich (500-700  nm) spektral separiert. Die Detektion von Fluoreszenz- und 
Massenänderungen an der Oberfläche wurde über die Fusion von Vesikeln mit 
Fluoreszenzmarkierten Lipiden charakterisiert. So konnte gezeigt werden, dass in 
der Tat beide Signale voneinander unabhängig voneinander und ohne detektierbares 
Übersprechen detektiert wurden. Das massensensitive Interferenzsignal wurde 
mittels Vesikelfusion kalibriert, da die dabei entstehende Lipiddoppelschicht eine 
definierte, reproduzierbare Masse auf der Oberfläche abscheidet. Für die 
massensensitive Interferenzdetektion ergab sich so ein Detektionslimit von etwa 
10 pg/mm².  Mittels  Fluoreszenzdetektion konnten Oberflächenbeladungen von 
wenigen Molekülen/µm² detektiert werden. Durch Kombination mit einer 
automatisierten Fluidik konnten schnelle Injektionsschemata realisiert werden, so 
dass Ratenkonstanten von bis zu 5 s
-1 aufgelöst werden konnten.   10
Diese kombinierte Detektionsmethode wurde zunächst eingesetzt, um die 
einzelnen Interaktionen von Fluoreszenz-markiertem IFNα2 sowie anderen IFN mit 
ifnar1-EC bzw. ifnar2-EC zu charakterisieren. So konnten die Ratenkonstanten 
dieser Interaktionen bei sehr geringen Oberflächenkonzentrationen charakterisiert 
werden, was für eine genaue Bestimmung ohne Einfluss von Massentransport-
Effekten notwendig ist. Durch simultane Detektion der Bindung über das 
Massensignal und das Fluoreszenzsignal wurde die Orts-spezifische 
Fluoreszenzmarkierung des Liganden IFNα2 untersucht, und gezeigt, dass die 
Bindung an die Rezeptoruntereinheiten durch die Fluoreszenzmarkierung nicht 
beeinflusst wurde. Zudem konnte kompetitive Bindung von IFN nicht nur an die hoch-
affine Untereinheit ifnar2, sondern auch an ifnar1, welche IFN nur mit sehr geringer 
Affinität erkennt, gezeigt werden. Im nächsten Schritt wurde die Ligand-induzierte 
Assemblierung des ternären Komplexes mit ifnar1-EC und ifnar2-EC auf fluiden 
Membranen untersucht. Dabei wurde bei hohen Rezeptorbeladungen sehr langsame 
Dissoziation des Liganden beobachtet, die bei niedrigen Rezeptorbeladungen 
deutlich schneller war. Diese Beobachtung deutete auf eine kinetische Stabilisierung 
des ternären Komplexes hin. Über Chasing-Experimente mit unmarkiertem Liganden 
konnte diese Vermutung bestätigt werden, da ein deutlich beschleunigter Austausch 
des Liganden beobachtet wurde. Da über das RIf-Signal die absoluten 
Oberflächenkonzentrationen von ifnar1-EC und ifnar2-EC bestimmt werden konnten, 
wurde so auch eine strikte 1:1:1 Stöchiometrie des ternären Komplexes gezeigt: war 
eine der Untereinheiten im Überschuss, dissozierte der überschüssige Ligand 
zunächst mit einer Kinetik, die dem entsprechenden 1:1-Komplex entsprach, bis sich 
ein stabiler 1:1:1-Komplex gebildet hatte. 
Die Bildung des ternären Komplexes wurde im Folgenden detailliert 
charakterisiert. Zunächst wurde die Dissoziationskinetik bei verschiedenen 
Oberflächenkonzentrationen der Rezeptoruntereinheiten in stöchiometrischem 
Verhältnis vermessen. Diese Kurven konnten durch ein 2-stufiges Assoziations- bzw. 
Dissoziationsmodell angepasst werden, in dem der Ligand im ersten Schritt an 
ifnar2-EC bindet und im zweiten Schritt mit ifnar1 auf der Membran einen ternären 
Komplex bildet. Dadurch, dass die Oberflächenkonzentrationen von ifnar1-EC und 
ifnar2-EC genau quantifiziert werden konnten, musste nur ein Parameter in diesem 
Modell angepasst werden, welcher der Gleichgewichts-Dissoziationskonstante der 2-
dimensionalen Interaktion des binären IFN/ifnar2-EC Komplexes mit ifnar1-EC 
beschreibt. Aus allen Experimenten mit Oberflächenbeladungen,  die über einen   11
Konzentrationsbereich von zwei Größenordnungen variierte, konnte reproduzierbar 
eine Bindungskonstante von ca. 40  Molekülen/µm² bestimmt werden. 
Erstaunlicherweise liegt diese Bindungskonstante deutlich über der typischen 
Konzentration von Rezeptoren auf der Zelloberfläche (ca. 1000/Zelle). Damit ist es 
wahrscheinlich, dass die Bildung des ternären Komplexes auf der Zelloberfläche 
durch die Bindungsaffinität bzw. die Rezeptorkonzentration limitiert ist. Diese Affinität 
lässt sich nicht durch Steigerung der Dosis kompensieren. Interessanterweise gibt es 
zudem IFN mit deutlich höherer Affinität zu ifnar1. Damit könnte diese Interaktion 
eine Schlüsselrolle bei der Regulation des Ansprechverhaltens verschiedener Zellen 
spielen. 
Weitere Untersuchungen zur Bildung des ternären Komplexes wurden mit IFNα2 
Mutanten durchgeführt, welche eine niedrigere Bindungsaffinität zu ifnar2-EC 
zeigten. Die Dissoziationskinetiken dieser Mutanten aus dem ternären Komplex mit 
ifnar1-EC und ifnar2-EC ergaben, dass selbst bei stöchiometrischen Konzentrationen 
der Rezeptoruntereinheiten durchaus auch die Bindung an ifnar1 im ersten Schritt 
erfolgen kann. Da die Ligandenbindung der Geschwindingkeits-bestimmende 
Schritte der Rezeptorassembliert darstellt, entscheidet die relative 
Assoziationswahrscheinlichkeit, inwieweit welcher dieser beiden Wege populiert ist. 
Damit ist nicht nur die Assoziationsratenkonstante, sondern auch die relative 
Konzentration der Rezeptoruntereinheiten für den Assemblierungsmechanismus 
wichtig. Da unterschiedliche IFN verschiedene Assoziationsratenkonstanten haben, 
sind durchaus verschiedene Assemblierungssmechanismen für verschiedene IFN 
denkbar. 
Um die Dynamik des ternären Ligand-Rezeptor-Komplexes auf der Membran zu 
charakterisieren wurden Assays etabliert, um die 2-dimensionale Interaktionskinetik 
direkt zu messen. Hier wurden zwei Strategien verfolgt. Zunächst wurde der Förster-
Resonanzenergietransfer  (FRET) zwischen Donor-markiertem ifnar2-EC und 
Akzeptor-markiertem ifnar1-EC eingesetzt, um die Ligand-Rezeptor Interaktion auf 
der Membran zu verfolgen. Durch schnelles Beladen mit einem Überschuss von 
unmarkiertem ifnar2-EC auf die Membran wurde ein Austausch von markiertem 
gegen unmarkierten ifnar2-EC über das Abklingen des FRET gemessen. Dieser 
Austausch wird bestimmt durch die 2-dimensionale Dissoziazionskinetik des ifnar2-
EC/IFNα2 Komplexes die aus der Änderung des FRET-Signals bestimmt werden 
kann. Interessanterweise war die Dissoziationsratenkonstante, die aus dieser Kinetik   12
bestimmt wurde, um einen Faktor 3-5 höher als die Dissoziationsratenkonstante des 
ifnar2-EC/IFNα2 Komplexes mit dem freien Liganden. Da die Bindung von ifnar1-EC 
keinen Einfluss auf die ifnar2-EC/IFNα2 Interaktion hat, müssen diese Unterschiede 
auf die Verankerung an der Membran zurückgeführt werden. Wahrscheinlich spielt 
die langsamere Diffusionskinetik hier eine entscheidende Rolle, die zu einer 
langsameren Separation der dissoziierten Komponenten führt. 
Diese Beobachtungen wurden bestätigt durch Bindungsassays, in denen die 
Austauschkinetik des Liganden im ternären Komplex bei Zugabe von unmarkiertem 
Liganden vermessen wurde. Dazu wurde eine der Rezeptoruntereinheiten im 
stöchiometrischen Überschuss auf die Membran geladen. Nach Bildung des ternären 
Komplexes mit Fluoreszenz-markiertem IFNα2 wurde der Überschuss an 
Rezeptoruntereinheit mit unmarkiertem Liganden in hoher Konzentration beladen. 
Der nun erfolgende Austausch von markiertem gegen unmarkierten Liganden wurde 
über das Fluoreszenzsignal verfolgt. Bei Verwendung geeigneter Mutanten ist diese 
Austauschkinetik wiederum durch die 2-dimensionale Dissoziationskinetik der 
Ligand-Rezeptor-Interaktion bestimmt. Mit diesen Bindungsassays wurden die 
Dissoziationskinetiken für ifnar1-EC und ifnar2-EC, sowie verschiedene Mutanten 
bestimmt. Aus der Gleichgewichts-Dissoziationskonstante und der 
Dissoziationsratenkonstante konnte auch die 2-dimensionale 
Assoziationsratenkonstante berechnet werden. Basierend auf systematischen 
Untersuchungen konnten einige prinzipielle Eigenschaften von 2-dimensionalen 
Protein-Protein Interaktionen identifiziert werden. So bestätigte sich für alle Ligand-
Rezeptor Interaktionspaare, dass die 2-dimensionale Dissoziationskinetik um einen 
Faktor 3-5 langsamer war als die entsprechende 3-dimensionale Dissoziation. 
Weiterhin ist konnte für die Assoziationskinetik beobachtet werden, dass die großen 
Unterschiede in der Assoziationsratenkonstante in Lösung, die durch 
elektrostatisches Wechselwirkungen zu erklären sind (electrostatic steering), nicht für 
die 2-dimensionale Interaktion auf der Membran beobachtet wurde. Weit wichtiger 
als elektrostatische Steuerung ist dagegen die „richtige“ Orientierung der Proteine an 
der Oberfläche: Durch Änderung der Orientierung von ifnar1-EC auf der Membran 
über ein N-terminales Histidin-tag sank die Assoziationratenkonstante um einen 
Faktor von >5. Dies ist insbesondere überraschend, weil ifnar1-EC eine flexible multi-
Domänenstruktur hat und zudem relativ flexibel über das Histidin-tag an der 
Membrane angebunden ist. Diese Ergebnisse zeigen, dass die Membran-
verankerung, die Flexibilität, die laterale Diffusionskinetik und die   13
Oberflächenkonzentration zentrale Parameter für die Bildung und die Dynamik 
Zytokin-Rezeptorkomplexen auf Membranen sind. Diese Eigenschaften hängen auch 
von der lokalen Umgebung auf der Plasmamembran ab, die sich auch durch die 
Komplexbildung ändern können. Damit lässt sich erwarten, dass 
Rezeptorassemblierung in Zellen einen noch durchaus komplexeren Verlauf nehmen 
kann. In dieser Arbeit konnten diese Prozesse unter kontrollierten Bedingungen 
charakterisiert werden. Dabei erwies sich die neu etablierte Methode der simultanen 
TIRFS-RIf Detektion als äußerst versatil. Die komplementären Messgrößen dieser 
Detektionsmethode waren insbesondere nützlich, um die multiplen Parameter 
(Membran-Assemblierung, Rezeptorkonzentrationen) zu kontrollieren, und 
gleichzeitig komplexe Bindungsassays mit hoher Zeitauflösung durchzuführen. Eine 
breite Anwendung dieser Methode, um komplexe Prozesse an Membranen und an 
nicht-fluiden Oberflächen zu charakterisieren, ist vorauszusehen. 
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3. Preface 
A cell uses cell surface receptors to constantly monitor its environment and 
initiate responses to environmental cues, e.g., signals such as hormones, growth 
factors and cytokines. The range of signals, typically ligands, a cell can detect and 
the concentrations at which ligands can be detected are determined by the array of 
receptors on the cell’s surface. When a receptor encounters an agonist ligand, 
ligand-receptor interaction triggers a cascade of intracellular signaling reactions that 
can lead to a variety of cellular responses, such as the secretion of mediators of cell–
cell communication, changes in gene expression, and cell proliferation. Protein-
protein interactions between cell surface receptors, triggered by ligand binding play 
crucial roles in signal transduction. Kinetic and equilibrium properties, stoichiometry 
and conformational states of the signaling complexes are suggested to be largely 
responsible for signaling amplitude and specificity. Type I interferons (IFNs) elicit 
their antiviral, antiproliferative and immunmodulatory responses through binding to a 
shared receptor consisting of the transmembrane proteins ifnar1 and ifnar2. 
Differential signaling by different interferons emphasize the importance of 2-
dimensional interactions between ifnar subunits in signal propagation. Therefore, 
understanding the determinants of protein-protein interactions on the biological 
membranes are important not only from the fundamental point of view, but also has a 
number of important practical applications. In 1968 Adam and Delbruck [1] 
introduced the concept of “reduction of dimensionality” which suggested that 
organisms handle some of the problems of timing, efficiency and sensitivity, in which 
small numbers of molecules and their diffusion are involved, by reducing the 
dimensionality in which diffusion takes place from the 3-dimensional space into 2-
dimensional surface diffusion. Later, the initial concept was expanded, and the 
consequences of dimensionality, diffusion, orientation, electrostatics and other 
variables on 2-dimensional association and dissociation rate constants and 
equilibrium dissociation constants were subject of intensive theoretical treatment. It 
was realized, that in some cases interaction between membrane anchored proteins 
can be much more potent than between their soluble counterparts. In general, 2-
dimensional interaction rate constants and equilibrium dissociation constants can not 
be deduced by measuring their 3-dimensional interaction in solution. Despite 
advances in experimental techniques little has been done to experimentally confirm   15
theoretical predictions and quantitatively understand determinants of protein-protein 
interactions in 2-dimensions.  
4.  Interactions in three dimensions 
4.1.  Basic description of biomolecular interactions 
When two molecular species, receptor R and ligand L with mutual affinity are 
mixed in a solution, a time-dependent association between these molecules is 
expected to occur following the simple model: 
RL +R L
ka
kd      E q .   1  
Where ka and kd are the association and the dissociation rate constants. 
This interaction mechanism is described by the differential equation of the type: 
[RL] [L] [L]
[RL] [R] [R]
[RL] k [R][L] k
dt
d[RL]
0
0
d a
+ =
+ =
− =
     E q .   2  
where [R], [L] and [RL] are concentrations of the reactants, [R]0 and [L]0 are the 
total amount of the receptor and the ligand respectively.  
After certain time, the reaction reaches equilibrium and concentrations of the 
reactants does not change during the time. Therefore  0 =
dt
] RL [ d
 and Eq.2 can be 
simplified to 
] RL [ k ] L ][ R [ k d a =      E q .   3  
The principle of microscopic reversibility at equilibrium states that, in a system at 
equilibrium, a number of association events is equal to the number of dissociation 
events. The equilibrium dissociation constant is defined as the ratio of concentrations 
between reagents and products at equilibrium: 
a
d
D k
k
] RL [
] L ][ R [
K = =     E q .   4  
As can be seen from Eq.4, the concentration of the free ligand [L], when half of 
the receptors are occupied is equal KD.   16
] RL [ ] R [ D ] L [ K = =      E q .   5  
The relationship between the thermodynamic parameters characterizing complex 
formation, such as the Gibbs free energy ∆G
0, and KD is described by following 
equation: 
) K ln( T R G D
gas 0 ⋅ = ∆      E q .   6  
Where R
gas is the gas constant, T – the absolute temperature.  
Eq.6 is the most important equation to predict the direction and the extent of an 
interaction. For spontaneous reaction the change in Gibbs free energy is negative 
∆G<0. The sequence of the several interactions will spontaneously proceed only if 
the overall change in free energy is negative. In the cell, thermodynamically 
unfavorable interactions are coupled with ATP hydrolysis and proceed spontaneously 
if ∆G+∆GATP<0. KD has a very strong dependence on ∆G
0, because of the logarithmic 
relationship. This emphasizes the importance of weak interactions, since small 
changes in ∆G
0 imply large changes in KD. For example, at room temperature an 
additional hydrogen bond of 5 kcal/mol would decrease KD more than three orders of 
magnitude. 
∆G
0 can be divided into enthalpic, ∆H
0, and entropic, ∆S
0, contributions: 
0 0 0 S T H G ∆ ∆ ∆ − =      E q .   7  
Change in enthalpy depends on hydrogen bond formation, electrostatic and Van 
der Waals interactions, steric hindrance, solvation and other effects. Change in 
entropy is primarily associated with randomness and rigidness of the system, 
restrictions of its translational, rotational or vibrational motions upon complex 
formation.  
Most of the biological interactions happen in aqueous solutions and water does 
not act as the inert space filler, but is significantly involved during the course of 
complex formation. This is especially true when ions or dipolar molecules are 
involved. Water dipoles orient themselves in the electrostatic field generated by ions 
or dipoles and this contributes to a large negative change in solution entropy. The 
mobility of the hydrated proteins is further decreased bringing additional change in 
entropy. Water forms weak bonds with proteins resulting in positive enthalpy. Thus, 
changes in enthalpy and entropy tend to compensate each other. The free energy   17
difference of the hydration shell between R, L and their complex RL can have 
substantial contribution to the interaction ∆G
0. 
4.2. Interaction  diagram 
The potential energy surface of an interaction is a geometrical hypersurface on 
which the potential energy of a set of reactants is plotted as a function of coordinates 
representing the molecular geometries (for example, a bond length or bond angle) of 
the system. The energetically easiest route from reactants to products on the 
potential energy contour map defines the interaction potential-energy profile. The 
interaction coordinate is typically chosen to follow the potential energy profile from 
the reactants to the products. The potential energy profile plotted against interaction 
coordinate is called the interaction diagram. The diagram for elementary interactions 
is presented in Figure 1A. In 1935 Eyring [2] and others described the theory that an 
interaction proceeds through a transition state or an activated complex. The 
reactants are in rapid equilibrium with the transition state. The activated complex can 
go forward to produce the product, the complex RL, or reverse to re-generate the 
reactants R and L. Only molecules, which have enough energy to reach the transition 
state can form a complex.  
Most biological interactions can not be explained by elementary interaction 
diagram presented in Figure 1A. The course from R and L to RL often involve 
multiple sequential elementary steps. These steps are bringing proteins to close 
proximity state, removal of interfacial water, bond breakage and conformational 
optimization of binding sites to form a complex, formation of the interaction bonds 
between the receptor and the ligand chains and formation of a new hydration shell 
around the complex. These steps appear on different time and length scales. If 
proteins are very flexible, multiple conformational optimization, bond formation and 
hydration / dehydration cycles are required to form the functional complex. This type 
of complex formation is also called “induced fit” interaction. During the course of 
sequential elementary interactions the local free energy minimums with a depth 
greater than the RT can be formed. Protein complexes in these local energy wells 
are called interaction intermediates and these states can be detected with modern 
ultrafast spectroscopic detection techniques. The interaction diagram for two proteins 
(Figure 1B) is a complex curve with multiple transition states (RL
‡, RL
‡‡ and RL
‡‡‡) 
and reaction intermediates (RL*and RL**). The energy barrier receptor and ligand   18
have to cross to associate is called activation energy or association free energy 
∆G
‡
on. Similarly, the energy barrier for dissociation is called ∆G
‡
off. The free energy 
difference between reactants R and L and their complex RL is the interaction free 
energy ∆G
0. 
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Figure  1.  Interaction diagram for (A) elementary reaction and (B) for receptor-
ligand complex formation. 
4.3.  Factors affecting association rate constant 
The association rate constant for protein-protein interactions was intensively 
studied and summarized in numerous books and reviews [3-5]: 
) T R G exp( Z p k
gas
on a ∆ − ⋅ ⋅ =     E q .   8  
where p is the orientation factor and Z is the collision frequency;  
The collision frequency for neutral spherical and uniformly reactive particles, R 
and L, in solution can be calculated from the Smoluchowski equation: 
r ) D D ( C C 4 Z
D 3
L
D 3
R
D 3
L
D 3
R
D 3 + = π     E q .   9  
where CR
3D and CL
3D – the concentrations of the R and the L respectively, DR
3D 
and DL
3D – the diffusion coefficients of the R and the L respectively, r – the encounter 
radius;  
The state of close proximity between the receptor and the ligand during collision 
is called diffusional encounter. Eq.8 shows that not every collision or not every 
diffusional encounter between R and L proteins leads to complex formation. First, 
) RT G exp( on ∆ −  represent fraction of collision pairs that have the necessary 
activation energy for biological interaction to take place. It should be noted, that only 
the activation energy which is localized in the protein binding site is important for 
association. Second, “p” is a steric or orientation factor, describing the probability that   19
energized collisions would have a geometry suitable for interaction. “p” values are 
difficult to predict and exact solutions can be found only in special cases [6,7].  
The long-range electrostatic interaction between R and L can change the 
association rate constant by increasing or decreasing collision frequency. Due to the 
attractive potential between opositively charged proteins, they will stay in the vicinity 
to each other and will collide several times before full separation. Additionally, charge 
distribution on protein interface affects the orientation at which they collide. This 
optimization of long range electrostatic interactions prior collision, also called 
electrostatic steering, can dramatically increase orientation factor “p” and 
corresponding association rate constant [8-10]. 
The solvent environment can influence the association rate constant and even 
the mechanism of complex formation by changing the force between the interacting 
proteins and hence altering the readiness with which they approach each other. Such 
phenomenon is illustrated by effect of solvent’s dielectric constant on electrostatic 
and Van der Walls forces among interacting proteins. Dissolved salts additionally 
minimize electrostatic and Van der Waals interactions affecting the orientation factor, 
the collision frequency and the activation energy barrier which needs to be 
overcome. Solvent viscosity affects the diffusion coefficients of proteins and hence 
alters the collision frequency “Z” between reacting species with possible effect on the 
association rate constant. Proteins are randomly activated / deactivated by solvent 
molecules during their collision. The translational energy of the solvent molecules 
can be converted to protein’s vibrational energy. Additionally, the energy between 
different vibration modes can be redistributed during collision. In favorable cases, 
these changes are delivered to the binding site, the protein gets activated and ready 
to form a complex. If no interaction partner is available in the vicinity of an activated 
protein, further collisions with solvent molecules will deactivate the protein until the 
next activation.  
4.4.  Factors affecting dissociation rate constant 
Similarly to the association kinetics, dissociation kinetics theory also deals with 
the problem of diffusion in the presence of forces. Dissociation can be imagined as 
thermally activated particle escape from the potential well [2,11,12]: 
) RT G exp( A k off d ∆ =       E q .   1 0  
where A is the preexponential factor.   20
In case of a receptor-ligand complex, dissociation involves bond breaking, 
dehydration, conformational changes of R and L, new bond and solvent shell 
formation and spatial separation. In high viscosity solvents, spatial separation of the 
reactants can become a rate-limiting step. If proteins will get activated, while being in 
close proximity state, they will reassociate back to the complex. Therefore, the 
observed dissociation rate constant will be lower than predicted from Eq.10.  
5.  Comparison of interactions in two and three dimensions 
Interactions in two dimensions can be described using the same basic equations 
(Eq.4, Eq.6, Eq.8 and Eq.10) as used to analyze 3-dimensional interactions. 
However, the limitations introduced by the membrane interface affect the interaction 
rates and equilibrium constants. Therefore, the parameters, such as p, Z or ∆G
0 will 
be different for membrane anchored proteins in comparison to the same proteins in 
aqueous solution. 
5.1.  Collision frequency in 2D 
The collision frequency for neutral, spherical and uniformly reactive particles, R 
and L distributed on the membrane was calculated and reviewed by several authors 
[3,13-15] to be: 
D 2
L
D 2
R
D 2
L
D 2
R D 2 C C
) r / b ln(
) D D ( 4
Z
+
=
π
   E q .   1 1  
where b is the average distance between R and L and r is the encounter radius. 
CR
2D and CL
2D are the concentrations of the receptor and ligand respectively, DR
2D 
and DL
2D – the diffusion coefficients of receptor and ligand respectively. 
It has been suggested that reactions between ligands and cell surface receptors 
can be speeded up by nonspecific adsorption of the ligand to the surface followed by 
2-dimensional surface diffusion to the receptor, a mechanism called “reduction of 
dimensionality rate enhancement” [16-21]. While this is certainly true for certain 
interactions [18] available data on lateral diffusion rates, membrane-substrate 
affinities and calculations have suggested that the encounter rates of membrane-
linked proteins, compared to cytosol-located proteins are actually very similar [22,23]. 
The reduction of dimensionality rate enhancement is getting significant only when the 
reactants are much diluted and the average distance between them exceeds well 
above the dimensions of an average cell.   21
Eq.11 was derived assuming infinitely large plane and homogeneous protein 
distribution on the membrane. Membrane proteins in vivo are often localized in 
membrane microdomains stabilized by the cytoskeleton, segregated lipids and 
special raft proteins [24-29]. Also because of high protein concentration in the 
membrane, temporal domains with moving boundaries can form. This effect is often 
described as macromolecular crowding [30-35]. Extensive computer simulations 
have shown that the long-distance molecular mobility is reduced when a particle 
diffuses in an environment with various size mobile or immobile obstacles [36,37]. 
Even if the translational diffusion coefficient is reduced, collision frequency within a 
domain can increase, depending on the domain size, in comparison to infinite plane 
situation [38]. 
5.2.  The effect of surface exclusion 
Theoretical and experimental studies of the effect of excluded surface indicate 
that when the fraction of membrane surface occupied by membrane receptors 
exceeds a few percent, the equilibrium dissociation constant KD
exc, characterizing the 
interaction between macromolecules, may be markedly different than in the limit of 
high dilution KD
diluted [39]. For a simple bimolecular interaction the correction factor, 
kexc, is defined: 
RL
L R
exc diluted
D
exc
D k
K
K
γ
γ γ
= =     E q .   1 2  
where γR, γL and γRL are the activity coefficients of receptor, ligand and receptor-
ligand complex, respectively.  
At the limit of 50% surface occupancy KD
exc is one order of magnitude higher in 
comparison to KD
diluted. This effect scales up with number of membrane proteins 
involved in complex formation. For tetramer kexc>100 at 50% surface occupancy. 
Effect of excluded surface is present on the membranes as well as for soluble 
proteins (the effect of excluded volume). However, excluded surface conditions are 
readily realized for membrane anchored proteins. A relatively low number of 
receptors on the membrane or membrane microdomain is needed to occupy 
substantial fraction of membrane or membrane domain surface area. This situation is 
very hard to achieve in solution.   22
5.3.  Lifetime of the diffusional encounter complex 
The translational diffusion coefficient of membrane-anchored proteins is reduced 
as much as two orders of magnitude compared to soluble proteins because of the 
high membrane viscosity. This means that the lifetime of the diffusional encounter 
complex is also hundred times longer. Extracellular or cytoplasmic parts of the 
transmembrane protein are exposed to aqueous (low viscosity) solution, so vibrations 
and movements of these protein domains are not affected. Flexible proteins will have 
more time to optimize their structure to form a complex; therefore the orientation 
factor “p” will increase. Increased lifetime of the diffusional encounter also means that 
probability of receptor and ligand activation by solvent molecules during collision is 
much higher compare to the situation in solution.  
Cells can fine tune interaction efficiency by varying the viscosity of the 
membrane and corresponding diffusion coefficient of membrane anchored proteins 
by localizing them in different microdomains. Depending on membrane composition 
diffusion coefficients can vary between (1-10)E-8 cm²/s [40]. It decreases with 
increasing fraction of saturated alkyl chain lipids. Membranes in the gel phase are 
essentially immobile with diffusion coefficient in the order of 1E-11 cm²/s. In 
microdomain caveolae [41-43], integral membrane protein caveolin is attached to the 
actin cytoskeleton. This immobilization has many biologically important 
consequences including reduced membrane fluidity and the diffusion coefficient.  
5.4. Orientation 
The presence of the membrane anchors has only a minute effect on vibrational 
modes of the membrane anchored receptor side chains in comparison with soluble 
protein case. The situation is completely different for rotational movement. Soluble 
receptor chains freely rotate and collide with random orientation against each other. 
The membrane introduces a high potential energy barrier for rotation about the 
membrane anchor. This effect, also called hindered or restricted rotation, reduces the 
range of available rotation angles and orients membrane-anchored receptors. In 
contrast to the soluble protein case, the membrane anchored receptor and the ligand 
will not collide randomly oriented to each other, but with the preferred orientation. If 
this preorientation brings their binding sites to the interaction favorable positions, the 
orientation factor “p” will be drastically higher in comparison to the soluble protein 
case. The degree of “p” enhancement depends on residual rotational flexibility [39].   23
For the very inflexible proteins “p” enhancement due to membrane anchoring can be 
as much as two orders of magnitude compare to the soluble protein case. The 
opposite scenario is also possible. If the binding sites are not positioned in the 
interaction favorable way, membrane anchored proteins will always collide with 
wrong geometrical orientation and complex will not form. In this case “p” will be lower 
than in interaction between soluble proteins. The unfavorable orientation constrains 
of some membrane receptors (epidermal growth factor receptor, insulin receptor) in 
the cell can be eliminated by ligand binding from solution. This is the effective way to 
switch receptors on and off and activate them only when it is required. 
The electrostatic steering, mechanism to enhance association rate constant 
between the soluble proteins, will not be strongly pronounced for interactions on 
membranes. Membrane anchored proteins are already oriented and additional 
orientation due to electrostatic steering should have only minor effect on “p” and 
association rate constant in general. 
5.5. Activation  energy  and  ∆G° 
The effect of dimensionality on the potential energy landscape and the interaction 
diagram has not been systematically addressed. It was suggested, that anchoring the 
receptor and the ligand to the membrane would restrict their rotational and 
translational freedom as well as the diffusional properties, altering the reaction 
thermodynamics and binding kinetics. The ∆H
0, which is related to the bond 
formation, is probably the same. But the entropic contribution, ∆S
0, related to loss of 
degrees of freedom is clearly higher (less negative) in 2-dimensional case [39]. For 
example, formation of the RL complex between soluble R and L would result in the 
loss of six translational and rotational degrees of freedom in contrast to five for the 
membrane anchored proteins. Therefore, the change in system randomness and 
flexibility will be lower for 2-dimensional interactions. Rigidness of the polypeptide 
chain in solution and on the membrane can also be different, but these effects are 
difficult to quantify.  
Favorable orientation and increased lifetime of the encounter complex can 
drastically increase the collision efficiency and decrease the effective activation 
energy needed for interaction. Together with the movement restrictions imposed by 
presence of the membrane, Gibbs free energy landscape and a corresponding   24
interaction diagram can have different profile comparing soluble and membrane 
anchored proteins.  
5.6. Concluding  remarks 
It is very likely, that cells use effects caused by receptor membrane anchoring to 
optimize interactions between membrane proteins. It is apparent that solubilization 
with detergents may disrupt the membrane protein-protein interactions of interest. 
Elimination of preferred orientation, shorter lifetime of the encounter complex and the 
substantial dilution can markedly shift the equilibrium towards dissociation. The 
change in entropy (and corresponding ∆G
0) associated with complex formation will 
be different for proteins confined to a membrane than for proteins in solution. From 
what was said above it is clear that the binding affinity between receptor and ligand, 
localized on the membrane, cannot be easily determined by using soluble forms of 
the membrane proteins. 
6.  Coupled three and two dimensional interactions 
When the receptors and the ligand are distributed both on the surface of the 
membrane and in the aqueous phase, two alternative mechanisms of bimolecular 
reactions differing in the dimensionality of reaction space are possible. These are the 
3-dimensional ligand binding to the membrane receptor and the 2-dimensional 
interaction between membrane receptors. Although both monovalent and multivalent 
ligands can bind to cell surface receptors, only multivalent ligands have the ability to 
simultaneously bind multiple receptors, that is, to crosslink receptors. The amount of 
crosslinked receptors, in contrast to ligand binding, is recognized to be the basic 
principle for signal transduction through cytokine receptors and growth factors [44-
48]. Crosslinked receptors can be considered a signaling unit. 
6.1.  Bivalent ligand induced receptor crosslinking 
The ability of bivalent ligands to aggregate receptors is shown schematically in 
Figure 2. Receptors, which are linked to other receptors, are said to be crosslinked or 
dimerized. The apparent KD of bivalent ligand binding to membrane anchored 
receptors is increased due to multivalent interactions [13,49-55] and this affinity 
increase is modulated by the receptor density on the membrane [49,50,56-63].    25
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Figure 2   Ligand  induced  receptor crosslinking. (A) Homodimeric ternary 
complex: ligand crosslinks two identical membrane anchored receptors. 
(B) Heterodimeric ternary complex: ligand crosslinks different 
membrane anchored receptors.  
6.2. Homodimerization 
Ligand induced receptor crosslinking occurs in two steps. The ligand binds to one 
receptor chain, with the equilibrium dissociation constant K1
3D, to form a binary 
complex RL. In a subsequent step RL recruits a second receptor chain to form the 
ternary complex RLR (Figure 3). The affinity of the second step, which is a 
bimolecular association event constrained to the two dimensions of the membrane, is 
given by dissociation constant K2
2D, which has units of molecules/µm² [64].  
membrane
K1
3D
K2
2D
R RL RLR  
Figure 3  Schematic of two step ligand induced receptor homodimerization 
The two interactions at equilibrium can be described:  
] RL [
] L ][ R [
K
D 3
1 =  
] RLR [
] R ][ RL [
K
D 2
2 =   ] RL [ ] RLR [ * 2 ] R [ ] R [ 0 − − =  Eq. 13 
Where [L] is the 3-dimensional concentration [mol/l] of the ligand and [R], [RL], 
[RLR] and [R]0 are the 2-dimensional concentrations [mol/mm²] of the receptor, the 
receptor-ligand complex, the crosslinked receptors and the total amount of receptor, 
respectively.  
Simulated [RLR], [RL] and [R] populations as a function of ligand concentration 
[L] are presented in Figure 4. Bell-shaped crosslinking curve is a characteristic   26
feature of homo and heterodimeric receptors that are activated by ligand induced 
dimerization. At low concentration of soluble ligand, most of the receptors are not 
occupied and the singly-bound ligand has a lot of free receptors available for 
crosslinking (Figure 4A and B). The amount of receptor crosslinking increases with 
increasing ligand concentration. When the concentration of soluble ligand increases 
even more, free receptor can be either occupied by ligand binding from solution or 
crosslinked by binary receptor-ligand complex. The two receptor chains involved in 
signaling complex are identical, so at very high concentration of the ligand, the 
system is forced to the state in which each receptor molecule is occupied by 
separate molecule of ligand (Figure 4C), such that, at equilibrium, virtually all 
receptor molecules are present in RL complexes. High concentration of the soluble 
ligand has a self-inhibiting effect, because receptor crosslinking, which initiates 
signaling, is prevented and receptor is present in the inactive state of binary complex 
(Figure 4C). There is, therefore, little formation of the ternary complex at either very 
low or very high concentration of ligand in solution. The concentration of the ligand 
that corresponds to the peak or mid point of the bell shaped curve equals K1
3D, the 
affinity of ligand binding to the first receptor chain. Figure 4C shows that initial 
binding of L to R and the self-inhibition, which occurs at very high concentrations of L 
are both governed by K1
3D, so at [L]= K1
3D these effects are equally balanced and the 
concentration of [RLR] is maximal.  
The amount of [RLR] at the peak of the bell shaped curve is another measure of 
how effective ligand induced receptor dimerization is. Equations from [60] predicts 
that the height of the peak is a function of K2
2D and [R]0 but not K1
3D. [R]0 has to be 
high relative to K2
2D to induce majority of the receptors to dimerize. For example, to 
dimerize 80% of the receptor molecules at [L]= K1
3D, [R]0/ K2
2D, must be equal 80.  
   27
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Figure 4  Dependence of the concentration of the RLR complex, expressed as a 
fraction of total receptor, [R]0, on the ligand concentration for a value 
[R]0/K2
2D = 10.  (A) Schematic of the dominant receptor states at 
different ligand concentration. (B) The ligand concentration that 
produces maximal level of RLR and therefore defines the peak of the 
bell shaped curve is equivalent to K1
3D, the width at half maximal RLR is 
designated as WHM. (C) The same simulation as shown in (A), but 
showing how each of the forms of the receptor, RLR (black), RL (red) 
and R (green) varies with the ligand concentration.  
The width of the bell-shaped curve at half maximum (WHM) is a measure of the 
ligand concentration range at which at least half maximal amount of crosslinked 
receptors is present. As it was calculated by Perelson and Delisi [60], the magnitude 
of the WHM is governed by the effective affinity of the second step in receptor 
crosslinking, which is the affinity of RL binding to R on the membrane. It is a function 
of [R]0*K2
2D, but not of K1
3D (Figure 5A). A low K2
2D and a high [R]0 both favor a wide 
WHM (Figure 5B). This is because the more thermodynamically stable RLR, the 
lower concentration of RL is required to form it, and the higher concentration of L is 
required to disrupt the RLR complex. The experimental observation of a very broad 
WHM would therefore indicate that the total concentration of receptor on the cell 
membrane, [R]0, is much larger than K2
2D. 
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Figure 5  Influence of K1
3D and K2
2D on the shape of the RLR crosslinking curves. 
(A) For fixed values of K2
2D and [R]0 ( [R]0=10*K2
2D), increasing or 
decreasing  K1
3D by a factor of 10 causes the mid point to shift to 
correspondingly higher or lower ligand concentrations. The width and 
the amplitude of the curve are unaffected. (B) For a fixed value of K1
3D 
and [R]0, decreasing K2
2D by increments of 10 over the range of values 
[R]0/K2
2D = 1 (black);  10 (red);  100 (green) increases the width and 
amplitude of the RLR curve without altering the mid point. (An identical 
result would be obtained if [R]0 were increased at constant K2
2D.)  
Only very few studies analyzed bivalent fluorescent ligand binding titration curves 
with above discussed two-step interaction model (Figure 3) [21,65-68]. The major 
difficulty associated with this type of data analysis is the requirement to parameterize 
the surface density of unoccupied receptors. In these studies, the density was 
calculated by using fluorescent standard or correlating the fluorescence signal with 
radioimmunoassay. 
6.3. Heterodimerization 
The same line of arguing is valid in the case when the ligand crosslinks different 
receptors, R1 and R2. Receptor crosslinking can be imagined as a two step process: 
3-dimensional ligand binding to R1 or R2 from solution and 2-dimensional 
crosslinking as depicted in Figure 6.    29
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Figure 6  Schematic of two step ligand induced receptor heterodimerization. 
The equilibrium dissociation constants of this system are defined as: 
] L 2 R [
] L ][ 2 R [
K
D 3
1 =  
] 1 LR 2 R [
] 1 R ][ L 2 R [
K
D 2
2 =  
] 1 LR 2 R [
] 2 R ][ L 1 R [
K
D 2
3 =  
] L 1 R [
] L ][ 1 R [
K
D 3
4 =   
] L 2 R [ ] T [ ] 2 R [ ] 2 R [ 0 − − =   ] L 1 R [ ] T [ ] 1 R [ ] 1 R [ 0 − − =  Eq.  14 
Where [L] is the 3-dimensional concentration [mol/l] of the ligand and [R1], [R2], 
[R1L],  [R2L],  [R2LR1],  [R2]0 and [R1]0 are the 2-dimensional concentrations 
[mol/mm²] of the receptors, the receptor-ligand complexes, the crosslinked receptors 
and the total amount of the receptors, respectively.  
Let us assume, without simplifying the system, that the ligand affinity towards R2 
is hundred times higher than for R1, i.e. K1
3D=0.01 K4
3D. Simulated [R2LR1], [R2L], 
[R1L],  [R2] and [R1] populations as a function of the ligand concentration [L] at 
stoichiometric concentrations of [R1]0 and [R2]0 are presented in Figure 7. Similarly 
to the situation, where ligand crosslinks identical receptors, the receptor crosslinking 
curve for non-identical receptors is also bell-shaped. At low ligand concentration, 
bound ligand can crosslink many unoccupied receptors and preferably will be present 
in R2LR1 state. When the ligand concentration continues to increase unoccupied 
receptor R2 or R1 can bind ligand L from solution or they can be crosslinked by 
singly bound receptor-ligand complex R2L and R1L. As [L] continues to increase, 3-
dimensional binding will more and more dominate over 2-dimensional crosslinking, 
and finally only monovalently bound R2L and R1L complexes will be present. As can 
be seen from the Figure 7B and proven mathematically [69], peak of ligand induced 
R2 and R1 crosslinking appears at ligand concentration sqrt(K1
3D*K4
3D). Initial binding 
of L to the membrane is governed by the high affinity interaction with R2 (K1
3D) self-
inhibition of receptor crosslinking is governed by low affinity interaction K4
3D between 
L and R1. So at [L]= sqrt(K1
3D*K4
3D) these effects are balanced and the concentration 
of RLR is maximal.   30
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Figure 7  Dependence of the concentration of the R2LR1 complex, expressed as 
a fraction of the maximum theoretical value, on the ligand concentration 
for a value [R1]0=[R2]0= 10*K2
2D and K1
3D=0.01 K4
3D. (A) Schematic of 
the dominant receptor states at different ligand concentration. (B) The 
ligand concentration that produces maximal level of RLR and therefore 
defines the peak of the bell shaped curve is equivalent to square root of 
(K1
3D*K4
3D), the width at half maximal R2LR1 is designated as WHM. 
(C) The same simulation as shown in (A), but showing how each of the 
forms of the receptor, R2LR1 (black), R1L (red), R2L (green), R1 (blue) 
and R2 (cyan) varies with the ligand concentration. 
Homo- and heterodimerization curves share similar features. For example, at 
fixed K2
2D, K3
2D and [R2]0=[R1]0 increasing or decreasing K1
3D and K4
3D by the same 
factor shifts the mid point of the crosslinking curve without altering the amplitude and 
width at half maximum (Figure 8A). Similarly, at fixed K1
3D, K4
3D and [R2]0=[R1]0, 
decrease of K2
2D increases the amplitude and WHM of the crosslinking curve without 
altering the mid point (Figure 8B)   31
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Figure  8  Influence of equilibrium dissociation constants on the shape of the 
R2LR1 crosslinking curves. (A) For the fixed values of K2
2D, K3
2D and 
[R2]0=[R1]0=10*K2
2D, increasing or decreasing K1
3D and K4
3D by a factor 
of 10 causes the mid point to shift to correspondingly higher or lower 
ligand concentrations. The width and the amplitude of the curve are 
unaffected. (B) For fixed values of K1
3D, K4
3D and [R2]0=[R1]0, 
decreasing K2
2D by increments of 10 over the range of values [R1]0/ 
K2
2D = 1 (black); 10 (red); 100 (green) increases the width and 
amplitude of the crosslinking curve without altering the mid point.  
However, there are a few important differences between ligand induced homo- 
and heterodimerization. At fixed 2-dimensional equilibrium dissociation constants and 
receptor surface densities, the rise of the bell shaped curve is dominated by the 
affinity towards the high affinity receptor R2. The second part, crosslinking self-
inhibition, is dominated by affinity towards low affinity receptor R1. Therefore, WHM 
can be effectively varied by decreasing K1
3D and increasing K4
3D (Figure 9A). The 
broader the WHM, the lower the maximum response sensitivity to ligand 
concentration. The position of the mid point is not affected and the amplitude is only 
slightly higher for different combinations of K1
3D and K4
3D (Figure 9A).  
Another important difference between homo- and heterodimerization is that the 
fraction of crosslinked receptors can be maximized by increasing the 2-dimensional 
concentration of only one of the subunits (Figure 9B). For example, an excess of R1 
in comparison to R2 shifts the K2
2D equilibrium towards ternary complex. Additionally, 
self-inhibition at high ligand concentrations will be buffered by excess R1 and higher 
[L] will be required to compete 2-dimensional interaction between receptors by 3-
dimensional ligand binding from solution (Figure 9B).    32
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Figure  9  Influence of equilibrium dissociation constants on the shape of the 
R2LR1 titration curves. (A) For fixed value of K2
2D,  K3
2D and 
[R2]0=[R1]0=10*K2
2D, decreasing K1
3D and increasing K4
3D by a factor of 
10 or 100 increases WHM of the crosslinking curve without altering the 
mid point. The amplitude is almost unaffected. (B) For fixed values of 
K1
3D, K4
3D and [R2]0=K2
2D, increasing [R1]0 by increments of 10 over the 
range of values [R1]0/K2
2D = 1 (black); 10 (red); 100 (green) increases 
the WHM and amplitude of the crosslinking curve without altering the 
mid point. An identical result would be obtained if [R2]0 was increased 
at constant [R1]0. 
6.4. Concluding  remarks 
The dependency of the ligand-induced receptor crosslinking on logarithm of 
ligand concentration is a bell shaped curve. The position of the mid point is effectively 
varied by 3-dimensional equilibrium dissociation constants. The amplitude and width 
at half maximum are mainly governed by 2-dimensional interactions. Significant 
amounts of ternary complexes are achieved only if receptor density on the 
membrane is much higher than 2-dimensional equilibrium dissociation constant. This 
situation is readily realized in case of membrane anchored proteins. The relatively 
low number of receptors on the membrane or membrane microdomain is needed to 
reach situation, where average distance between receptors gets comparable with 
their dimensions. This situation is very hard to achieve in solution.  
Ternary complex between different receptors gives additional flexibility to the 
system and provides possibility to manipulate the shape of the crosslinking curve. If 
ligand affinity towards R2 and R1 is different by several orders of magnitude, the 
amount of crosslinked receptors in the area of few log units around the mid point will 
be essentially independent on the ligand concentration. This is an attractive feature   33
for pharmaceutical applications. Large excess of one of the receptors has a buffering 
effect, which leads to a increased amplitude and WHM of the crosslinking curve.  
The crosslinking of the cell surface receptors by interaction with cytokines has 
been shown to be an important event in triggering cellular responses. It is very likely 
that cells use above-described crosslinking properties to optimize their 
communication and transmembrane signaling. For example, it can explain how 
differential signaling is realized by different cytokines through shared receptors. High 
affinity ligands will crosslink more receptors and initiate stronger cellular responses in 
comparison to low affinity ones. If different threshold values of receptor crosslinking 
are required to initiate different responses, lower concentrations of high affinity 
ligands will be required to activate them. It should be emphasized that amount of 
receptor crosslinking can not be higher than maximum value determined by receptor 
densities on the membrane and 2-dimensional equilibrium dissociation constants. 
Therefore some low affinity ligands will not be able to initiate responses, which 
require high crosslinking threshold; no matter how much ligand concentration (dose) 
is increased. Additionally, different densities of receptors in the membrane can 
explain why different cells or cells at different stage of differentiation respond 
differently to the same cytokine. For a given ligand concentration, the amount of 
receptor crosslinking will depend on the 2-dimensional density of receptors on the 
membrane. Different cells can have different receptor densities and will start different 
responses or same responses with different signaling intensity.  
Thus, it is essential to measure 2-dimensional interaction rate and equilibrium 
dissociation constants in order to understand receptor crosslinking and differential 
signaling. Experimental observation of membrane receptors in vitro and in vivo, 
differentiation between free and crosslinked state is of primary importance in the field 
of cellular signaling.  
7.  Experimental techniques to study interactions on membranes 
In recent years, the combined advances in fluorescence labeling, imaging 
methods and technical equipment provided the possibility for detecting and analyzing 
protein-protein interactions on membranes in real time with high sensitivity and high 
temporal as well as spatial resolution. Cost-effective computing resources have 
become available to handle large amounts of data, and powerful software packages 
are easily obtainable for analyzing digital information. Therefore, biomolecular   34
interactions and translocations on membranes now can be routinely observed in 
living cells or on model membranes.  
7.1.  Diffusion and mobility techniques 
Fluorescence recovery after photobleaching (FRAP) [40,70-77], fluorescence 
correlation spectroscopy (FCS) [29,40,77-90] and single particle tracking (SPT) [91-
97], belongs to the family of methods that yield rates of diffusion and active transport 
from measurements of spontaneous thermally driven microscopic fluctuations in the 
positions of molecules or their local densities. The diffusion coefficient (D) of the 
freely diffusing membrane protein is dominated by the high viscosity of the 
membrane and the radius of the transmembrane segment. The aqueous portion 
usually does not significantly contribute to the D value [98]. Protein–protein 
interactions or binding to a scaffold may slow down or immobilize a protein, and 
collisions with other membrane-anchored receptors hinder free diffusion. Commonly, 
above-mentioned techniques allow to determine whether protein mobility is rapid or 
slow, whether binding interactions are present, whether an immobile fraction exists, 
or how a particular treatment (such as ligand binding or a mutation in the protein of 
interest) affect these properties. Proper interpretation of the data also yields 
information about binding interactions of fluorescently tagged molecules, including 
the number of binding states and the binding strength of each state. 
 
Figure 10  Mechanisms  that reduce the mobility of membrane proteins. (a) An 
unrestricted membrane protein freely diffuses in the lipid bilayer of the 
membrane. (b) Membrane proteins bound to an immobile matrix (e.g. 
cytoskeleton) become immobilized. (c) Large multimeric protein 
complexes diffuse at significantly reduced rates within the bilayer 
compared with monomeric proteins with small transmembrane radii. (d) 
Corralling of a membrane protein by aggregated or matrix bound 
membrane proteins effectively reduces the long distance mobility of the 
protein. (taken from [40])   35
However, it is rather challenging and imprecise to determine interaction rate 
constants and equilibrium constants based on diffusion coefficients of membrane 
proteins. First, the unknown geometry of the membrane leads to a uncertainty in 
protein mobility by a factor of two or more. Second, the diffusion of membranes is 
often anomalous and measurement usually does not permit to distinguish between 
subdiffusion (Figure 10d) and a mixture of fast moving monomers and/or slow 
moving complexes (i.e. multiple populations having different diffusion coefficients) 
(Figure 10a and c).  
7.2.  Direct interaction detection using spectroscopic probes 
Interaction between membrane proteins can be sensed more reliably by labeling 
both proteins with the spectroscopic probes or fluorescent proteins. Interactions can 
be detected using various experimental approaches. (i) During the course of the 
interaction both fluorescent labels are colocalized in the same membrane area and 
can be detected by standard fluorescence microscopy. However, colocalization does 
not necessarily mean interaction. (ii) Dual-colour cross-correlation analysis 
[78,81,89,99], a conceptual modification of FCS using two spectrally separable 
fluorescent labels, yields a considerable improvement in signal specificity for 
heterogeneous systems where molecular interactions of different species are to be 
observed. In principle, any molecular association and dissociation can be studied by 
simultaneous detection of two spectrally separated fluorophores, following the 
amplitude of the cross-correlation function in real time during the reaction. (iii) 
Fluorescence resonance energy transfer (FRET) [80,100-102] is one of the most 
elegant methods to quantify protein-protein interactions by measuring the rate of non-
radiative transfer from the excited state of a fluorophore attached to one protein 
(donor) to another fluorophore attached to a binding partner (acceptor). The rate of 
energy transfer strongly depends on the distance between the donor and acceptor 
probes and their relative orientation. The FRET efficiency is usually determined by 
measuring the quantum yield or the fluorescence lifetime of the donor probe in the 
absence and presence of the acceptor probe, respectively. FRET proved particularly 
suitable for detecting dimerization and complex formation events in signaling 
networks [103-109]. FRET techniques usually provide qualitative information about 
dimerization events. Experimental limitations such as relatively high background of 
cellular autofluorescence, direct excitation of the acceptor, sensitivity to   36
photobleaching frequently biases the interaction experiments and require extensive 
correction factors [110-112]. 
8.  Problem of quantitative detection 
The interaction between receptor chains on the cell surface is constrained to the 
2-dimensions of the membrane and thus the  D K  has a dimension [molecules/µm²] or 
[mol/µm²]. Parameterization of receptor concentration on the membrane is a 
necessary requirement for quantitative studies. Different mathematical ways were 
suggested how to relate 2-dimensional interaction rate constants with readily 
measurable 3-dimensional rate constants. These are: (i) Introducing dimensionless 
rate constants [19] and corresponding equilibrium dissociation constants [113]; (ii) 
introducing 3D to 2D conversion coefficient [13,23,58,59]; (iii) use of interaction rate 
constant dimension [s
-1] for 2-dimensional association rate constant [62,114] or 3-
dimensional units like [M
-1] for species placed in vesicles or cells, which are 
dispersed in aqueous solution [115]. Therefore, theoretical results concerning 
interactions in 2-dimensions were hardly confirmed experimentally. The complexity of 
in vivo systems usually does not allow drawing solid conclusions about determinants 
of protein-protein interactions on membranes. The requirement to parameterize 2-
dimensional concentrations of interacting proteins as well as their complex was a big 
obstacle to determine 2-dimensional equilibrium dissociation constants (Eq.4). 
Fluorescent standards and correlation with radioimmunoassay are not readily 
available and does not offer real time monitoring.  
Quantitative understanding of how membrane proteins function requires that the 
interactions of their components are monitored as they occur. Perturbations of the 
environment in which they operate, either before, during or after their assembly, may 
also give mechanistic insight. The possibility not only to monitor, but also to change 
2-dimensional concentrations of receptors during the course of the experiment would 
be a powerful approach to dissect interactions on membranes. A systematic study of 
protein-protein interactions in well defined in vitro lipid bilayer would provide a firmer 
basis for the interpretation of experimental results in cells. Solid phase detection 
techniques, measuring time-resolved kinetics on a surface or in a layer, allow 
questions of size, valency, orientation and receptor density to be experimentally 
addressed.   37
9. Objectives 
Protein-protein interactions on and within biological membranes play crucial roles 
in variety of cellular processes, and in particular in signal transduction. Despite 
advances in experimental techniques little has been done to quantitatively asses 
determinants of protein-protein interactions in two dimensions. The objective of this 
work was to establish detection techniques for studying ligand induced receptor 
assembling on a mechanistic and quantitative level in vitro. Based on this approach, 
the role of dimensionality and receptor orientation on interferon (IFN) induced 
interferon receptor (ifnar) crosslinking was quantitatively addressed. This study can 
be divided into following steps: 
● Establishing an optical solid phase detection approach to quantitatively study 
lateral interactions on model lipid membranes in vitro. 
● Applying this detection technique to study type I interferon (IFN) induced 
heterodimerization of the interferon receptor (ifnar) extracellular domains.  
● Development of the mechanistic model for IFN induced ifnar assembling and 
determination of the 2-dimensional interaction rate and equilibrium dissociation 
constants involved in complex assembling.  
● Exploring the influence of ifnar orientation on the 2-dimensional interaction rate 
and equilibrium dissociation constants.   38
10.  Biological model system 
10.1.  Ifnar and differential signaling 
Type I interferons (IFNs), first discovered by Isaacs [116,117], are a family of 
cytokines which act early in the innate immune response. IFNs initiate different signal 
transduction pathways leading to a pleiotropic response with antiviral, antiproliferative 
and immunmodulatory effects [118-129].  
 
Figure 11 Schematic of type I interferon signaling. Binding of IFN crosslinks its 
common receptor chains, ifnar2 and ifnar1, and induces trans-
phosphorylation of cytoplasmic domains, JAK kinases and associated 
STAT transcription factors. This leads to the activation of several signal 
transduction pathways.  
The type I IFN receptor (ifnar) consists of 2 subunits: the high affinity subunit 
ifnar2 and the low affinity subunit ifnar1 (Figure 11). Ligand binding induces the 
assembling of the active receptor complex, which leads to the phosphorylation of 
tyrosine residues located in the intracellular domain of each receptor chain. These 
tyrosine phosphorylation events are carried out by Janus kinases (JAKs), JAK1 and 
TYK2, which are themselves activated by tyrosine phosphorylation. The subsequent 
substrates of the JAK1 and TYK2 are the signal transducer and activator of   39
transcription (STAT) proteins that are recruited and phosphorylated at the 
phosphotyrosines located at the cytoplasmic tail of receptor. Modified STATs are 
released from the cytoplasmic region of the receptor subunits to form homo- or 
heterodimers. Dimerized STATs are rapidly translocated to the cell nucleus and 
interact with specific regulatory elements to induce target gene transcription. The 
interferon-induced heterodimerization of ifnar2 and ifnar1 appears to have two 
purposes: to bring the JAKs into proximity and allow transphosphorylation, and to 
form a scaffold for the binding of STAT proteins. 
10.2. Differential  signaling 
There are more than 10 different type I interferons [121] and all of them initiate 
different activity patterns by recruiting the same pair of receptor subunits. Different 
cell lines or cells at different stages of differentiation respond differently to the same 
interferon. Type I interferons do not enter the cell, so ifnar receptor crosslinking is 
essential in determining which signal transduction pathway will be initiated [13,130-
132]. Initially it was suggested that different interferons form structurally different 
complexes with its shared receptor. The ifnar subunits crosslinked with different 
interferons bring cytoplasmic domains to different degree of proximity and orientation 
against each other. This results in different tyrosine phosphorylation pattern and 
different times will be required to phosphorylate them. Finally, different STATs will be 
recruited and different cellular responses initiated. Additionally, signaling complexes 
with different stoichiometry of ligand and receptor subunits have been suggested to 
be responsible for differential signaling. Also it was found that in some cases after 
receptor crosslinking large signaling complexes are formed on the intracellular side 
with scaffold, signaling, docking and effector proteins. Different combinations of these 
proteins were proposed to initiate different signals. Each cell can have a different set 
and different concentration of these proteins, which would define signaling specificity 
[131,133-136] and explain why different cell lines respond differently to the same 
interferon. However, the crystal structures of different interferons appeared to be very 
similar and the main difference between them were different affinities and interaction 
rate constants towards receptor subunits. Therefore, kinetics and equilibrium 
properties of crosslinking dynamics on membranes were suggested to be responsible 
for differential signaling. Signaling intensity is proportional to the amount of 
phosphorylated STATs and probably different threshold concentrations are required 
to initiate different responses. The amount of phosphorylated STATs depends on the   40
amount of crosslinked receptor. As it was presented in chapter 5.3, it depends on 
ligand concentration in solution, concentrations of the receptor subunits on the 
membrane and corresponding 3- and 2-dimensional equilibrium dissociation 
constants. Having receptors in different compartments with different densities could 
help to code the response to ligand concentration. Membrane compartments with 
high and low receptor density will have different amounts of crosslinked receptors at 
the same ligand concentration [137-139]. The kinetics of receptor assembling and the 
lifetime of the ternary complex explain differential signaling in terms of kinetic 
proofreading [140-144]. The cytoplasmic receptor domains must undergo a series of 
modifications before generating a productive signal. If a ligand dissociates before 
these modifications are completed, the generation of a productive signal is 
prevented. When many steps are involved, then slowly dissociating ligands will 
generate stronger cellular responses than rapidly dissociating ones. In case of fewer 
modification steps ligands with different kinetic properties may trigger similar 
responses or even responses in which the expected sensitivity to ligand-receptor 
binding kinetics is reversed. In conclusion, the 2-dimensional interactions between 
ifnar subunits can be largely responsible for defining specificity of differential 
signaling. Therefore, investigation of IFN induced ifnar crosslinking is important not 
only from fundamental understanding of 2-dimensional interactions point of view, but 
it is also a prerequisite for systematic manipulation of receptor mediated responses in 
therapeutical applications. 
10.3.  Model in vitro system 
Several striking features make the IFN-ifnar interaction a particularly suitable 
model system for studying 2-dimensional interactions: First, the receptor subunits 
interact independently from each other with the ligand, and do not interact in the 
absence of the ligand as proposed for other cytokine receptors. Second, only a 
heterodimeric ternary complex was detectable, involving ifnar2, ifnar1 and IFN in a 
1:1:1 stoichiometry. Thus, the receptor heterodimerization is triggered by a ligand 
binding from solution and 2-dimensional interactions can be probed by the 
dissociation kinetics of the ligand away from the membrane.  
There is no interaction between ifnar intracellular and extracellular domains. One 
transmembrane helix allows reducing overall complexity to only the extracellular   41
domains (Figure 12). A decahistidine-tag was fused to the C-terminus instead of the 
transmembrane helix for tethering the proteins to the membrane (see chapter 11).  
 
 
Figure 12  Model in vitro system to study IFN induced ifnar assembling.  
11. Solid  phase  detection 
2-dimensional concentrations of the biomolecules on surfaces are quantitatively 
detected in a straightforward manner by solid phase label-free detection techniques. 
These techniques sense changes in optical or acoustic properties at the interface 
layer above the surface induced by molecules binding to or dissociating from the 
surface, and are particularly suitable to study interactions between soluble and 
membrane-anchored proteins. 
Solid phase detection of molecular interactions offers a substantial advantage 
over investigations in bulk solution. If a receptor is immobilised on the sensor 
surface, the subsequent binding of the ligand is detected by a change of the optical 
or acoustic properties of the sensor surface, without an additional separation step. 
From the practical point of view, additional important advantages come into play. 
These techniques can be combined with modern fluid handling devices, thus not only 
equilibrium signals, but also interaction kinetics can be measured and quantitatively 
analyzed. Measurements require minimal sample volumes and receptor quantities 
and furthermore can be fully automated resulting in a substantial increase of 
sensitivity and reproducibility of signal detection. 
Different physical phenomenons are employed to detect molecular binding to the 
surface, which will be discussed in more detail in the following chapters.    42
11.1.  Quartz crystal microbalance with dissipation monitoring 
The quartz crystal microbalance with dissipation monitoring (QCM-D) [145,146] 
measures mass and viscosity changes in processes occurring at or near surfaces, or 
within thin films. The instrument measures the resonance frequency and energy 
dissipation of a piezoelectric quartz crystal. The resonance frequency changes 
linearly with the amount of biomolecules deposited on the crystal surface. The energy 
dissipation at the resonance frequency changes with the viscosity / elasticity of the 
material in contact with the crystal surface. Adsorbed biomolecular film may consist 
of a considerably high amount of water, which is sensed as an additional mass. By 
measuring the dissipation it becomes possible to judge if the adsorbed film is rigid or 
water rich (soft) which is not possible by detecting at the frequency response alone. 
The amount of water may be very different depending on the kind of molecule and 
the type of surface studied.  
QCM-D is one of the few solid phase detection techniques, where kinetics of 
protein adsorption and subsequent structural rearrangements can be directly 
measured and analyzed simultaneously in real time [147]. However, the resonance 
frequency and the energy dissipation are not independent parameters. The 
resonance frequency is dependent on the buffer viscosity and conformational 
changes change not only the dissipation but also the resonant frequency. 
Commercial QCM-D devices have lower detection limit of 50 pg/mm² and can detect 
submonolayer surface coverage by small molecules or protein films. At the upper 
end, they are capable of detecting whole cells bound to the surface [148] or 
biomolecular layers with thicknesses up to 10µm. 
11.2.  Optical reflectometric techniques  
Optical techniques are relatively simple, non-destructive and non-invasive, do not 
require vacuum and can be applied in any transparent media and are the natural 
choice to study real time protein-protein interactions in vitro and in vivo. Optical label-
free detection is based on the fact that biomolecules have different refractive index 
than aqueous solution. Proteins, bound to the surface, replace the buffer and change 
effective refractive index of the solid-liquid interface. This refractive index change is 
the main parameter which is used to sense biological interactions by variety of optical 
detection schemes. Additionally, the thickness of the biomolecular layer and the   43
absorption of adsorbed molecules can be used as readout to monitor biomolecular 
interactions in real time. 
11.2.1. Ellipsometry 
Historically ellipsometry was the first method introduced to quantitatively 
investigate thin layers of adsorbed biomolecules at solid-liquid interfaces. 
Ellipsometry is a technique that can be used to measure the thickness and refractive 
index of the thin transparent or semi-transparent films [149]. The technique utilizes 
the polarization change of light upon reflection from a surface (Figure 13). The 
polarization change is defined by the ratio of the total reflectance coefficients, Rp and 
Rs, for light polarized parallel (p) and perpendicular (s) to the plane of incidence, 
respectively.  
 
Figure 13 Principle of ellipsometry. Properties of biomolecular film are calculated 
by measuring polarization changes before and after reflection from the 
surface.  
This ratio can also be expressed in terms of ellipsometric angles Ψ and ∆. 
) exp( tan ∆ ⋅ Ψ = i
R
R
s
p      E q .   1 5  
In short, ∆ is the difference in phase shift between p-wave and s-wave of the light 
before reflection from the surface minus the difference in the phased shift after 
reflection from the surface. TanΨ is the corresponding amplitude ratio of Rp and Rs. 
Ellipsometry is not a direct technique. Thickness and refractive indexes are 
calculated from measured ellipsometric angles Ψ and ∆ using optical models. The 
final result depends on the model used for data evaluation.  
The surface mass density, Γ, for an adsorbed protein layer can be calculated 
from the thickness and refractive index using de Feijtert’s formula [150]:   44
dc dn
n n d ) ( 2 1 − ⋅
= Γ       E q .   1 6  
where d is the thickness of the layer, n1 is the refractive index of the adsorbed 
layer, n2 is the refractive index of the solution and dn/dc is the refractive index 
increment of the solute. For proteins, dn/dc is 0.18  cm³g
-1 and for lipid layers 
0.16 cm³g
-1 [151].  
The traditional technique used in real-time ellipsometric studies is null 
ellipsometry presented in Figure 14. Positions of the polarizer, compensator and 
analyzer (another polarizer) are adjusted to get minimum (null) signal to the detector 
and these values are used to calculate the ellipsometric angles [149] and the 
corresponding thickness of the biomolecular layer.  
 
Figure  14  Schematic of a nulling ellipsometer. The optical components are 
adjusted to minimize (null) the signal reaching the detector. 
In more advanced studies such parameters as tilt angle of molecules in a 
monolayer, density of a protein layer, mass distribution (density gradient) over a 
protein layer, lateral mass distribution (surface clustering) can be determined. Such 
studies require state of the art spectroscopic and imaging ellipsometers [152,153] as 
well as advanced optical modeling.  
11.2.2. Interferometry 
Reflectance interferometry (RIf) measures the intensity of the reflected light, 
which is modulated by the thin layer interference (Figure 15A) [154-158]. 
For perpendicular incidence and a single non-absorbing layer the reflected 
intensity I is equal: 
) / nd 4 cos( I I 2 I I I 2 1 2 1 λ π + + =     Eq.  17   45
where I1 and I2 are the reflected intensities from the bottom and top interfaces of 
the thin film, d is the physical thickness of the film, n is the refractive index and λ is 
the wavelength of the incident light.  
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Figure 15  (A) Principle of the detection of affinity interactions by reflectance 
interferometry. n and d are the refractive index and the average 
physical thickness of the layer, respectively, I1 and I2 are the intensities 
of the light beams, reflected at the interfaces of the layer. (B) Spectral 
reflectance pattern due to constructive and destructive interference of 
the reflected radiation (green). Upon ligand binding, interference pattern 
shifts to the longer wavelengths (blue). The interaction is detected by 
monitoring the position of the extremum (horizontal arrow) of the 
interference pattern or by change in intensity at a given wavelength 
(vertical arrows).  
A typical spectral interference pattern showing the modulation of intensity with 
cos(1/λ) is presented in Figure 15B. During the protein deposition on the surface, the 
optical thickness (n*d) of the interference layer increases and interference pattern 
shifts to longer wavelengths (Figure 15B). This shift can be detected by measuring 
the position of the interference pattern maximum or by change in intensity at given 
wavelength. 
Interferometric detection can be readily realized with standard light sources, 
detectors and fiber optic components (Figure 16A). White light from a tungsten 
halogen lamp is delivered to the surface via a bifurcated optical fiber. The intensity of 
the reflected light is detected by a spectral or non-spectral detector. Flow through 
conditions allows real time detection of binding kinetics. Spectral shifts or intensity 
changes, monitored in real time, are converted into a binding curve (Figure 16B). 
   46
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Figure 16  (A) Schematic of reflectance interferometric detection. (B) Typical 
example of the binding curve.  
11.3. Evanescent  field techniques 
When light reaches the interface between two mediums, it is reflected and 
refracted. The incidence and refraction angles are related by Snell’s law: 
2 2 1 1 sin n sin n θ θ =      E q .   1 8  
If the refractive index of the first medium is higher than for the second, n1>n2, 
then θ1<θ2. The incidence angle when θ2=90° is called the critical angle θc.  
) n / n ( sin 1 2
1
c
− = θ      E q .   1 9  
If the angle of incidence is higher than θc, then the light is totally internally 
reflected and does not propagate into the second medium. Even so, some of the light 
still penetrates the medium of lower diffractive index as an electromagnetic field 
called the “evanescent wave” [159,160]. A key characteristic of the evanescent wave 
is that it propagates parallel to the interface, vanishing exponentially with distance. 
The decay length (dp) of the evanescent wave along the depth of field depends on 
the incident angle (θ), the wavelength of the excitation beam (λ) and the diffractive 
indices of both media: 
2
2 1
2 2
1
p
p 0 z
n sin n 4
d
) d / z exp( I I
−
=
− =
θ π
λ     Eq.  20 
It should be emphasized that when the incident light is s-(perpendicular) polarized 
the evanescent field is purely transverse to the direction of propagation. In the p-
(parallel) polarization case, the evanescent field has two non-zero components with a   47
phase difference equal to π/2. Therefore the extremity of the field vector will describe 
ellipse as time evolves. 
An evanescent field can be generated also by diffraction from a sub wavelength 
size aperture or a grating. The smaller the diameter of the aperture, the large the 
bending of the diffracted beam. When the width of a slot is equal to λ/2, the emerging 
beam fills the entire half space (Figure 17). If the aperture size is reduced below this 
value evanescent waves will be generated at the interface and their intensity will 
decay exponentially with the distance from the interface. 
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Figure 17 The systems generating an evanescent field. (A) total internal reflection 
of a light beam; (B) diffraction of a beam from an aperture; (C) 
diffraction from the grating; (D) evanescent field of a guided mode. 
(Adapted from [160]) 
The phenomenon of TIR, it be generated by a prism or by a waveguide, is highly 
sensitive to all parameters involved, namely to the wavelength, refractive indices of 
the media, surface roughness, etc. This sensitivity has given rise to the production of 
several different types of sensors, especially in the field of optics and 
nanobiotechnology. The exploitation of evanescent properties of light has led to 
impressive progress in such areas as fibre optics, near-field microscopy and 
biomolecular interaction analysis.  
11.3.1. Evanescent  field  interferometric techniques 
The evanescent wave velocity is sensitive to the refractive indices of both 
materials at the interface. This effect was used to construct interferometric sensors. 
The basic principle of fiber optic Mach-Zehnder type interferometer is depicted in 
Figure 18. A linear waveguide (I) is divided into two arms at a Y junction (II), where 
light is distributed equally between the waveguides (III) and (IV). Branch (III) presents 
locally a depression where the waveguide is in contact with the buffer. Upon protein 
binding to the waveguide, the refractive index at the waveguide-buffer interface will 
change and will be different from the one in branch 2 (IV). For the same geometrical 
distance travelled inside the waveguide, the optical path in each branch will be   48
different. After the second Y junction (V), the two modes recombine. Depending on 
the phase difference they will produce constructive or destructive interference, which 
is used as the readout for binding or dissociation events from the waveguide surface. 
 
Figure 18  Evanescent field Mach-Zehnder interferometer. (taken from [160]) 
11.3.2. Resonant  mirror. 
Resonant mirror is a optical biosensor design [161,162], which uses the 
evanescent wave associated with a dielectric resonant structure to probe binding 
events occurring in a sensing layer, deposited within few hundred nanometers of the 
device surface (Figure 19). The evanescent field, generated upon light reflection from 
the prism is perturbed by a high refractive index waveguide layer. Light may couple 
to the resonant layer via the evanescent field. Efficient coupling occurs only for 
certain incident angles, where phase matching between in incident beam and the 
resonant modes of the high index layer is achieved. At the resonant point, light 
couples into the high refractive index layer and propagate some distance along the 
sensing interface before coupling back to the prism. The resonant angles are 
different for p and s polarisations. Therefore interference between them is used for 
readout. Binding of the protein to the sensing layer increases the angle of incidence, 
at which resonance coupling occurs.    49
 
Figure 19  Structure of the resonant mirror biosensor (taken from [160]) 
11.3.3.  Internal reflection spectroscopy 
Another application of great importance concerns the possibility of producing 
spectroscopic measurements by total internal reflection. Evanescent light, like 
propagating light, can be absorbed, depending on the material deposited at the 
interface where it arises. This property is used to obtain absorption spectrums of the 
deposited materials. Sensitivity can be enhanced by using multiple internal 
reflections in optical fibers, waveguides or other optical elements and by means of 
Fourier transforms. Binding of the proteins to the interface can be followed as an 
increase in the absorption at a specific wavelength in the infrared. This combination 
is also widely used to detect conformational state and conformational changes of the 
proteins adsorbed to the interface or to biological membrane.  
11.3.4.  Surface plasmon resonance-based detection 
When there is a thin gold (or other noble metal) layer at the interface between two 
dielectric materials then the evanescent field interacts with free electrons and a 
charge density wave, also called surface plasmon is generated. Under resonance 
conditions, the energy from the evanescent light is efficiently transferred to these 
charge oscillations, which cause drastic reduction in the intensity of the reflected 
light. The resonance angle, at which the intensity minimum occurs, is a function of 
the refractive index of the solution close to the gold layer (Figure 20). 
As biomolecules are immobilized on a sensor surface, the refractive index at the 
interface between the gold surface and a solution flowing over the surface changes,   50
altering the angle, at which reduced intensity light is reflected from a supporting glass 
plane. The change in the resonance angle, caused by binding or dissociation of 
molecules from the sensor surface, is proportional to the mass of bound material. 
Surface plasmon resonance detection is the most sensitive and most popular 
commercially available label free solid phase detection technique today. 
 
Figure  20 Surface plasmon resonance (SPR) detects changes in the refractive 
index in the immediate vicinity of the surface layer of a sensor chip. 
SPR is observed as a sharp decrease in the reflected light from the 
surface at an angle that is dependent on the mass of material at the 
surface. The SPR angle shifts (from I to II in the lower left-hand 
diagram) when biomolecules bind to the surface and change the mass 
of the surface layer. This change in resonant angle can be monitored 
non-invasively in real time (taken from [163]).  
11.3.5.  Total internal reflection fluorescence spectroscopy (TIRFS) 
Fluorescent molecules in the medium with the lower refractive index that are on or 
near interface are selectively excited by the evanescent illumination (Figure 21A) 
[164-171]. This type of excitation is particularly suitable to analyze interactions at 
membranes because only fluorophores at the interface will be excited and others in 
solution remain dark. This feature drastically reduces the background level, and even 
single molecule fluorescence detection becomes possible [96,171,172]. TIR is 
realized with different prism (Figure 21B) [173-180] and objective type [168,171,181] 
optical geometries and can be combined with many fluorescence detection modes 
like FRAP [182,183], FCS [82,184], and FRET [174].    51
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Figure 21  (A) Principle of total internal reflection fluorescence spectroscopy. (B) 
Schematic of prism based TIRFS detection. 
In contrast to the relatively constant fluorescence emission rates in free solution, 
it is known that the radiative emission rates can be modified by placing the 
fluorophores at suitable distances from metallic surfaces and particles [185-190]. The 
effects of metallic surfaces are complex and include quenching at short distances, 
spatial variation of the incident light field, and change the fluorescence lifetime rates. 
The evanescent field, amplified by the surface plasmons will enhance fluorescence 
intensity of the fluorophores at the interface. Due to fluorophore dipole interaction 
with free electrons in the thin metal layer, normally isotropic emission is converted 
into highly directional emission at a well-defined angle from the normal axis (Figure 
22). Therefore, surface plasmon enhanced and directional fluorescence emission 
increases signal to noise, simplifies detection and provides numerous opportunities 
for new approaches in surface sensitive fluorescence spectroscopy. 
 
Figure 22 Cone of the surface plasmon coupled directional fluorescence emission 
of the fluorophores at the surface of the thin metallic film. (taken from 
[188])   52
11.4.  Combined label and label-free solid phase detection 
Label free detection allows absolute quantification of adsorbed biomolecules on 
the surface. However, the response is directly related to the molecular mass of the 
species bound to the sensor surface, and it is difficult or sometimes impossible to 
detect small analytes or do measurements at very low surface concentrations of the 
immobilized receptor. The sensitivity of signal detection is in general far below that of 
fluorescence measurements. Fluorescence detection is very sensitive, and with 
modern detectors single fluorophore sensitivity can be achieved. However, the 
amplitude of fluorescence signal is difficult to quantify absolutely because it depends 
on the excitation power, the light collection efficiency, the excitation and the detection 
filters, the labeling degree and other experimental parameters. In complex receptor-
ligand interactions it is not always possible to have all interacting proteins labeled 
and to exclude that labeling has no effect on protein function. Therefore the 
combination of fluorescence and label free-techniques is an ideal solution to study 
ligand induced receptor crosslinking. Label-free detection allows to absolutely 
quantify the amount of interacting proteins on the surface and simultaneously 
provides possibility to convert arbitrary fluorescence signal into absolute units like 
ng/mm² or mol/mm². Simultaneous fluorescence detection allows to measure 
interaction kinetics with high signal to noise ratio and automatically solves sensitivity 
the problem associated with label free detection. Additionally, effects of local probe 
environment on the fluorescent probe brightness and energy transfer between donor 
and acceptor probes can serve as the readout for receptor crosslinking and allow 
differentiating between different conformational states.  
Typical experiment of combined label and label free detection is showed in Figure 
23. All steps of surface architecture formation are detected by label-free detection: 
vesicle fusion on the surface, bilayer conditioning, immobilization of the receptor. 
None of these molecules are labeled, so fluorescence channel shows no signal. The 
labelled ligand binding to surface anchored receptor is simultaneously detected on 
both channels. Due to higher sensitivity, the fluorescence signal provides much 
higher signal-to-noise ratio.    53
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Figure 23 Course of a typical binding experiment on supported lipid bilayers as 
detected by label-free (black) and fluorescence (green) detection. 
Injection of (1) vesicle fusion, (2) and (3) – membrane conditioning, (4) 
receptor immobilization and (5) binding of the fluorescently labeled 
ligand. 
From technical point of view, the combination of fluorescence and label-free 
detection techniques is a straightforward approach. The same light beam can be 
used to probe refractive index changes due to protein binding to the surface and 
excite fluorophores which are present at the interface. Fluorescence can be emitted 
directly to the optical fiber or waveguide and later spectral detector will be used to 
independently detect changes of refractive index and measure fluorescence intensity 
(Figure 24).  
D D D
Spectral
detector
 
Figure 24 Combination of evanescent field fluorescence and label free detection 
techniques. The same light beam (blue) is used to probe the amount of 
proteins on the surface and to excite fluorophores present at the 
interface. The fluorescence is emitted to the same optical fiber or 
waveguide (green) and both signals are independently detected by 
spectral detector (not shown).  
Another detection scheme would be to use interferometric, resonant mirror or 
surface plasmon resonance biosensors and collect fluorescence signal from the top 
of the surface (Figure 25). Combination of evanescent field excited fluorescence with   54
SPR, called surface plasmon field-enhanced fluorescence spectroscopy, has been 
shown to be a powerful tool for characterizing processes at interfaces (Liebermann 
and Knoll, 2000; Neumann et al., 2002).  
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Figure 25 Combination of fluorescence and label-free detection techniques. The 
same light beam (cyan) is used to probe the amount of proteins on the 
surface and excite fluorophores present at the interface. Fluorescence 
is collected from the top of the surface. (A) Interferometric – 
epifluorescence approach; light beam comes perpendicular to the 
surface. Optical thickness of the biomolecular layer is probed 
interferometrically by RIf detection. Fluorescence is detected from the 
top of the surface. (B) Combined SPR or resonant mirror and TIRFS 
approach. Changes in refractive index are probed by measuring 
intensity of the reflected light. Evanescent field excited fluorescence is 
collected and detected from the top of the surface.  
All presented detection schemes use the same light source for fluorescence 
excitation as for label-free detection, thus limiting the flexibility of each technique. 
Additionally, absorption by the fluorophores affects the intensity and phase difference 
of TIR beam, thus, introducing a crosstalk between the two detection techniques. The 
refractive index close to the absorption band differs from the one far from absorption 
peak; it has a different absolute value and a sharp negative dispersion profile. 
Furthermore, strong light intensity required for label-free detection can bleach 
fluorophores and complicate fluorescence experiments. The metal layers required for 
SPR are furthermore disadvantageous due to their strongly surface distance-
dependent fluorescence quenching. Ideally, combined fluorescence and label-free 
detection should be simultaneous, independent and without crosstalk. 
We combined reflection interferometry (RIf) and total internal reflection 
fluorescence spectroscopy (TIRFS) detection techniques into a single experimental   55
set-up which fully implements above-mentioned features and is schematically 
presented in Figure 26. Fluorescence excitation and emission were kept independent 
of RIf illumination by implementing monochromatic RIf detection in the near infrared 
region. Complete spectral separation of the two techniques proved valuable as high-
power illumination for optimum RIf detection could be applied without photobleaching 
the fluorophores absorbing in the visible region. This allowed us to fully eliminate 
crosstalk between two techniques by using proper combinations of detection filters. 
Flow through conditions allowed real-time detection of ligand binding and receptor 
crosslinking events.  
 
Figure  26 Schematic of combined reflectance interferometric and total internal 
reflection fluorescence spectroscopic detection.  
12.  Solid-supported lipid bilayers 
It is known that membrane environment is important, if not essential, for 
membrane receptor function and reconstitution of membrane proteins in model lipid 
membranes is a necessary requirement to study their interactions in vitro. The 
combination of optical biosensor (label and label free) techniques with fluid lipid 
membranes fused on a solid support [191-197] offers the advantages of surface 
sensitive solid phase detection with keeping membrane proteins in their natural 
environment. Small unilamelar vesicles (SUV) fused on hydrophilic surfaces form 
solid supported bilayer with well-defined composition, electrostatic and fluidic 
properties. SUV fusion and bilayer formation was intensively studied with many 
techniques including QCM-D [198,199], ellipsometry [200], interferometry [201], 
surface plasmon resonance [202], fluorescence microscopy [203] and atomic force   56
microscopy [204,205]. Solid supported membranes offer the platform to reconstitute 
membrane receptors and quantitatively study effects of dimensionality, fluidity and 
electrostatics on 2-dimensional interactions under defined conditions. 
Specific and oriented tethering of C-terminal decahistidine-tagged extracellular 
domains of ifnar2 and ifnar1 was achieved using lipid molecules which carry 
covalently attached chelator bis-nitrilotriacetic acid (bis-NTA) groups (figure 26A) 
[206]. The formation of the decahistidine and bis-NTA complex is highly specific. 
Furthermore it is fully reversible upon addition of a competitive ligand (imidazole), 
protonation of the histidines, or removal of the metal ions by EDTA complexation. 
FRAP measurements confirmed that bis-NTA lipids do not phase segregate and 
bilayer fluidity is not affected by bis-NTA attachment or decahistidine tagged protein 
immobilisation (figure 26B). 
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Figure 27  (A) structure of bis-NTA lipids. (B) FRAP experiment confirm bilayer 
fluidity and homogeneity of bis-NTA lipid bilayer.  
13. Approach  summary 
Solid supported lipid bilayer provided 2-dimensional interaction environment for 
membrane receptors. Ifnar2-EC and ifnar1-EC were reconstituted in the specific, 
oriented and stable yet reversible manner on fluid lipid bilayer via decahistidine and 
bis-NTA interaction. The 2-dimensional concentrations were absolutely quantified by 
label-free interferometric detection and ligand induced receptor crosslinking kinetics 
were sensitively and simultaneously detected by total internal reflection fluorescence 
spectroscopy. Binding curves were fitted with 2-step interaction model and 2-
dimensional dissociation and association rate constants of ifnar crosslinking were 
independently determined. Detection system allowed parameterizing all variables in 
the model leaving 2-dimensional interaction rate constants the only variables during 
the fitting.   57
14. Papers 
14.1.  Paper I.  
Lamken P, Lata S, Gavutis M Jacob Piehler: Ligand-induced Assembling of 
the Type I Interferon Receptor on Supported Lipid Bilayers. Journal of Molecular 
Biology, 2004, 341: 303-318 
This paper presents the in vitro approach to study type I interferon (IFN)-induced 
crosslinking of its receptor subunits, ifnar2 and infar1. SOPC lipid vesicles doped with 
bis-NTA chelator groups were fused on to silica transducer surface and formed fluid 
solid supported lipid bilayer. Membrane fluidity was confirmed by FRAP experiments. 
The extracellular domains of the interferon receptor subunits ifnar2-EC and ifnar1-EC 
carrying C terminal decahistidine tag were anchored to solid-supported membranes 
via C-terminal decahistine tag and bis-NTA chelator interaction. The high stability and 
specificity of this interaction ensured stable and oriented reconstitution of receptor 
subunits. Interactions on solid supported membrane were optically detected using 
novel combination of two solid phase detection techniques: label-free reflectance 
interferometry (RIf) and total internal reflection fluorescence spectroscopy (TIRFS). 
Flow through conditions allowed monitoring of interaction events in real time. 
Main results: 
● Equilibrium dissociation constants and association / dissociation rate constants 
of individual interactions between IFNα2 and individual subunits were measured and 
parameterized. 
● No interaction between the receptor subunits in absence of the ligand was 
detected. 
● The stoichiometry of the ternary complex between ligand and receptor subunits 
was estimated to be 1:1:1.  
● Stoichiometric coimmobilization of receptor subunits on solid supported 
membrane decreased observed ligand dissociation rate constant 2-200 times 
depending on 2-dimensional concentrations of the membrane-anchored receptor 
subunits. 
● Dissociation rate constant of fluorescence labelled IFNα2 is increased in 
presence of nonlabelled ligand indicating kinetic nature of interactions between 
membrane anchored ifnar subunits.   58
● Based on experimental data an IFN-induced 2-step ifnar assembling model was 
proposed. 
14.2.  Paper II.  
Gavutis M, Lata S, Lamken P, Müller P, Piehler J: Lateral Ligand-Receptor 
Interactions on Membranes Probed by Simultaneous Fluorescence-Interference 
Detection. Biophysical Journal, 2005, 88: 4289–4302 
This paper describes in detail simultaneous, real-time RIf-TIRFS detection, 
introduced in paper 1 and its potential for quantitative studying interactions on 
membranes. RIf and TIRFS techniques were combined in single experimental setup 
and allowed simultaneous real-time detection of both signals without crosstalk 
between them. This was achieved by using separated excitation and detection 
modules for both techniques and spectrally separating them. RIf detection was 
performed in NIR and TIRFS in VIS spectral regions. Flow-through conditions 
allowed to monitor binding assays in real time. 
Main results: 
● The RIf-TIRFS setup was characterized and calibrated with respect to noise 
and detection limits using Oregon Green 488 labelled lipid bilayer and Oregon Green 
488 fluorophore solution as a model systems. Detection limits were determined to be 
10  pg/mm² for RIf and 10  fluorophores/µm² for TIRFS. The flow through system 
allowed measuring interaction rate constants up to 5 s
-1. 
● Sensitive fluorescence detection allowed measuring binding kinetics at very low 
surface concentrations of immobilized receptor subunits. Dissociation rate constants 
of IFNα2 were found to be 0.013  s
-1 and 1  s
-1 for ifnar2-EC and ifnar1-EC 
respectively. 
● The observed ligand dissociation rate constant depends on absolute as well as 
relative 2-dimensional concentrations of co-immobilized receptor subunits ifnar2-EC 
and ifnar1-EC on the membrane 
● 2-step dissociation model based on an interaction model presented in paper 1 
was used to fit the ligand dissociation curves at different stoichiometric amounts of 
immobilized receptor subunits. The detection system allowed parameterizing all 
variables in the model except the 2-dimensional association rate constant ka
T 
between ifnar1-EC and binary complex between ifnar2-EC and IFNα2.   59
● k a
T was found to be 16  mm²fmol
-1s
-1 and the corresponding 2-dimensional 
equilibrium dissociation rate constant KD
T 0.06  fmol/mm². Experiments with IFNα2 
mutants M148A and R144A showed that deviations from the model appear when 
association rate constants of IFN towards the individual ifnar subunits gets 
comparable. 
14.3.  Paper III  
Lamken P, Gavutis G, Peters I, Van der Heyden J, Uzé G, Jacob Piehler: 
Functional Cartography of the Ectodomain of the Type I Interferon Receptor 
Subunit ifnar1. Journal of Molecular Biology, 2005, 350: 476-488 
In this paper, the role of ifnar1-EC subdomains with respect to ligand binding and 
receptor crosslinking was investigated using the experimental approach described in 
paper 1 and 2, and by FACS analysis. Different C and N terminal decahistidine 
tagged Ifnar1-EC fragments were expressed in Sf9 insect cells and purified to 
homogeneity.  
Main results: 
● From binding assays with IFNα2 and IFNβ it was concluded that all the three N 
terminal ifnar1-EC subdomains are involved in ligand binding.  
● IFNα2 and IFNβ bind competitively to ifnar1-EC and the fragments with three N 
terminal subdomains indicating the same binding site for both IFNs.  
● The role of orientation in ternary complex assembling was qualitatively 
compared for different constructs by comparing observed ligand dissociation rate 
constant at similar (e.g. same surface concentrations of receptor subunits on the 
membrane) conditions. N terminal ifnar1-EC was crosslinked with ifnar2-EC with 
much lower efficiency in comparison to C terminal ifnar1-EC. Deletion of the 
membrane-proximal domain increased the observed ligand dissociation rate costant 
even more and no difference was observed for C and N terminal constructs. 
● The membrane proximal subdomain, SD4, is not involved in ligand binding, but 
is important in IFN-induced receptor assembling and signal transduction in vivo. Cells 
expressing ifnar1 without membrane proximal domain were not able to transmit the 
cellular signal.   60
14.4. Paper  IV 
Lata S, Gavutis M, Piehler J: Monitoring the Dynamics of Ligand-Receptor 
Complexes on Model Membranes. submitted 
This letter describes the synthesis of bis-NTA lipids and presents binding assay 
to calculate 2-dimensional dissociation rate constant of ifnar2-EC leaving ternary 
complex using the experimental approach described in paper 1 and 2. 
Fluorescence from donor (OG488) labelled ifnar2-EC is quenched upon ternary 
complex formation with acceptor (Cy3) labelled IFNα2 and unlabeled ifnar1-EC. 
Upon pulse-chasing the ternary complex by rapidly tethering an excess of unlabeled 
ifnar2-EC to the membrane, donor-labeled ifnar2-EC is competed out of the complex, 
leading to a recovery of the fluorescence. The rate-limiting step of donor 
dequenching is the 2-dimensional dissociation rate constant of labelled ifnar2-EC 
from the ternary complex. 
Strikingly, the 2-dimensional dissociation rate constant was about 5 times lower 
than the corresponding 3-dimensional dissociation rate constant. The reasons for this 
could be slower diffusion of the proteins in the membrane, the reduced degree of 
freedom affecting the reaction coordinate or cooperative interaction with ifnar1-H10. 
14.5. Paper  V 
Gavutis M, Jaks E, Lamken P, Jacob Piehler: Determination of the 2-
dimensional interaction rate constants of a cytokine receptor complex. 
Biophysical Journal, accepted  
This paper describes binding assays, based on the experimental approach 
presented in paper 1 and 2, to independently determine 2-dimensional association 
and dissociation rate constants of ifnar2-EC and ifnar1-EC crosslinking.  
Main results: 
● Ligand dissociation from the ternary complex is a 2-step process with 
sequential dissociation of ifnar1-EC and ifnar2-EC from IFN. The concentration of the 
receptor subunits on the membrane and their affinity towards the ligand define, which 
subunit will dissociate first.  
● The 2-dimensional dissociation and association rate constants of ifnar2-EC with 
ifnar1-EC-IFN complex were determined comparing IFN dissociation into solution at 
10 fold excess of ifnar1-EC on the membrane in presence and absence of the high   61
affinity competitor IFNα2 HEQ. Dissociation traces were fitted with a 
monoexponential function and the 2-step dissociation model described in paper 2. 
Strikingly, the 2-dimensional dissociation rate constant was 3-5 times slower than the 
corresponding 3-dimensional rate constant which was in good agreement with FRET 
based binding assay described in paper 4.  
● The same type of binding assay with 10 fold excess of ifnar2-EC was 
performed to calculate 2D dissociation and association rate constant between the 
ifnar1-EC and the ifnar2-EC-IFN complex.  
● The 2-dimensional interaction rate constants were determined for several 
combinations of IFNα2 and ifnar2-EC mutants and ifnar1-EC tethered to the 
membrane via C and N terminal decahistidine tag. In contrast to the interaction in 
solution, the association rate constants depended on the orientation of the receptor 
components. Furthermore, the large differences in association kinetics observed in 
solution were not detectable on the surface. The key roles of orientation and lateral 
diffusion on the kinetics of protein interactions in plane of the membrane are 
emphasized and discussed.   62
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Type I interferons (IFNs) elicit antiviral, antiproliferative and immuno-
modulatory responses through binding to a shared receptor consisting of
the transmembrane proteins ifnar1 and ifnar2. Differential signaling by
different interferons, in particular IFNas and IFNb, suggests different
modes of receptor engagement. Using reﬂectometric interference spec-
troscopy (RIfS), we studied kinetics and afﬁnities of the interactions
between IFNs and the extracellular receptor domains of ifnar1 (ifnar1-
EC) and ifnar2 (ifnar2-EC). For IFNa2, we determined a KD value of
3 nM and 5 mM for the interaction with ifnar2-EC and ifnar1-EC, respect-
ively. As compared to IFNa2, IFNb formed complexes with ifnar2-EC as
well as ifnar1-EC with substantially higher afﬁnity. For neither IFNa2
nor IFNb was stabilization of the complex with ifnar1-EC in the presence
of soluble ifnar2-EC observed. We investigated ligand-induced complex
formation with ifnar1-EC and ifnar2-EC being tethered onto solid-
supported, ﬂuid lipid bilayers by RIfS and total internal reﬂection ﬂuor-
escence spectroscopy. We observed very stable binding of IFNa2 at high
receptor surface concentrations with an apparent kd value approximately
200 times lower than that for ifnar2-EC alone. The apparent kd value was
strongly dependent on the surface concentration of the receptor com-
ponents, suggesting kinetic stabilization. This was corroborated by the
fast exchange of labeled IFNa2 bound to the receptor by unlabeled
IFNa2. Taken together, our results indicate that IFN ﬁrst binds to ifnar2
and subsequently recruits ifnar1 in a transient fashion. In particular, this
second step is much more efﬁcient for IFNb than for IFNa2, which could
explain differential activities observed for these IFNs.
q 2004 Elsevier Ltd. All rights reserved.
Keywords: type I interferon receptor; protein–protein interaction; solid-
supported lipid bilayer; reﬂectometric interference spectroscopy; total
internal reﬂection ﬂuorescence spectroscopy *Corresponding author
Introduction
Signaling induced by type I interferons (IFNs)
plays a key role in host innate response to viral
infection by eliciting a pleiotrophic response
including antiviral, antiproliferative and
immunmodulatory activities. Because of these
activities, type I IFNs are attractive for clinical
applications in different ﬁelds.
1 Although type I
interferons are already used successfully in the
treatment of several diseases, the complexity of
their action interferes with a pharmacologically
controlled administration. Thus, better under-
standing of the receptor recruitment by IFNs and
the following downstream events is required for
fully exploiting the therapeutical potentials of
IFNs.
All type I interferons (13 different IFNas, 1 IFNb
and 1 IFNv) exert their activity through binding to
the same receptor components, ifnar1 and ifnar2.
2
Upon ligand binding, tyrosine kinases associated
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auto-phosphorylation, followed by phosphoryl-
ation of several tyrosine residues on the receptor
and other effector molecules, which are mainly
members of the STAT family. It appears, however,
that the function of different type I IFNs is not
fully redundant, and differential signaling by
different IFNs has been observed.
3–8 In particular
between IFNa subtypes and IFNb, substantial
differences have been observed on the level of
receptor phosphorylation
3 and STAT recruitment,
9
as well as on the level of gene induction.
10,11 As so
far no further receptor component has been identi-
ﬁed, these differences need to be explained
through the mode of interaction of IFNs with the
extracellular domains of ifnar1 and ifnar2 (ifnar1-
EC and ifnar2-EC, respectively). Therefore, a com-
prehensive structural, biophysical and mechanistic
picture of how the receptor domains are recruited
in time and space is required for understanding
the speciﬁcity of signal propagation through the
membrane. In the absence of structural data, the
recognition of IFNs by the receptor components
has been intensively investigated by mutagenesis.
1
The high-afﬁnity interactions between ifnar2-EC
and different IFNs have been investigated in
detail,
12–14 and a model for the complex between
IFNa2 and ifnar2-EC based on double mutant
cycle analysis has been reported.
15,16 However, the
differences in afﬁnity, binding kinetics and orien-
tation, which have been so far observed for the
interaction of IFNa2 and IFNb with ifnar2-EC are
only minute,
13,15,17 and therefore can hardly explain
the functional differences. The low-afﬁnity inter-
action of IFNs with ifnar1 has been much less well
characterized and the KD value was estimated to
be in the micromolar range. Compared to cells
expressing ifnar2 alone a 10–40-fold decrease in
the KD value has been reported. By using neutraliz-
ing antibodies, the binding site for IFNs on ifnar1
was mapped to the Ig-like domains 2 and 3 of
ifnar1.
18 This observation was conﬁrmed by several
studies with bovine ifnar1,
19,20 which binds human
IFNas with high afﬁnity. These results indicated
that the ligand binding site of ifnar1 does not
correspond to a classical cytokine binding module.
In vitro, a stable ternary complex of IFNb with
ifnar1-EC and ifnar2-EC was observed by size-
exclusion chromatography.
21 As no stable complex
between IFNb and ifnar1-EC was detectable
under these conditions, this result indicated that
cooperative interaction leads to stabilization of the
ternary complex. For members of the class I
cytokine family, contacts between the two extra-
cellular receptor domains apparently contribute to
the stability of the ternary complex,
22–26 and
pre-association of the receptor chains has been
proposed for several receptors.
25,27,28 For the IFNg-
receptor as a member of the class II cytokine
receptor family, a similar mechanism was
suggested recently.
29 However, the role of stem–
stem contacts between the extracellular receptor
domains has not been clearly resolved so far,
because lateral interactions between membrane-
anchored proteins are difﬁcult to study: cellular
assays with the full-length receptors do not
provide the experimental control required for
analyzing inter-receptor interactions properly;
binding studies with the extracellular receptor
domains in solution do not provide the biophysical
constraints of protein–protein interaction within
biological membranes such as the reduced number
of degrees of freedom (reduced dimensionality)
and the reduced diffusion rates.
30
Here, we have analyzed the interactions at the
extracellular domains of ifnar involved in the for-
mation of the active ternary complex for both
IFNa2 and IFNb. We furthermore present a novel
approach for studying ligand-induced receptor
assembling by combining full experimental control
of an in vitro reconstituted system with mimicking
two-dimensional protein–protein interactions
within the plane of the plasma membrane.
Through their C-terminal histidine tags, we
tethered ifnar1-EC and ifnar2-EC in an oriented
manner onto supported ﬂuid lipid bilayers con-
taining lipids carrying high-afﬁnity chelator head
groups. We evaluated the interaction of IFNs to
the receptor components reconstituted on ﬂuid
lipid bilayers by reﬂectometric interference
spectroscopy (RIfS) and total internal reﬂection
ﬂuorescence spectroscopy (TIRFS). Based on these
results, we discuss a biophysical model of the tern-
ary complex formation and for differential receptor
recruitment by IFNs.
Results
Expression and puriﬁcation of ifnar1-EC
Ifnar1-EC with a C-terminal decahistidine-tag
was expressed in Sf9 cells infected with a baculo-
virus harboring the gene of mature ifnar1-EC
fused to the secretion sequence of the baculoviral
protein gp67. The protein was puriﬁed to homo-
geneity from the supernatant by IMAC and size-
exclusion chromatography (Figure 1A). In SDS-
PAGE, a molecular mass of approximately 57 kDa
was observed (Figure 1A), suggesting substantial
glycosylation of the protein. Removal of the
glycans with PNGaseF yielded a protein with an
apparent molecular mass of 48 kDa (Figure 1B) cor-
responding to the expected molecular mass of the
polypeptide chain. Under non-reducing conditions
the band of ifnar1 was shifted to a lower molecular
mass compared to the reduced protein, indicating
internal disulﬁde bridge formation (Figure 1B).
Glycosylated ifnar1-EC proved to be a stable
protein, which was stored frozen at 280 8C. After
one cycle of freezing and thawing, only insigniﬁ-
cant loss of monomeric protein was observed by
size-exclusion chromatography (Figure 1C). For all
the following binding experiments, the glycosyl-
ated protein was used, because it was more stable
than the deglycosylated protein.
304 Type I Interferon Receptor AssemblingWe ﬁrst characterized the interaction of ligands
(IFNa2 and IFNb with each of the receptor com-
ponents (ifnar1-EC and ifnar2-EC) separately, in
order to precisely determine afﬁnities, rate con-
stants and stoichiometries. These measurements
were carried out by immobilizing either ifnar1-EC
or ifnar2-EC via their C-terminal His-tag on the
planar surface of the PEG polymer brush in an
oriented fashion using high-afﬁnity chelator head
groups. Under these conditions, lateral interactions
between the surface-attached proteins are mini-
mized due to the short, covalently bound PEG
chains. Protein binding was monitored label-free
by RIfS detection. All binding data obtained from
these measurements are summarized in Table 1.
Interaction of IFNs with ifnar2-EC
Binding of IFNa2 to immobilized ifnar2-tl has
been studied before on different surfaces.
31 IFNa2
interacted speciﬁcally with ifnar2-EC immobilized
via its C-terminal His-tag (Figure 2A) and the
stoichiometry as determined from the relative
binding amplitudes was 1 : 1. From concentration-
dependent binding curves, a kd value of
0.010(^0.002) s
21,aka of 3(^1) £ 10
6 M
21 s
21 and a
KD of 3(^1) nM were determined. These values
are in excellent agreement with the values obtained
for ifnar2-tl immobilized via monoclonal
antibodies.
31 The association phase was signiﬁ-
cantly biased by mass transport limitation as
indicated by the systematic deviation from the
model (Figure 2C). Also the dissociation phase
deviated signiﬁcantly from a single-exponential
decay indicating rebinding (Figure 2C) in agree-
ment with that reported.
31 The interaction of IFNb
with immobilized ifnar2-EC had been investigated
only at increased ionic strength in order to over-
come its otherwise strong non-speciﬁc binding to
the surface.
13 At the PEG polymer brush surface
used in this study, no signiﬁcant non-speciﬁc bind-
ing of IFNb was detectable at physiological ionic
strength after fully blocking the chelator head
groups with MBP-H10 (Figure 2A). Under these
conditions, IFNb bound substantially tighter to
ifnar2-EC compared to IFNa2( Figure 2A), while
from the relative signals, a 1 : 1 stoichiometry
between ifnar2-EC and IFNb was conﬁrmed. The
dissociation was very slow with an estimated kd
value of 0.0005 s
21. From the I47A mutant of
ifnar2-EC, IFNb dissociated with a rate constant
of 0.005(^0.002) s
21 (Figure 2B). From this value,
the kd of approximately 0.0005 s
21 was conﬁrmed
for the wild-type complex, assuming the same ten-
fold difference as observed at high ionic strength.
13
Thus, the half-life of the complex with ifnar2-EC is
probably about 20-fold higher for IFNb compared
to IFNa2. The observed association was strongly
mass transport limited (Figure 2D), indicating that
the association rate constant, ka, is well above
5 £ 10
6 M
21 s
21. The high ka value can be explained
by electrostatic rate enhancement, as IFNb is posi-
tively charged and ifnar2-EC is strongly negatively
charged at physiological pH.
The strong dependence of the complex stability
on the ionic strength suggests that electrostatic
forces also stabilize the interaction of IFNb with
ifnar2-EC. This effect, however, could also be due
to rebinding on the surface, which is dependent
on the ka, value and thus also on the ionic strength.
We therefore investigated the contribution of
rebinding by injecting ifnar2-tl at high concen-
tration (10 mM) during the dissociation phase
(Figure 2E and F). In both cases, a signiﬁcant faster
Figure 1. Puriﬁcation and bio-
chemical characterization of ifnar1-
EC. A, SDS-PAGE of the puriﬁed
protein: elution fraction from
IMAC (lane 1) and fractions from
size-exclusion chromatography
(lane 2–8). B, SDS-PAGE of puriﬁed
ifnar1-EC after deglycosylation
with PNGaseF under non-reducing
and reducing conditions in com-
parison to the non-deglycosylated
protein. C, Size-exclusion chroma-
togram (Superdex 200 HR10/30) of
puriﬁed ifnar1-EC after freezing
and thawing (E, exclusion volume;
B, bed volume).
Type I Interferon Receptor Assembling 305Table 1. Rate and equilibrium constants of the interaction with ifnar1-EC and ifnar2-EC determined for different IFNs and different mutants
Ifnar2-EC Ifnar1-EC Ifnar2-EC/Ifnar1-EC
a
IFN ka (M
21 s
21) kd (s
21) KD (nM) ka (M
21 s
21) kd (s
21) KD (nM) ka (M
21 s
21) kd (s
21) KD (nM)
IFNa2w t ( 3^ 1) £ 10
6 0.012 ^ 0.002 3 ^ 1– .0.5 5000 ^ 2000 (3 ^ 1) £ 10
6 ,0.0001 ,0.03
IFNa2 S136C
b (3 ^ 1) £ 10
6 0.013 ^ 0.002 3 ^ 1 .0.5 ,5000 (3 ^ 1) £ 10
6 ,0.0001 ,0.03
IFNa2w t
c n.b. n.b. n.b. – .0.5 4000 ^ 2000 n.b. n.b. n.b.
IFNa2w t
d (3 ^ 1) £ 10
6 0.20 ^ 0.04 60 ^ 20 – – – – 0.0012 ^ 0.0002 –
IFNa2 R149A – ,2 500 ^ 100 – .0.5 5000 ^ 2000 – 0.010 ^ 0.003 –
IFNb .5 £ 10
6 ,0.001 ,0.1 (3 ^ 2) £ 10
5 0.017 ^ 0.004 50 ^ 30 – ,0.0005 –
IFNb
c n.b. n.b. n.b. (4 ^ 2) £ 10
5 0.019 ^ 0.004 50 ^ 30 n.b. n.b. n.b.
IFNb
e .5 £ 10
6 0.003 ^ 0.001 ,0.6 – – – – – –
IFNb
d .5 £ 10
6 0.005 ^ 0.002 ,1– – – –,0.0005 –
Mean values and standard deviations were determined from at least three independent experiments. n.b., no binding detectable.
a Co-immobilized on lipid bilayers at high surface concentration.
b Labeled with OG-488 or AF-488 at the additional cysteine residue.
c In stoichiometric complex with ifnar2-tl.
d With the mutant ifnar2-EC I47A.
e At 500 mM NaCl.dissociation was observed resulting in corrected
dissociation rate constants of 0.012(^0.003) s
21 for
IFNa2 and ,0.001 s
21 for IFNb, respectively.
Interaction of IFNs with ifnar1-EC
Binding of IFNa2 to immobilized ifnar1-EC was
only detectable at concentrations above 300 nM
and rapid dissociation was observed (Figure 3A).
This interaction was entirely speciﬁc as conﬁrmed
by control experiments without ifnar1-EC on the
surface (data not shown). From the equilibrium
responses, Req, observed for IFNa2 at concen-
trations between 100 nM and 100 mM, titration
curves were obtained (Figure 3B). A KD value of
5(^2) mM was determined by ﬁtting a Langmuir
isotherm. Hence, the afﬁnity of IFNa2 towards
ifnar1-EC is about three orders of magnitude
lower than for ifnar2-EC. The maximum binding
signal, Rmax, obtained from such titration corre-
sponded to a 1 : 1 interaction between ifnar1-EC
and IFNa2 assuming full activity of the immobi-
lized ifnar1-EC. The same experiment was carried
out with a stoichiometric complex of IFNa2 with
ifnar2-tl. This complex with a life-time of ,100 s
can be assumed static during the time-scale of the
interaction with ifnar1-EC. Binding curves for the
0.1 mM and 10 mM IFNa2–ifnar2-tl complex are
shown in Figure 3E. The relative binding signals
obtained from a full titration (results not shown)
conﬁrmed a 1 : 1 stoichiometric ratio between the
IFNa2–ifnar2-tl complex and immobilized ifnar1-
EC. A KD value of 4(^2) mM was obtained, which
was not signiﬁcantly different from the KD deter-
mined for IFNa2 alone. This result suggests that
the ternary complex of ifnar1, ifnar2 and IFNa2i s
Figure 2. Interaction of IFNa2 and IFNb with ifnar2-EC on a PEG polymer brush. A, Binding curve for 50 nM IFNa2
(······) and 50 nM IFNb (—) to ifnar2-EC in comparison to 50 nM IFNb exposed to immobilized MBP-H10 (- - - -).
B, Dissociation of IFNa2 (······) and IFNb (—) from immobilized ifnar2-EC I47A. C, Fit and residuals for association
and dissociation of IFNa2 shown in A. D, Fit and residuals for association and dissociation of IFNb shown in A.
E and F, dissociation of IFNa2 (E) and IFNb (F) from immobilized ifnar2-EC in the absence (—) and in the presence
(······) of 10 mM ifnar2-tl.
Type I Interferon Receptor Assembling 307not stabilized by additional interactions between
ifnar1-EC and ifnar2-EC.
The interaction of IFNb with immobilized ifnar1-
EC was much more stable compared to the binding
of the IFNa2( Figure 3C). Association and dis-
sociation phases were well ﬁtted by mono-
exponential models (Figure 3D). From the ﬁtting, a
ka value of 3(^2) £ 10
5 M
21 s
21 and a kd value of
0.017(^0.004) s
21 wereobtained.The bindingsignals
corresponded to a 1 : 1 stoichiometry between IFNb
andifnar1-EC.SimilartoIFNa2,nosigniﬁcantdiffer-
ences in the binding rates were observed for ifnar2-
tl-bound IFNb compared to free IFNb (Figure 3E
and F). Also a 1 : 1 stoichiometric ratio was con-
ﬁrmed. For free as well as ifnar2-tl-bound IFNb a KD
value of 50(^30) nM was obtained. The interaction
of the IFNb–ifnar2-tl complex with ifnar1-EC was
also investigated in solution by a binding inhibition
assay (data not shown). The KD value obtained from
this experiment was 30(^10) nM, i.e. in good agree-
ment with the KD value determined for the inter-
action at the surface. Thus, the afﬁnity of ifnar1-EC
for IFNb is two orders of magnitude higher than for
IFNa2. Intriguingly, the association rate constant of
IFNbbindingtoifnar1-ECisatleast anorderofmag-
nitude lower compared to the binding to ifnar2-EC.
Complex formation on lipid bilayers
In order to analyze how the ternary complex is
stabilized by lateral interaction on the membrane
we investigated ternary complex formation on
Figure 3. Binding of IFNs to immobilized ifnar1-EC on a PEG polymer brush. A, Binding of IFNa2 in various con-
centrations (100 nM, ······; 1 mM, –·–·–, 10mM ,–––– ;1 0 0 mM, —) to immobilized ifnar1-EC. B, Equilibrium
response of IFNa2 binding to ifnar1-EC versus concentration and the ﬁtted Langmuir isotherm. C, Binding of 50 nM
IFNb to immobilized ifnar1-EC. D, Monoexponential ﬁt to the association and dissociation shown in C. E, Binding of
100 nM IFNb–ifnar2-tl, 100 nM IFNa2–ifnar2-tl and 10 mM IFNa2–ifnar2-tl to immobilized ifnar1-EC in comparison
(normalized to the amount of ifnar1-EC on the surface). F, Fit of single exponential models to the association and dis-
sociation phase for the interaction of 100 nM IFNb–ifnar2-tl with ifnar1-EC as shown in E, and the residuals of the ﬁt.
308 Type I Interferon Receptor Assemblingsolid-supported membranes. We tethered ifnar1-
EC and ifnar2-EC to the surface of a solid-
supported ﬂuid lipid bilayer doped with chelator
lipids using their C-terminal histidine-tags. When
ifnar1-EC or ifnar2-EC were individually immobi-
lized on solid-supported lipid bilayers, the binding
curves obtained for IFNa2 and IFNb binding to
ifnar2-EC (Figure 4A and B) and ifnar1-EC
(Figure 4C and D), respectively, were very similar
to the corresponding measurements on the non-
ﬂuid polymer brush support. The rate and equi-
librium constants obtained from these curves
matched the rate constants determined from the
measurements on non-ﬂuid support. Neither for
IFNa2 nor for IFNb was signiﬁcant non-speciﬁc
binding detectable on the solid-supported lipid
bilayers (Figure 4A, C and D).
Upon co-immobilization of ifnar1-EC and ifnar2-
EC the binding kinetics of IFNa2 drastically
changed (Figure 5A and B). No signiﬁcant dis-
sociation was observed within 15 minutes, and a
second injection of IFNa2 did not give any signiﬁ-
cant signal (data not shown). Also the association
kinetics was changed (Figure 5C–E): a constant
binding rate until saturation was observed indicat-
ing highly diffusion-controlled binding. No dis-
sociation of IFNa2 was discernible only if a 1 : 1
molar ratio for ifnar1-EC and ifnar2-EC was strictly
maintained. With a molar excess of ifnar1-EC, we
observed partial fast dissociation of IFNa2, and
the amount of stably bound ligand corresponded
to the amount of tethered ifnar2-EC (data not
shown). With a molar excess of ifnar2-EC, we
observed partial dissociation with a rate constant
corresponding to the ifnar2–IFNa2 interaction,
and the amount of stably bound ligand corre-
sponded to the amount of ifnar1-EC on the bilayer
(results not shown). These results conﬁrmed that
with IFNa2 a complex with a stoichiometry of
1 : 1 : 1 (or multiples thereof) was formed. For-
mation of a stable stoichiometric ternary complex
was observed only on ﬂuid supports (Figure 5B),
conﬁrming that orientation and lateral reorganiz-
ation of the receptor domains were required to
obtain maximum binding afﬁnity. In order to
characterize the lateral distribution of the immobi-
lized proteins, laser scanning confocal ﬂuorescence
microscopy was carried out using ifnar2-EC-S35C
labeled with OG-488 as a probe. Homogeneous
lateral distribution of ifnar2-EC was observed on
both polymer brush and supported membrane.
The lateral diffusion of the receptor was investi-
gated by FRAP experiments (Figure 6). No FRAP
was observed for the polymer brush support (data
not shown), while full FRAP was observed for the
supported lipid bilayers (Figure 6A and B). For
ifnar2-EC tethered to the chelator lipid, a diffusion
constant of 1(^0.5) mm
2/s was determined,
which is very similar to the diffusion constant
of GPI-anchored proteins in living cells.
32 No
Figure 4. Ligand binding to ifnar1-EC and ifnar2-EC tethered on solid-supported lipid bilayers as detected by RIfS.
A, Interaction of 50 nM IFNa2 (······) and 50 nM IFNb (—) with ifnar2-EC in comparison to 50 nM IFNb exposed to
a surface loaded with MBP-H10 (- - - -). B, Fit of the association and dissociation curves shown in A. C, Interaction of
10 mM IFNa2 (—) with immobilized ifnar1-EC in comparison to 10 mM IFNa2 exposed to a surface loaded with
MBP-H10 (······). D, Interaction of 100 nM IFNb (—) with ifnar1-EC in comparison to 100 nM IFNb exposed to a
surface loaded with MBP-H10 (······).
Type I Interferon Receptor Assembling 309signiﬁcant change in recovery time was observed
upon co-immobilization with ifnar1, while binding
of IFNa2 clearly reduced the recovery rate by a
factor of 2 (Figure 6C). These results also conﬁrmed
that no substantial interaction between ifnar1-EC
and ifnar2-EC takes place in the absence of the
ligand.
Since for the wt proteins no dissociation from the
ternary complex was observed, we investigated
several mutants of ifnar2-EC and IFNa2 forming
relatively less stable binary complexes with each
other compared to their wild-type counterparts
(Figure 7A and B). IFNa2 dissociates from ifnar2-
EC I47A with a rate constant of 0.2 s
21 (20-fold
higher than wt ifnar2-EC). Upon co-immobilization
of ifnar-1EC, a kd value of 0.0012(^0.0002) s
21 was
observed (Figure 7C). For IFNa2 R149A (KD,
500 nM, kd < 2s
21), a dissociation rate constant of
0.01(^0.003) s
21 in the presence of tethered ifnar1-
EC was observed (Figure 7D). From these experi-
ments it was estimated that in the presence of
ifnar1-EC the apparent afﬁnity is approximately
200-fold higher compared to the afﬁnity towards
ifnar2-EC alone.
All these measurements, however, were carried
out at very high receptor surface concentrations
(approximately 20–40 fmol/mm
2, i.e. 20–40% of a
monolayer). The stability of the ternary complex
at lower receptor concentration was studied using
TIRFS because of the higher sensitivity of ﬂuor-
escence detection compared to RIfS. Binding of
ﬂuorescent IFNa2 (S136C labeled with AF-488) to
the receptor on lipid bilayers was measured at
different surface concentrations of the receptor
(Figure 8). At a high surface concentration of
ifnar1-EC and ifnar2-EC, ﬂuorescence detection
principally showed similar dissociation phase as
did RIfS (Figure 8A). However, a decay of the sig-
nal while rinsing was observed. This was not due
to ligand dissociation, as stable binding was con-
ﬁrmed by simultaneous RIfS detection (data not
shown), but can be ascribed to photobleaching.
With a decreasing surface concentration of ifnar1-
EC and ifnar2-EC we observed a decreasing
stability of the ternary complex (Figure 8B). The
dissociation curves were ﬁtted by a single-expo-
nential decay (Figure 8B and C), and increasing kd
values were obtained with decreasing surface con-
centrations. In Figure 8D, the dissociation rate
constants were plotted as a function of receptor
surface concentration, the corresponding values
are listed in Table 2. At the lowest receptor
surface concentration of approximately 0.3 fmol/
mm
2 (,200 molecules/mm
2), the stability of the
ternary complex was only three times higher than
for ifnar2-EC alone. For surface concentrations of
2–4 fmol/mm
2 we determined kd values corre-
sponding to the afﬁnities that have been
Figure 5. Ligand binding to ifnar1-EC and ifnar2-EC co-immobilized on solid-supported, ﬂuid lipid bilayers.
A, Immobilization of ifnar2-EC and ifnar1-EC in stoichiometric ratio, and interaction with 50 nM IFNa2. B, Dis-
sociation of IFNa2 from the ternary complex with ifnar1-EC and ifnar2-EC on lipid bilayers (—) and on polymer brush
support (- - - -), compared to the dissociation from ifnar2-EC alone (······). C, Comparison of the association phases for
binding of 50 nM IFNa2 to ifnar1-EC and ifnar2-EC on supported bilayers (—) and to ifnar2-EC alone (······). D and E,
Mono-exponential ﬁt and residuals of the associations phases shown in C (with the same coding of the curves).
310 Type I Interferon Receptor AssemblingFigure 6. FRAP experiment with ifnar2-EC S35C labeled with OG488 tethered to chelator lipids in a solid-supported
lipid bilayer. A, Fluorescence images of ifnar2-EC OG-488 tethered to a solid-supported lipid bilayer before and after
bleaching of a circular spot (the time after bleaching is indicated in the lower left corner of each image, the bar
represents 20 mm). B, Fluorescence intensity in the bleached spot as a function of time (—) compared to a non-bleached
reference spot (······). C, Recovery curves of ifnar2-EC OG-488 in the presence of ifnar1-EC before (—) and after (······)
addition of 100 nM IFNa2.
Figure 7. Dissociation of IFNa2 from both ifnar1-EC and ifnar2-EC on lipid bilayers (—) compared to ifnar2-EC
alone (······) observed for ifnar2-EC I47A with wild-type IFNa2 (A) and for wild-type ifnar2-EC with IFNa2 R149A
(B). C and D, Fit of a mono-exponential decay to the dissociation from the ternary complex shown in A (C) and B
(D), and the residuals.
Type I Interferon Receptor Assembling 311observed in binding assays with living cells.
33 The
association phases of the binding curves
normalized to the saturation signal are shown in
Figure 8E. At receptor surface concentrations
below 8 fmol/mm
2, the association curves over-
layed. These curves were ﬁtted well by a pseudo-
ﬁrst-order model (Figure 8F) and gave association
rate constants very similar to the interaction of
IFNa2 with ifnar2-EC alone (Table 2). At a higher
surface concentration, signiﬁcant lower association
rate constants were obtained and systematic
deviations from the model, as well as from the
other binding curves were observed (Figure 8F).
This was probably due to mass transport
limitations at these high receptor surface concen-
trations, which have already been observed for the
interaction of IFNa2 with ifnar2-EC alone.
The dependence of the complex stability on the
receptor surface concentration suggested that the
ternary complex is not static, but stabilized by fast
re-association, the kinetics of which depends on
the receptor surface concentration. This was
further corroborated by the observation that stable
ternary complexes were formed at low surface
concentrations of ifnar2-EC but high surface con-
centrations of ifnar1-EC (results not shown). In
 
 
Figure 8. The IFNa2 interaction with ifnar1-EC and ifnar2-EC tethered onto supported lipid bilayers as detected by
TIRFS. A, Binding of 100 nM AF-488-labeled IFNa2 at different surface concentrations of ifnar2-EC and ifnar1-EC in
a stoichiometric ratio (black, 12 fmol/mm
2; red, 8 fmol/mm
2; green, 4 fmol/mm
2; blue, 2 fmol/mm
2; brown, 1 fmol/
mm
2; orange, 0.5 fmol/mm
2). B, Dissociation phases of the binding curves shown in A normalized to the signal at the
beginning of dissociation (same color coding as for A) including the ﬁt curve of a mono-exponential decay (black
lines). C, Residuals for ﬁtting curves shown in B (same color coding as for A). D, Dissociation rate constant as a func-
tion of the surface concentration of the receptor. E, Association phases of binding curves shown in A normalized to
the saturation signal (same color coding as for A). F, Residuals of a ﬁrst-order association model ﬁtted to the curves
shown in E.
312 Type I Interferon Receptor Assemblingorder to analyze this kinetic stabilization, we
challenged the apparently stable ternary complex
formed with ﬂuorescently labeled IFNa2 (S136C
with OG-488) by injecting unlabeled IFNa2o r
ifnar2-tl (Figure 9A). Already at a concentration
of 1 mM unlabeled IFNa2, an exchange rate of
0.002 s
21 was observed. At the same time the total
amount of bound IFN did not change as simul-
taneously detected by RIfS (data not shown). In
contrast, no signiﬁcant change in dissociation
kinetics was observed when ifnar2-tl was injected,
even at a concentration as high as 10 mM
(Figure 9A). Furthermore, even at much lower sur-
face concentrations of ifnar2-EC (,0.5 fmol/mm
2),
fast exchange was observed in the presence of
1 mM unlabeled IFNa2( Figure 9B). These experi-
ments conﬁrm that the ligand does not dissociate
from the surface and re-associates (rebinding-
effect), because then ifnar2-tl should interfere as
efﬁciently as does IFNa2, and the effect should be
much less pronounced at low surface concen-
trations. The fact that the ligand is exchanged
much faster than the apparent dissociation rate
furthermore corroborates the kinetic stabilization
of the ternary complex.
Binding assays with ifnar1 and ifnar2
co-immobilized on lipid bilayers were also carried
out with IFNb. However, very stable binding was
observed already for the interaction with ifnar2-
EC alone, and thus no substantial difference in
stability could be observed in the presence of
ifnar1-EC. Upon challenging the ternary complex
formed with IFNb by injecting ﬂuorescently
labeled IFNa2, no exchange could be observed
(data not shown), conﬁrming the anticipated high
stability of the ternary complex. Since the already
formulated IFNb could not be labeled appropri-
ately, binding assays at low surface concentration
were also not feasible.
Discussion
In this study we dissected the individual contri-
butions of the different interactions between
ifnar1-EC, ifnar2-EC and IFNs involved in for-
mation of the ternary complex. For understanding
their role for ligand-induced receptor assembling,
we investigated the ternary complex formation by
tethering the extracellular receptor domains in an
oriented fashion on supported membranes. Based
on combined ﬂuorescence and label-free detection
we studied receptor assembling on a mechanistic
level, which may help to explain how differences
in receptor engagement by IFNa2 and IFNb result
in differential signaling.
Interaction between ifnar1 and ifnar2
Interaction between receptor components cross-
linked by binding to different sites of a ligand is
the basic paradigm for cytokine receptor activation.
Yet the mode of its induction is currently under
controversial debate, and probably different
modes apply for different systems.
34,35 Increasingly,
pre-association of the receptor chains,
27,29,36 and
their activation by ligand-induced conformational
Table 2. Rate and equilibrium constants of IFNa2 bind-
ing at different stoichiometric surface concentrations of
ifnar1-EC and ifnar2-EC on supported lipid bilayers
Ifnar1-EC
(fmol/mm
2)
ka
(10
6 M
21 s
21)
kd
(10
23 s
21)
KD
(nM)
a
12 ^ 31 ^ 0.3 0.5 ^ 0.1 0.17 ^ 0.06
8 ^ 21 ^ 0.3 0.5 ^ 0.1 0.17 ^ 0.06
5.5 ^ 13 ^ 1 0.6 ^ 0.1 0.21 ^ 0.07
4 ^ 14 ^ 1 0.8 ^ 0.2 0.28 ^ 0.1
2 ^ 0.4 5 ^ 2 1.4 ^ 0.2 0.46 ^ 0.16
1 ^ 0.2 3.5 ^ 1 2.1 ^ 0.2 0.70 ^ 0.24
0.5 ^ 0.1 3 ^ 1 3.3 ^ 0.3 1.11 ^ 0.4
0.3 ^ 0.1 4 ^ 1 4.4 ^ 0.4 1.48 ^ 0.5
04 ^ 11 2 ^ 14 ^ 1.5
a Calculated using the average ka of 3(^1) £ 10
6 M
21 s
21.
Figure 9. Chase experiments with ﬂuorescent-labeled IFNa2 bound to ifnar2-EC and ifnar1-EC co-immobilized on
supported lipid bilayers. A, Dissociation of OG-488-labeled IFNa2 (—) at high surface concentrations of both ifnar2-
EC and ifnar1-EC, in the presence of 1 mM (- - - -) and 10 mM( –––– )ifnar2-tl, and in the presence of 1 mM unlabeled
IFN (······). B, Dissociation of OG-488-labeled IFNa2 from the ternary complex at low surface concentration of ifnar2-
EC in the absence (—) and in the presence (······) of 1 mM unlabeled IFNa2.
Type I Interferon Receptor Assembling 313changes have been postulated. In the case of class I
cytokine receptors, namely growth hormone
receptor,
37,26 interleukin-4 receptor
23 and inter-
leukin-6 receptor,
24 stem–stem contacts between
the membrane-proximal, extracellular receptor
domains have been shown to be important for the
formation of stable ternary complexes. Though the
afﬁnities of such receptor–receptor interactions
have not been quantiﬁed yet, stabilization by
cooperative inter-receptor and ligand-receptor
contacts was clearly shown. Gel-ﬁltration assays
carried out with recombinant ifnar1-EC, ifnar2-EC
and IFNb indicated a similar scenario for the type
I interferon receptor.
21 For both IFNa2 and IFNb,
we could clearly exclude such co-operative inter-
action, as we did not detect a signiﬁcant difference
in the afﬁnity of ifnar1-EC for free compared to
ifnar2-tl-complexed ligand. Furthermore, no direct
interaction between ifnar1-EC and ifnar2-EC was
detectable, neither by solid-phase detection nor by
FRAP. These results suggest a different mode of
interaction for this member of the class II cytokine
receptor superfamily compared to the members of
the class I family mentioned above. This is in
good agreement with the observation that the
binding site for IFNa is not located on the mem-
brane-proximal tandem Ig-like domains, but at the
hinge between the two extracellular tandem Ig-like
domains of ifnar1-EC.
18,20
Kinetic stabilization of the ternary complex
with IFNa2
In order to understand the contributions of the
individual interactions towards the stability of the
ternary complex on the cell surface, we studied
complex formation with ifnar1-EC and ifnar2-EC
tethered onto solid-supported membranes. IFNa2
binding was extremely stable at high surface con-
centrations of ifnar1-EC and ifnar2-EC, decreasing
the apparent kd value compared to ifnar2-EC alone
by approximately 200-fold. The dependence of the
complex stability on the surface concentration of
the receptor and the possibility of exchanging the
bound ligand with much faster rates than the
apparent dissociation rate constant suggest kinetic
rather than static stabilization of the complex. The
kd value of .0.5 s
21 for the interaction between
ifnar1-EC and the IFNa2–ifnar2-tl complex implies
that the life-time of an individual ternary complex
is of the order of a second. Since we could not
observe direct interactions between ifnar2-EC and
ifnar1-EC, we propose a two-step assembling
mechanism as shown in Figure 10 after binding of
IFNa2 to ifnar2 (k1), ifnar1 transiently associates in
a second step to the complex. Owing to the short
life-time of the IFNa2–ifnar1 interaction, the com-
plex dissociates (k22) and re-associates (k2) in a fast
manner (on a sub-second scale). Thus, depending
on the receptor surface concentrations, only part
of the bound ligand is involved in the ternary com-
plex. This fraction is deﬁned by the equilibrium
dissociation constant for the interaction of the
ifnar2-EC–IFN complex with ifnar1-EC on the sur-
face K2 ¼ k22=k2: Since direct dissociation of IFNa2
from the ternary complex is very unlikely (at least
200-fold slower than from ifnar2-EC alone), the
apparent kd value reﬂects the fraction of ifnar2-
EC–IFNa2 not in complex with ifnar1-EC. In cellu-
lar binding assays, a 10–40-fold decrease in KD
caused by ifnar1 has been observed for IFNa2.
33
Assuming that the biophysical environment is in
principle mimicked appropriately, our results
have several important implications for the mech-
anism of receptor assembling. (i) The formation of
a stable pre-formed receptor-complex by inter-
actions mediated via the extracellular domains as
suggested for other receptors
25,27,28 is very unlikely.
(ii) The receptor components are in some way
co-localized on the surface of the plasma mem-
brane, as random distribution of several hundred
receptors on the plasma membrane would not be
sufﬁcient for gaining 20–40 times increased
stability. This is in line with the observation that
ifnar1 and ifnar2 are located in caveolae,
38 leading
to a higher effective concentration. (iii) Different
receptor concentrations not only lead to different
apparent binding afﬁnities, but also different frac-
tions of IFN involved in the ternary complex. This
could explain the different actions and relative
activities of IFNs on different cell types.
Differential signaling
One striking observation of this study was the
much higher afﬁnity of IFNb compared to IFNa2
not only towards ifnar2-EC, but even more
dramatically towards ifnar1-EC. This result is con-
sistent with the observation that ifnar1 co-immuno-
precipitated with ifnar2 in presence of IFNb, but
Figure 10. Scheme of a two-step
formation and kinetic stabilization
of the ternary complex upon IFN
binding.
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5,8 The higher afﬁnity of ifnar1-EC
towards ifnar2-EC and ifnar1-EC has two main
consequences: ﬁrst of all it implies that IFNb
binds to the cellular receptor with more than one
order of magnitude higher afﬁnity than IFNa2.
For IFNa2 mutants, a clear correlation between
afﬁnity towards ifnar2-EC and anti-viral activity
has been shown.
14 The antiviral activity of IFNb is
only by a factor of 2 to 4 higher than for IFNa2,
and not by orders of magnitude. However, satur-
ation of activity has also been observed for human
growth hormone upon enhancing its binding
afﬁnity substantially.
39 While the reason for this
saturation is not fully clear, it is plausible, that this
effect is different for different types of responses.
Second, the higher afﬁnity of IFNb towards ifnar1
implies more efﬁcient ternary complex formation
at low receptor surface concentrations and longer
stability of individual ternary complexes compared
to IFNa2. Such differential efﬁciencies in the
engagement of ifnar1 (and ifnar2) by IFNb com-
pared to IFNa2 could then explain several features
of differential signal activation by IFNs: (i) com-
pared to IFNa, IFNb shows additional gene acti-
vation at lower (i.e. physiological) concentrations,
while at higher concentration similar activities
were observed;
11 (ii) differential signaling is depen-
dent on the cell type,
9 which may be related to
(local) receptor concentrations. Further studies,
and in particular binding experiments with full
transmembrane proteins in living cells, will be
required to test this hypothesis fully. Strikingly,
the important role of the surface afﬁnity K2 (cf.
Figure 10) for the formation of the IL4 receptor
complex has been demonstrated in living cells.
40
Materials and Methods
Materials
IFNb (formulated Rebif 22 mg and 44 mg) was a gift
from Serono GmbH, Unterschleißheim, Germany.
Oregon green 488 (OG-488) maleimide and Alexa Fluor
488 (AF-488) maleimide were purchased from Molecular
Probes Europe BV, Leiden, Netherlands. Synthetic
stearoyl-oleoyl phosphatidylcholine (SOPC) was pur-
chased from Avanti Polar Lipids, Alabaster, USA. The
vector pACgp67B and the BaculoGold baculovirus kit
were purchased from BD Biosciences GmbH, Heidel-
berg, Germany. The vector pMAL-c2x and PNGaseF
were purchased from New England Biolabs, Frankfurt
am Main, Germany.
Protein expression, puriﬁcation and labeling
IFNa2, IFNa2-R149A and tag-less ifnar2-EC (ifnar2-tl)
were expressed in Escherichia coli, refolded from
inclusion bodies and puriﬁed by anion-exchange and
size-exclusion chromatography as described.
41 The wt
ifnar2-EC carrying a C-terminal decahistidine-tag and
its mutant I47A were expressed and puriﬁed in the
same manner. The ifnar2-EC mutant S35C and the
IFNa2 mutant S136C were refolded and puriﬁed as
the wt. After size-exclusion chromatography, the pro-
teins were labeled by adding a threefold molar excess of
OG-488 maleimide or AF-488 maleimide at 4 8C for 18
hours. Finally, they were further puriﬁed by desalting
and anion-exchange chromatography. Binding experi-
ments conﬁrmed that the interaction properties of both
proteins were not affected by mutagenesis and labeling.
OG-488 and AF-488 labeled proteins showed very simi-
lar properties in terms of ﬂuorescence intensities and
bleaching rates. Ifnar1-EC with a C-terminal His-tag
was cloned into the vector pACgp67B and expressed in
Sf9 insect cells using the baculovirus system (Baculo-
Gold). The supernatant was harvested three to four
days after infection and ifnar1-EC was puriﬁed by
immobilized metal chelate afﬁnity chromatography
(IMAC) and size-exclusion chromatography. The protein
was analytically deglycosylated using PNGaseF.
MBP-H10 was expressed using the pMal-c2x vector and
puriﬁed by IMAC and size-exclusion chromatography.
All puriﬁed proteins were more than 95% homogeneous
and monomeric as detected by non-reducing SDS-PAGE
and size-exclusion chromatography.
Solid phase detection techniques
Receptor immobilization, lipid bilayer assembling and
protein interactions were monitored by RIfS. This label-
free detection technique monitors binding on the surface
of a thin silica interference layer,
42,43 and therefore is
compatible with ﬂuorescence detection. Furthermore,
background signals due to changes in the bulk refractive
index as observed by evanescent ﬁeld detection are
much less critical in RIfS-detection.
31 Binding curves
were obtained from the shift of the interference spectrum
of the silica layer: a shift of 1 nm corresponds to approxi-
mately 1 ng/mm
2 protein on the surface. Measurements
were carried out in a ﬂow chamber with an acquisition
rate of 1 Hz under continuous ﬂow-through conditions
as described.
31,42
Binding of ﬂuorescence-labeled proteins was moni-
tored by TIRFS using a home-built setup. A 25 mW
argon ion laser was used for ﬂuorescence excitation at
488 nm. Typically a low excitation power of 2–3 mW
focused onto an area of ,1–2mm
2 was used in order to
minimize photobleaching. Fluorescence was collected by
an optical ﬁber and detected by a photomultiplier tube
through a bandpass ﬁlter. The same transducer slides as
for RIfS detection were used as substrates, and all pro-
cesses on the surface were monitored simultaneously by
single-wavelength RIfS detection at 800 nm. The com-
bined TIRFS-RIfS set-up will be described in more detail
elsewhere. Continuous ﬂow-through conditions were
maintained for all experiments. Data were acquired
with a time resolution between 1.5 s and 16 s, depending
on the kinetics of the process. Photobleaching was mini-
mized by closing the shutter of the excitation source
between the measurements.
Surface modiﬁcation
For probing the interactions between individual
proteins involved in the formation of the ternary com-
plex, the silica surface of the transducer was modiﬁed
with a two-dimensional molecular polymer brush of
poly(ethylene glycol) (PEG) as described.
44 For oriented
immobilization, a chelator head group carrying nitrilo-
triacetic acid (NTA) moieties was covalently coupled to
the PEG polymer brush. This chelator head group binds
decahistidine-tagged proteins with high stability
Type I Interferon Receptor Assembling 315allowing complete blocking of excessive binding sites. Its
synthesis and characterization will be described
elsewhere.
Solid-supported lipid bilayers were obtained by
vesicle fusion on the bare silica surface of the transducer
as described.
45 SOPC in chloroform was mixed with
1–5 mol% of a chelator lipid based on the same chelator
head group mentioned above. After removing the
solvent in vacuo and resuspension into buffer, small
unilaminar vesicles (SUV) were prepared by probe
sonication. The transducer surface was incubated for
30 minutes in a freshly prepared mixture of two parts
30% (v/v) hydrogen peroxide and three parts concen-
trated sulfuric acid. After extensive washing with water,
the transducer was mounted immediately into the ﬂow
cell. SUVs at a concentration of 250 mM were injected
and bilayer formation was followed by RIfS-detection.
Binding assays
All binding assays were carried out in 20 mM Hepes
(pH 7.5) and 150 mM NaCl. The chelator head groups
were loaded with Ni ions by injecting 15 mM nickel(II)-
chloride in running buffer. Depending on the targeted
surface concentrations, the histidine-tagged receptor pro-
teins were injected at concentrations between 2 nM and
1 mM for 100–400 s. Excessive binding sites were blocked
by injecting 1 mM decahistidine-tagged maltose-binding
protein (MBP-H10). Immobilized proteins were removed
with a pulse of 200 mM imidazole (pH 8.0). Ligand bind-
ing experiments and their evaluation were carried out as
described.
31 Protein solutions were diluted at least ﬁve-
fold into the running buffer to avoid background
signals. As a control for speciﬁcity, the highest protein
concentration was applied either without immobilized
protein or after immobilizing MBP-H10. Complex
stoichiometries were estimated from the relative satur-
ation signals taking the molecular masses of the proteins
into account. In the case of rate constants below 0.3 s
21,
association and dissociation rate constants were deter-
mined by ﬁtting a single-exponential function and
assuming a 1 : 1 interaction stoichiometry. Low-afﬁnity
interactions with kd . 0:3s
21 were investigated by deter-
mining the equilibrium response at various ligand con-
centrations. The equilibrium dissociation constant KD
was determined from dose-response curves by ﬁtting
the Langmuir equation. For studying the interaction of
complexes of IFNs and ifnar2-EC with immobilized
ifnar1-EC, ifnar2-tl was added in stoichiometric
amounts, and formation of the stoichiometric complex
was veriﬁed by analytical gel-ﬁltration.
41 The KD value
of the interaction of ifnar1-EC with IFNb–ifnar2-EC
complex in solution was determined by a binding
inhibition assay with 20 nM IFNb–ifnar2-EC and ifnar1-
EC at concentrations between 10 nM and 1 mM. The
initial slope versus ifnar1-EC concentration in solution
was plotted and the KD value determined by ﬁtting the
exact solution of the law of mass action as described.
46
Fluorescence recovery after photo-bleaching (FRAP)
Fluorescence imaging and recovery experiments were
carried out with a laser scanning confocal microscope
(LSM 510; Zeiss, Jena) equipped with a 25 mW argon
ion laser. Bilayer assembling and receptor attachment
were carried out in a ﬂow cell with automated sample
handling. The ifnar2-EC mutant S35C labeled with OG-
488 was immobilized as described above. A circular
spot with a diameter of 20–30 mm was bleached by scan-
ning for 9 s at 75% laser power. Immediately afterwards
images were acquired at 0.1–0.4% laser power by scan-
ning for 1.9 s with a time interval of 5–10 s. Diffusion
constants were calculated from the t1=2 determined from
the recovery curves as described
47 using a g-factor of 1.
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318 Type I Interferon Receptor AssemblingPaper II Lateral Ligand-Receptor Interactions on Membranes Probed by
Simultaneous Fluorescence-Interference Detection
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ABSTRACT We describe an experimental approach for studying ligand-receptor interactions in the plane of the membrane.
The extracellular domains of the type I interferon receptor subunits ifnar1-EC and ifnar2-EC were tethered in an oriented fashion
onto solid-supported, ﬂuid lipid bilayers, thus mimicking membrane anchoring and lateral diffusion of the receptor. Ligand-
induced receptor assembling was investigated by simultaneous total internal reﬂection ﬂuorescence spectroscopy and
reﬂectance interferometry (RIf). Based on a rigorous characterization of the interactions of ﬂuorescence-labeled IFNa2 with
each of the receptor subunits, the dynamics of the ternary complex formation on the ﬂuid lipid bilayer was addressed in further
detail making use of the features of the simultaneous detection. All these measurements supported the formation of a ternary
complex in two steps, i.e., association of the ligand to ifnar2-EC and subsequent recruitment of ifnar1-EC on the surface of the
membrane. Based on the ability to control and quantify the receptor surface concentrations, equilibrium, and rate constants of
the interaction in the plane of the membrane were determined by monitoring ligand dissociation at different receptor surface
concentrations. Using mutants of IFNa2 binding to ifnar2-EC with different association rate constants, the key role of the asso-
ciation rate constants for the assembling mechanism was demonstrated.
INTRODUCTION
Lateral interactions between membrane proteins play a key
role for activation and propagation of cellular signaling.
These lateral interactions are not static in nature and are often
triggered or stabilized by interactions with further, soluble
interaction partners such as ligands, effectors, and binding
proteins from the matrices adjacent to the lipid bilayer. Thus,
ligand-induced interaction between two or more transmem-
brane proteins has been recognized as the basic principle for
signal transduction through receptor tyrosine kinases,
(Ullrich and Schlessinger, 1990) as well as cytokine recep-
tors (Cunningham et al., 1991). Although recent studies have
challenged this model for several cytokine receptors and
more complex mechanisms for interreceptor interactions
have been proposed (Gent et al., 2003; Grotzinger, 2002;
Remy et al., 1999; Sebald and Mueller, 2003; Stroud and
Wells, 2004), simultaneous interaction of the ligand with
several transmembrane proteins is still believed to be the
cause of receptor activation. The interactions involved in the
formation of these complexes have been characterized in
solution to much detail. To conclude their consequences for
signaling, a better understanding of the biophysical princi-
ples governing ligand-induced assembling of the signaling
complex on the cellular membrane is needed. After ligand
binding, the subsequent interactions take place in the plane
of the membrane. This reduction in dimensionality has been
proposed to have important physicochemical consequences
(Adam and Delbruck, 1968; Axelrod and Wang, 1994;
DeLisi, 1980; Vanden Broek and Thompson, 1996; Wang
et al., 1992). Therefore, lateral rate and afﬁnity constants
cannot be readily deduced from the interaction parameters
determined in solution. Furthermore, the coupling of ligand
binding with the lateral interactions makes deconvolution of
the two processes difﬁcult as subtle interactions undetectable
in bulk phase could still affect the complex formation on the
surface of the membrane.
Recently, we have established detection means for as-
saying the interaction of type I interferons (IFNs) with their
soluble receptor domains ifnar1-EC and ifnar2-EC tethered
onto solid-supported membranes (Lamken et al., 2004).
Although only three components are involved, the assembly
process could be considerably complicated. Thus, surface-
sensitive techniques suitable for deconvoluting different
facets of the assembling process in real time are required.
Total internal reﬂection ﬂuorescence spectroscopy (TIRFS)
has been frequently used for monitoring ligand binding at
surfaces and solid-supported membranes (Axelrod et al.,
1984; Schmid et al., 1998; Thompson et al., 1997, 1993;
Thompson and Lagerholm, 1997). High sensitivity of TIRFS
makes binding events detectable even at very low surface
concentrations, and provides the versatility of ﬂuorescence
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sorbed molecules without a reference/standard is not possible.
By exclusive detection of the ﬂuorescent molecules, high
signal/background ratios are achieved, but only a very
limited picture of all binding events at the surface is
obtained. As an alternative, label-free detection of surface-
adsorbed molecules by optical techniques (Haake et al.,
2000), e.g., surfaceplasmonresonance (SPR),gratingcouplers
or resonant mirror, as well as by nonoptical techniques, e.g.,
quartz crystal microbalance (Marx, 2003) or surface acoustic
waves (Gizeli et al., 1997) has been described. These
techniques detect and quantify all adsorbed materials in real
time, but lack the speciﬁcity and sensitivity of ﬂuorescence
detection. Thus, TIRFS would be ideally complemented
with label-free detection. Combination of TIRFS with SPR
(surface plasmon ﬁeld-enhanced ﬂuorescence spectroscopy)
has been shown to be a powerful tool for characterizing
processes at interfaces (Liebermann and Knoll, 2000;
Neumann et al., 2002). This technique uses the same light
source for ﬂuorescence excitation as for SPR detection, thus
limiting the ﬂexibility of each technique. The metal layers
required for SPR are furthermore disadvantageous due to
their strongly surface distance-dependent ﬂuorescence
quenching.
Here, we describe a novel combination of TIRFS with
reﬂectance interferometry (RIf) at a thin silica layer for
studying lateral interactions at supported lipid bilayers.
Spectral RIf has proven rugged and powerful for label-free
detection of cytokine-receptor interactions (Piehler and
Schreiber, 2001). The interaction of ﬂuorescence-labeled
IFNa2 with the extracellular domains of its receptor subunits
ifnar1-EC and ifnar2-EC tethered onto solid-supported, ﬂuid
lipid bilayers containing chelator lipids (Dorn et al., 1998;
Schmitt et al., 1994) was used as a model system. Based on
simultaneous ﬂuorescence and mass sensitive detection, we
deconvoluted the interactions of this ligand with its receptor
components on the lipid bilayer. Assuming a two-step
kinetic complex assembling and disassembling model, we
determined the association rate constant and the equilibrium
dissociation constant of the lateral interaction of ifnar1-EC
with IFNa2 bound to ifnar2-EC on the lipid bilayer surface.
Further mechanistic aspects of receptor assembling were
demonstrated by using mutants of IFNa2 binding to ifnar2-
EC with different association rate constants.
MATERIALS AND METHODS
Proteins expression and puriﬁcation
IFNa2, ifnar2-EC carrying a C-terminal decahistidine tag and tagless ifnar2-
EC (ifnar2-tl) were expressed in Escherichia coli, refolded from inclusion
bodies, and puriﬁed by ion exchange and size exclusion chromatography as
described before (Piehler and Schreiber, 1999). In the structure of the ifnar2-
EC-IFNa2 complex obtained by NMR and distance-constrained docking
(Chill et al., 2003; Roisman et al., 2001), the residue S136 of IFNa2 was
found proximal, yet not in contact with ifnar2-EC. This residue was mutated
to a cysteine residue for site-speciﬁc ﬂuorescence labeling. IFNa2-S136C,
IFNa2-S136CR144A, and IFNa2-S136CM148A were refolded and pu-
riﬁed as the wt, and labeled with Alexa Fluor 488 (AF488) maleimide or
Oregon Green 488 (OG488) maleimide (both from Molecular Probes,
Eugene, OR). After the labeling reaction, the labeled protein was further
puriﬁed by a ﬁnal step of anion exchange chromatography (HiTrap Q,
Amersham Biosciences, Buckinghamshire, UK), by which the ﬂuorescence-
labeled species was further enriched. In a ﬁnal desalting step (HiTrap
desalting, Amersham Biosciences), residual ﬂuorescence dye was removed.
Typical labeling degrees were 60–80% as estimated from the absorbance
spectra. These ﬂuorescence-labeled IFNs will be referred to as
AF488IFNa2,
AF488IFNa2-M148A, and
OG488IFNa2-R144A,respectively.Ifnar1-ECwith
a C-terminal decahistidine tag was expressed in Sf9 insect cells and puriﬁed
from the supernatant by immobilized metal afﬁnity chromatography and by
size exclusion chromatography as described earlier (Lamken et al., 2004).
All binding assays were carried out with the glycosylated protein, which had
an average molecular mass of 57 kDa as determined by mass spectrometry.
Simultaneous TIRFS-RIf detection
The experimental setup was implemented as schematically shown in Fig. 1.
The beam of a 488-nm Argon ion laser (162LGA/LGL, LG Laser Tech-
nologies, Kleinostheim, Germany), equipped with an electrical shutter
(Uniblitz, Vincent Associates, Rochester, NY), was coupled into a 50-mm
core diameter optical ﬁber (Ocean Optics, Duiven, The Netherlands).
Excitation power was attenuated by misaligning the laser-to-ﬁber coupling.
The light from the ﬁber output was focused onto the sample surface with
an adjustable collimator lens (OFR-CSMA-5-VIS, Optics for Research,
Verona, NJ) through a custom-made glass prism (Berliner Glas KGaA,
Berlin, Germany) with a 2.8-mm hole in the center. This hole was used for
attaching the ﬁber optics for ﬂuorescence detection as well as for reﬂectance
interferometry (c.f. Fig. 1 C) using a custom-made optical ﬁber bundle
(Ratioplast, Lo ¨hne, Germany), which is depicted in Fig. 1 B. The 600-mm
ﬁber in the center was used for ﬂuorescence detection. After passing an
infrared cutting ﬁlter (Linos Photonics, Go ¨ttingen, Germany) the appropri-
ate spectral range was selected with a 532-nm interference ﬁlter (Edmund
Optics, Blackwood, NJ) mounted in a motorized ﬁlter wheel (AB-303, CVI
Laser, Albuquerque, NM) and detected by a photomultiplier module
(H7711-02, Hamamatsu, Herrsching, Germany). For reﬂectance interfer-
ometry, the surrounding 200-mm ﬁbers of the ﬁber bundle were used: half
of them were combined into a ﬁber bundle for illumination, whereas the
other half was combined into a ﬁber bundle for detecting the reﬂected light.
The transducer element (10 nm Ta2O5 and 400 nm silica on a glass
substrate, custom-made from AMP Du ¨nnschichttechnik GmbH, Tornesch,
Germany) was optimized to give a spectral interference pattern with the
inﬂection point at 800 nm upon perpendicular illumination (Fig. 1 D).
White light from a tungsten halogen lamp (Avantes, Boulder, CO) was
monochromatized using an 800-nm interference ﬁlter (Edmund Optics) and
a 780-nm-long pass ﬁlter (LOT Oriel, Darmstadt, Germany), and was
coupled into the illumination ﬁbers. The reﬂected light collected by the
detection ﬁbers passed a second 800-nm interference ﬁlter (Edmund Optics)
and was detected with a photomultiplier tube (H7711-02, Hamamatsu). The
spectral characteristics of the detection system are shown in Fig. 1 D,
demonstrating the strict spectral separation of ﬂuorescence and interference
signals.
The transducer was mounted to a ﬂow cell with a 1-mm wide and
100-mm deep ﬂow channel. Sample handling was carried out in a ﬂow-
through format using a syringe pump (Microlab 541C) with two 250-ml
syringes and a four-way distribution valve (MVP) (both from Hamilton,
Bonaduz, Switzerland) as in principle described before (Piehler and
Schreiber, 2001), which were combined with an autosampler (PS 60, MLE
GmbH, Radebeul, Germany). With this system, ﬂow rates between 1 and
500 ml/s can be employed. Sample handling and data acquisition were
controlled with software written in LabVIEW (National Instruments,
Munich, Germany).
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The ﬂuorescent vesicles used for characterization of the setup were prepared
by doping SOPC with the ﬂuorescent lipids as obtained by reacting SOPE
with OG488 N-hydroxysuccinimide ester (Molecular Probes). The lipids
were homogeneously mixed in the appropriate proportion by dissolving in
chloroform. The solvent was then removed in vacuo and the thin lipid ﬁlm
was suspended in the buffer. The translucent solution was intermittently
probe sonicated in a water bath at 4C for 15 min followed by centrifugation
to obtain small unilaminar vesicles (SUV) in the supernatant. For protein
tethering to the lipid membrane, the vesicles were prepared in an identical
fashionasfortheﬂuorescentvesicles,except,SOPCwasdopedwith5mol%
of a chelator lipid based on a novel chelator headgroup containing two NTA
moieties (termed bis-NTA). This chelator headgroup binds decahistidine-
tagged proteins with substantially increased stability compared to the
conventional mono-NTA, and no signiﬁcant dissociation of decahistidine-
tagged ifnar2-EC was detectable (i.e., kd , 0.0005 s
 1) even at low surface
concentrations of chelator headgroups (Lata and Piehler, 2005). To avoid
phase segregation, this chelator lipid contained one unsaturated alkyl chain.
Its synthesis and characterization will be detailed in a forthcoming article.
Beforevesiclefusion,thetransducerwasincubatedfor30mininafreshly
prepared 2:3 mixture of two parts 30% hydrogen peroxide and three parts
concentrated sulfuric acid. After extensive washing with water, the trans-
ducer was dried in a nitrogen stream and mounted immediately into the ﬂow
cell. Bilayer assembling, immobilization of the receptor domains and ligand
binding assays were carried out with 20 mM HEPES, pH 7.5, and 150 mM
NaCl as the running buffer. Solid supported lipid bilayers were obtained by
injecting SUVs at a lipid concentration of 250 mM on the surface of the
transducer. Protein immobilization and binding assays were in principle
carried out as described earlier (Lamken et al., 2004). For tethering the
histidine-tagged proteins to the supported membranes, the chelator head-
groups were loaded with Ni
21-ions by injecting 10 mM nickel(II)chloride in
the running buffer for 150 s followed by a 150-s injection of 200 mM
imidazole to remove nonspeciﬁcally attached lipids. Depending on the
targeted surface concentrations, the histidine-tagged receptor proteins were
injected at concentrations between 2 nM and 1 mM for 100–400 s. For
coimmobilization ofifnar1-ECandifnar2-EC,the proteinswereinjected one
after the other to quantify the amount of each of the receptor components.
The ligand was then injected at concentrations between 100 and 200 nM for
150 s with a ﬂow rate of 1 ml/s, followed by a wash with 10 ml/s. Maximum
ﬂow rates of 250 ml/s were applied for measurement of fast kinetics. After
a set of ligand binding experiments, all attached proteins were removed by
a 150-s pulse of 200 mM imidazole, and the subsequent binding assays were
carried out on the same lipid bilayer.
Data evaluation
Data were analyzed using Origin (Microcal Software), Biaevaluation 2.1
(Biacore), or Berkeley Madonna (UCB) software packages. If necessary, RIf
curves were corrected for a linear drift based on the signals before tethering
the proteins and after regeneration with imidazole. Different models were
used for data evaluation of individual ligand-receptor interaction and for
ligand binding and dissociation to ifnar1-EC and ifnar2-EC coimmobilized
on supported lipid bilayers.
Pseudo-ﬁrst-order binding model
Ligand binding to individual receptors was ﬁtted with standard pseudo-ﬁrst-
order kinetic models for association (Eq. 1) and dissociation (Eq. 2)
(Eddowes, 1987):
RðtÞ¼Reqð1   e
 ðka 3 c1kdÞ 3 ðt t0ÞÞ (1)
RðtÞ¼R0 3 e
 kd 3 ðt t0Þ: (2)
R(t) is the signal at time t, Req is the equilibrium signal, R0 is the signal at
t ¼ t0, ka and kd are association and dissociation rate constants, respectively,
and c is the ligand concentration. The equilibrium dissociation constant KD
was determined from the rate constants of the interaction according to Eq. 3:
KD ¼ kd=ka: (3)
FIGURE 1 (A) Schematic of the setup for simultaneous TIRFS-RIf
detection (details in the text). (B) Cross section of the ﬁber at the interface to
the transducer: The 600-mm ﬁber in the center was used for ﬂuorescence
detection. The surrounding 200-mM ﬁbers where used for RIf illumination
and for RIf detection. (C) Enlarged view of the coupling of the light beam
for ﬂuorescence excitation into the RIf transducer, and the ﬁbers for RIf
illumination (1), RIf detection (2), and ﬂuorescence detection (3). (D)
Spectral separation of RIf and TIRFS detection: reﬂectivity of the RIf
transducer at perpendicular illumination (dashed line) and transmission of
the interference ﬁlter used for RIf detection (dotted line), in comparison to
the ﬂuorescence emission spectrum of AF488 (solid line).
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No interactions between the extracellular domains of the receptor subunits
have been detectable by several techniques (Lamken et al., 2004), and
therefore preassembling of the receptor could be excluded under the
experimental conditions employed in this study. Furthermore, no co-
operative effect of ifnar2-EC/IFN complex formation on the IFNa2-ifnar1-
EC interaction has been observed (Lamken et al., 2004). Therefore, the
formation and the dissociation of the ternary complex on supported lipid
bilayers was modeled as a two-step process (Whitty et al., 1998) as depicted
in Fig. 2. After binding ligand of IFNa2 (L) to the high-afﬁnity receptor
ifnar2-EC (R2) on the membrane surface to form the binary IFNa2-ifnar2-
EC-complex (B), ifnar1-EC is recruited by lateral interaction on the surface
into the ternary complex (T). The rate constants kB
a and kB
d are the solution
association and dissociation rate constants of the IFNa2-ifnar2-EC inter-
action with the volume-related equilibrium constant KB
D. The rate constants
kT
a and kT
d are the surface association and dissociation rate constants,
respectively, of the formation of the ternary complex from the binary com-
plex and ifnar1-EC, and KT
D the corresponding surface-related equilibrium
dissociation constant. The following set of differential equations (as derived
in more detail in the Appendix) was used for ﬁtting the dissociation phase:
d½T 
dt
¼ k
T
a 3 ½B  3 ð½R1 0  ½ T Þ   k
T
d 3 ½T 
d½B 
dt
¼  k
T
a 3 ½B  3 ð½R1 0  ½ T Þ1k
T
d 3 ½T  k
B
d 3 ½B 
½S ¼½ T 1½B : (4)
[R1]0 and [R2]0 were initial surface concentrations of ifnar1-EC and
ifnar2-EC, respectively. [S] was the total surface concentration of the ligand,
which was detected in a time-resolved manner by the TIRFS signal and
converted into an absolute surface concentration using a calibration by RIf.
Because [T] and [B]a tt ¼ 0 could not be parameterized, we assumed
[T] ¼[R2]0 and[B]¼ 0as startingparameter for theﬁtting.Owingto the fast
exchangekinetics,theactualvaluesfor[T]and[B]werereachedwithinafew
seconds—much faster than the dissociation of the ligand. The parameters
[R1]0 and [R2]0 were estimated from the RIf signal of the respective
experiment, whereas the values for kB
d and kT
d were taken from the binding
assays with the individual receptors. The only ﬁtted parameter was kT
a . The
surface dissociation constants KT
D were determined from kT
a and kT
d;
according to Eq. 3. Ligand association and ternary complex assembling
kinetics was simulated using Eq. A5 using the experimentally determined
parameters.
RESULTS
Characterization of the detection system
Solid-supported lipid bilayers are reproducibly formed by
vesicle fusion on glass-type surfaces (Brian and McConnell,
1984), and have been characterized in detail with various
techniques (Nagle and Tristram-Nagle, 2000; Sackmann,
1996). We therefore used lipid bilayer formation to assess
the performance of TIRFS-RIf detection setup. SUVs con-
taining OG488-labeled lipids were injected onto hydrophilic
silica surfaces and fusion was monitored simultaneously on
the ﬂuorescence (TIRFS) and the interference (RIf) channels
(Fig. 3 A). Upon a complete bilayer formation, a total de-
crease of (6.7 6 0.2) % in the light intensity was measured in
the RIf channel. Assuming a surface density of 5 ng/mm
2 for
a lipid bilayer (Keller and Kasemo, 1998), the RIf signal was
calibrated to a mass loading of 0.7 ng/mm
2 per percentage
decrease in intensity. By comparing the signals obtained for
vesicle fusion by RIf and by spectral RIf, for which the mass
sensitivity has been determined with radioactively labeled
proteins (Hanel and Gauglitz, 2002), this mass sensitivity
was also conﬁrmed for proteins (data not shown). For clarity
sake, the RIf signal converted into surface mass loading will
be shown in the measurements to follow (Fig. 3 B). Based on
this calibration, a typical rms noise of 10 pg/mm
2 was deter-
mined for the RIf signal at a data acquisition rate of 1 Hz.
This value is ;53 higher than the rms noise of optimized
spectral RIf systems under similar conditions of data acqui-
sition (Piehler and Schreiber, 2001). In contrast to the un-
altered RIf signal, the ﬂuorescence signal for a full bilayer
FIGURE 2 (A) Structure of the bis-NTA lipid used for tethering the
extracellular receptor domains on supported lipid bilayer in a stable, yet
reversible manner (B). (C) Illustration of the two-step mechanism assumed
for the formation and dissociation of the ternary complex. (D) The
corresponding interaction scheme with the identiﬁers used in the equations.
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vesicles (Fig. 3 C). At concentrations below 1 mol%, the
signalobserved fora full lipid bilayer linearly correlated with
the fraction of the labeled lipids. Assuming an area of 70 A ˚ 2
per lipid molecule (Nagle and Tristram-Nagle, 2000), a
detection limit of ;0.1 fmol/mm
2 was reached with an
excitation power of ;3 mW/mm
2 (Fig. 3 D). Consequently,
by increasing the excitation power, considerably lower
surfaceconcentrationsthan;0.1fmol/mm
2shouldbedetect-
able. Yet all further experiments were carried out at this low
a power so that the binding curves were least biased by
photobleaching. For the same reason, shutter-triggered data
collection was applied while monitoring slow dissociation
processes. An important feature of this setup is that the two
optical techniques are spectrally separated: the light intensity
of the RIf channel was several orders of magnitude higher
than the typical ﬂuorescence intensity, yet no cross talk be-
tween the channels was detected. This holds true also for
yellow-ﬂuorescent dyes, which were also successfully used
with this setup using a frequency-doubled Nd-YAG laser
(532 nm) for excitation (data not shown).
To assess the ability of measuring transient interactions by
TIRFS, the contribution of the background ﬂuorescence
from the bulk was investigated by injecting OG488 dye at
different concentrations (Fig. 4 A). These experiments were
carried out on solid-supported lipid bilayers containing
chelator lipids. The signal from bulk ﬂuorescence was above
the noise level at dye concentrations of 200 nM and higher.
The signals were fully transient and their amplitudes cor-
related linearly with the dye concentrations (Fig. 4 A). We
used the dye injections to estimate the upper limit of the
determinable rate constants. For the rise as well as the decay
of the concentration in the ﬂow cell, rate constants of ;5s
 1
were obtained by ﬁtting monoexponential curves (Fig. 4 B).
IFNa2 interaction with ifnar2-EC and ifnar1-EC
The interaction of wild-type IFNa2 with its receptor subunits
ifnar1-EC and ifnar2-EC was previously described in detail
(Lamken et al., 2004). Here, we used the IFNa2 mutant
S136C with an additional cysteine, to which the ﬂuorophore
AF488 was coupled site speciﬁcally (
AF488IFNa2). To ex-
clude that these modiﬁcations of the protein affected its
binding properties, we characterized the interaction with
each of the receptor subunits. The interaction parameters ob-
tained from these measurements are summarized in Table 1.
Fig. 5 shows TIRFS and RIf signals during the course of a
typical binding assay that includes the following main steps:
bilayer formation by fusion of vesicles containing 5% bis-
NTA lipids (1); tethering of the high-afﬁnity receptor
component ifnar2-EC through their C-terminal decahistidine
tags (4); binding of the ﬂuorescently labeled ligand (5), and
removal of the bound proteins with imidazole (6). Each of
these steps was monitored quantitatively by RIf, conﬁrming
stable tethering of ifnar2-EC. The binding of the labeled
ligand, was also detected on the TIRFS channel with sub-
stantially higher signal/noise ratio in comparison to the RIf
channel. An overlay of the signals obtained by TIRFS and by
RIf for the injection of
AF488IFNa2 is shown in Fig. 6 A. For
both the association and the dissociation phase, very similar
shapes of TIRFS and RIf signals were observed. The dis-
sociation curves were ﬁtted by a monoexponential decay
(Eq. 2) yielding a dissociation rate constant kd of (0.010 6
0.002) s
 1 for both signals. An association rate constant ka of
;3 3 10
6 M
 1s
 1 estimated from a monoexponential ﬁt of
the association phase (Eq. 1). Both ka and kd obtained for the
AF488IFNa2 were in good agreement with the data obtained
with wild-type IFNa2 (Lamken et al., 2004; Piehler and
Schreiber, 2001) under similar experimental conditions, con-
ﬁrming that the mutation and the coupling of a ﬂuorophore
FIGURE 3 Characterization of simultaneous TIRFS-RIf
detection. (A) Fusion of unilaminar vesicles containing
ﬂuorescently labeled lipids simultaneously detected by RIf
(solid line) and TIRFS (dotted line). (B) Overlay of the
curves shown in panel A after RIf intensity change was
converted into surface mass deposition. (C) RIf (h) and
TIRFS (d) signals observed for a full lipid bilayer at
different fractions of labeled lipids. (D) RIf (solid line) and
TIRFS (dotted line) signals at a fraction of 10
 4%
ﬂuorescent lipids.
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tion and dissociation curves indicated mass transport effects,
which have been frequently observed for interactions at the
solid-liquid interface at high surface concentrations (Glaser,
1993; Lagerholm and Thompson, 1998; Schuck and Minton,
1996). Therefore, ligand binding at lower surface concen-
tration of ifnar2-EC was investigated (Fig. 6 B), which was
possible because of the higher signal/noise ratio of ﬂuo-
rescence detection. At ifnar2-EC surface concentrations
below 150 pg/mm
2 (6 fmol/mm
2), association and dissoci-
ation phases basically unbiased by mass transport limitation
were observed. Furthermore, dissociation of
AF488IFNa2i n
the presence of 1 mM IFNa2 was measured (Fig. 6 C), which
gave a very similar dissociation curve as obtained at low
ifnar2-EC surface concentrations (Fig. 6 D). From these
experiments, an average kd of 0.013 6 0.002 s
 1 was deter-
mined for the molecular interaction of
AF488IFNa2 with
ifnar2-EC. Furthermore, a strict 1:1 interaction between
ifnar2-EC and IFNa2 on the lipid bilayer was conﬁrmed. No
differences in binding properties were observed between
AF488IFNa2 and
OG488IFNa2 (data not shown).
For the interaction of IFNa2 with ifnar1-EC, a KD of
5 mM has been previously determined, which is three orders
of magnitude higher than the KD of the interaction of IFNa2
with ifnar2-EC (Lamken et al., 2004). Dissociation of the
ligand was too fast to be resolved by RIf. Owing to a higher
signal/noise ratio, dissociation of
AF488IFNa2 from ifnar1-
EC could be resolved by TIRFS detection at low receptor
surface concentration (i.e., unbiased by rebinding). To mini-
mize background signals, the ligand was injected at a con-
centration of 200 nM. The ﬂuorescence signal upon ligand
injection is shown in (Fig. 6 C). From these experiments, a kd
of (1 6 0.3) s
 1 was determined by ﬁtting Eq. 2. Thus, the
IFNa2-ifnar1-EC complex is ;100-fold less stable than the
IFNa2-ifnar2-EC complex (Fig. 6 D). The ka could not be
reliably determined from these curves. However, a similar
KD of ;5 mM was concluded for
AF488IFNa2 as for wild-
type IFNa2 by comparing the equilibrium amplitudes
determined by RIf at different ligand concentrations (data
not shown). From these values, a ka of ;2 3 10
5 M
 1s
 1
was estimated for this interaction using Eq. 3. Thus, the
ligand binds .10 times faster to ifnar2-EC than to ifnar1-
EC. The same binding experiment was carried out with
AF488IFNa2 in stoichiometric complex with ifnar2-tl (data
not shown). A dissociation rate constant of ;1s
 1 was
determined, conﬁrming the similar afﬁnity of IFNa2 and the
IFNa2-ifnar2-EC complex for ifnar1-EC (Lamken et al.,
2004). Thus, the interaction of ifnar2-EC with IFNa2 does
not signiﬁcantly affect the binding afﬁnity of IFNa2 toward
ifnar1-EC. The same binding experiments were carried out
with the ﬂuorescence labeled mutants
AF488IFNa2-M148A
and
OG488IFNa2-R144A, which bind with altered afﬁnity to
ifnar2-EC. Also for these proteins, the S136C mutation and
coupling of the ﬂuorophore did not affect the binding prop-
erties (see below).
Ligand-induced receptor assembling
To study ligand-induced receptor assembling, both ifnar2-
EC and ifnar1-EC were tethered sequentially to the lipid
bilayer. The absolute amounts tethered to the surface were
quantiﬁed by RIf detection. Then, 100 nM
AF488IFNa2 was
injected for ensuring maximum coverage of the high-afﬁnity
component ifnar2-EC, and the interaction was monitored
simultaneously by RIf and TIRFS. A set of experiments with
different absolute and relative surface concentrations of
ifnar2-EC and ifnar1-EC is shown in Fig. 7. At high sur-
face concentrations of both the receptor components in
stoichiometric amounts (;12 fmol/mm
2), ligand dissociated
very slowly (Fig. 7 A). When the surface concentrations of
both receptor components were reduced by a factor of ;6,
considerably faster dissociation was observed (Fig. 7 B).
However, when only the surface concentration of ifnar2-EC
was low (;2 fmol/mm
2), and the surface concentration of
ifnar1-EC was high (;12 fmol/mm
2), the ligand dissociated
at a comparably slow rate (Fig. 7 C). With a stoichiometric
excess of ifnar2-EC on the surface, a biphasic decay with a
high offset of stable-bound IFNa2 was observed (Fig. 7 D).
The kd of the faster decay matched the kd of the IFNa2-
ifnar2-EC interaction, whereas the remaining amount of
IFNa2 conﬁrmed a 1:1:1 stoichiometry of the complex of
IFNa2 with ifnar2-EC and ifnar1-EC. The association phases
for these experiments are compared in Fig. 7 E. Again, mass
transport limitation was observed at high surface concen-
trations of ifnar2-EC (.4 fmol/mm
2). At low surface con-
centrations, the association phase perfectly matched the
FIGURE 4 Background signals and time resolution. (A)
Background ﬂuorescence signals from OG488 dye in
solution. The inset shows the linear dependence of the
signal on the ﬂuorophore concentration. (B) Concentration
proﬁle obtained from bulk ﬂuorescence measurements and
ﬁt of the rise and decay phases by monoexponential
functions.
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was obtained by ﬁtting Eq. 1.
The striking differences in the dissociation kinetics
observed in these experiments support a kinetic stabilization
of the ternary complex, and underscore the importance of
quantifying receptor surface concentrations. The dynamic
nature of the ternary complex was furthermore corroborated
by challenging the ternary complex formed with
AF488IFNa2
with unlabeled IFNa2 (Fig. 8 A). This experiment was
carried out at relatively low receptor surface concentration,
thus excluding bias of the dissociation kinetics by rebinding.
Fast exchange of the labeled ligand was observed with much
higher rate constant than the dissociation of the unchallenged
ligand. Chasing with tagless ifnar2-EC did not accelerate
ligand dissociation (data not shown), excluding that this
effect was due to rebinding. We explain this fast exchange of
the ligand by additional binding of the unlabeled ligand to
unoccupied receptor subunits, which could even be detected
by RIf (Fig. 8 B). This fast ligand exchange strongly supports
a dynamic equilibrium between ternary and binary com-
plexes.
Interaction in plane of the membrane
With stoichiometric amounts of ifnar1-EC and ifnar2-EC,
we assumed a simpliﬁed two-step mechanism for receptor
formation and dissociation as depicted in Fig. 2 because of
the higher afﬁnity and association rate constants of IFNa2
binding to ifnar2-EC. Under these conditions, the rate of
ligand dissociation from the surface in the presence of
ifnar1-EC is a probe of the dynamic equilibrium between
binary (ifnar2-EC/IFNa2) and ternary complex on the
membrane. We therefore determined this surface dissoci-
ation constant of this lateral interaction by evaluating
ligand dissociation at various stoichiometric surface
concentrations of ifnar2-EC and ifnar1-EC at stoichiomet-
ric ratio. For calculating the signals into surface concen-
trations, the ﬂuorescence signal was calibrated against the
mass-sensitive signal. A linear correlation of the maximum
ligand binding ﬂuorescence signals with the receptor
surface concentration as determined by RIf was observed
(Fig. 9 A). This calibration allowed: i), conversion of the
ﬂuorescence signals, as observed during ligand binding
and dissociation, into mass loading (Fig. 9 B), and ii),
precise assessment of absolute receptor surface concen-
trations even at low surface coverage. To determine the
association rate constant kT
a of the interaction of ifnar2-EC-
bound IFNa2 with ifnar1-EC on the bilayer surface, Eq. 4
was ﬁtted to the ligand dissociation phase with kT
a as the
only ﬁtting parameter, whereas all the other parameters
were ﬁxed at the values determined in the previous
measurements: kB
d was parameterized with the rebinding-
corrected kd of the ifnar2-EC-IFNa2 interaction (0.013
s
 1); kT
d was parameterized with the kd of the interaction of
the ligand with ifnar1-EC from solution (1 s
 1), assuming
that tethering the complex on the membrane did not affect
the complex lifetime. The receptor surface concentrations
[R1]0 and [R2]0 were determined directly from the RIf
signals. Despite the constrained parameterization, very
good agreement of the ﬁt was observed for all the
measured curves (Fig. 9, C and D), which was
signiﬁcantly better than a monoexponential ﬁt (Lamken
et al., 2004). The kT
a determined at different surface
concentrations and the corresponding surface dissociation
constant KT
D are listed in Table 2. Strikingly, similar values
for kT
a were obtained for all dissociation curves, resulting
into an average kT
a of (16.5 6 1.6) mm
2fmol
 1s
 1 or
;0.027 mm
2molecules
 1s
 1. From the surface rate con-
stants, a surface equilibrium dissociation constant KT
D of
0.061 6 0.006 fmol/mm
2 or ;36 mol/mm
2 was de-
termined using Eq. 3.
FIGURE 5 Course of a typical binding experiment on supported lipid
bilayers as detected by RIf (solid line) and TIRFS (dashed line). Injection of
(1) SOPC SUVs, (2) 10 mM nickel(II)chloride, (3) 200 mM imidazole, (4)
300 nM ifnar2-H10, and (5) 100 nM
AF488IFNa2.
TABLE 1 Parameters of the interaction with ifnar2-EC and ifnar1-EC for IFNa2 and the mutants used in this study
Ifnar2-EC Ifnar1-EC
IFNa2* ka [M
 1s
 1] kd [s
 1] KD [nM] kd [s
 1] KD [mM] ka [M
 1s
 1]
wt (3 6 1) 3 10
6 0.013 6 0.002 4 6 21 6 0.3 ;5 ;2 3 10
5
M148A (3 6 1) 3 10
6 0.3 6 0.05 100 6 40 1 6 0.3 ;5 ;2 3 10
5
R144A (3 6 1) 3 10
5 0.04 6 0.005 130 6 50 0.9 6 0.3 ;5 ;2 3 10
5
*All species carried the S136C mutation and were site-speciﬁcally labeled with OG488 or AF488.
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Based on these results we simulated the assembling kinetics
at different receptor surface concentrations (Fig. 10 A) and
different stabilities of the ligand complex with ifnar2-EC
(Fig. 10 B). These simulations showed that ligand associa-
tion to ifnar2-EC is the rate-determining step in ternary
complex assembling (Fig. 10 A). Consequently, assembling
mechanism should be primarily determined by the faster
association of the ligand to ifnar2-EC compared to ifnar1-
EC, and not by the stability of the complex with ifnar2-EC
(Fig. 10 B). Owing to the principle of microscopic re-
versibility, this faster interaction of the ligand with ifnar2-EC
should also dictate the dissociation mechanism. To test this
hypothesis, the dissociation from the ternary complex was
probed with the mutants IFNa2-M148A and IFNa2-R144A.
These mutants bind ifnar2-EC with 25–30-fold lower afﬁnity
than the wild type, but with very different rate constants
(Piehler et al., 2000): for IFNa2-M148A, the ka is unchanged
compared to the wild type, whereas for IFNa2-R144A, the ka
is decreased by one order of magnitude. These mutants were
site-speciﬁcally ﬂuorescence labeled with AF488 (M148A)
and OG488 (R144A) through the S136C mutation as the
wild-type protein (
AF488IFNa2-M148A and
OG488IFNa2-
R144A, respectively), and the interaction with ifnar2-EC
was characterized by TIRFS-RIf detection. The dissociation
of these IFNa2 mutants from ifnar2-EC are compared in Fig.
11 A. The rate constants obtained for the mutants (Table 1)
were in good agreement with the published values, while
binding to ifnar1-EC was unchanged compared to the wild
type (data not shown).
With ifnar2-EC and ifnar1-EC coimmobilized on lipid
bilayers, for both
OG488IFNa2-R144 and
AF488IFNa2-
M148A signiﬁcantly faster ligand dissociation compared to
AF488IFNa2 was observed (Fig. 11 B). For
AF488IFNa2-
M148A, however, the dissociation at different receptor sur-
faceconcentrationswasstillﬁttedwellbythesamemodeland
the stringent parameterization as used for
AF488IFNa2 (Fig.
11, C and D). Moreover, a surface association rate constant
kT
a of (18 6 1) mm
2fmol
 1s
 1 was obtained, resulting into
a surface equilibrium dissociation constant KT
D of 0.056 6
0.004fmol/mm
2(i.e.,33molecules/mm
2).Thesevaluesarein
very good agreement with the values obtained for
AF488IFNa2. In contrast, considerable systematic deviation
oftheﬁtwasobtainedfor
OG488IFNa2-R144A(Fig.11,Eand
F),andasigniﬁcantlylowerkT
a of(961)mm
2fmol
 1s 1was
obtained, resulting into a higher apparent KT
D of 0.11 6 0.01
fmol/mm
2.(i.e.,67molecules/mm
2).Weconcludefromthese
results that the model shown in Fig. 2 holds true only for the
FIGURE 6 Interaction of
AF488IFNa2 separately with
each of the receptor subunits ifnar2-EC (A–D) and ifnar1-
EC (E and F) tethered to supported lipid bilayers. (A)
Ligand binding (100 nM) to ifnar2-EC and dissociation as
detected simultaneously by TIRFS (red) and RIf (black).
(B) Interaction of 100 nM ligand with ifnar2-EC at
different ifnar2-EC surface concentrations (20 pg/mm
2,
blue; 150 pg/mm
2, green; 500pg/mm
2, red; and 1000 pg/
mm
2, black) as detected by TIRFS. The signals were
normalized to the maximum signal, which at this ligand
concentration corresponds to Rmax.( C) Chasing of
AF488IFNa2 bound to ifnar2-EC by injection of 1 mM
unlabeled IFNa2 as detected by RIF TIRFS (red) and RIf
(black). (D) Comparison of the dissociation curves at high
ifnar2-EC surface concentration (black), at low ifnar2-EC
surface concentration (blue), and for chasing with un-
labeled IFNa2( orange). (E) Binding of 200 nM
AF488IFNa2 with (black) and without (orange) immobi-
lized ifnar1-EC, and the ﬁt of the dissociation curve (red).
(F) Comparison of the dissociation of IFNa2 from ifnar1-
EC (black) including the ﬁt curve (red) with the
dissociation from ifnar2-EC (blue).
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exceeds the ka the interaction with ifnar1-EC.
DISCUSSION
Simultaneous TIRFS-RIf detection
Precise quantiﬁcation of the interacting species is a key re-
quirement for studying biomolecular interactions in a quan-
titative manner. For studying protein-protein interaction on
solid supported membranes, we incorporated label-free de-
tection by RIf into a prism-based TIRFS setup. Mass-
sensitive detection by RIf enabled for monitoring and
quantifying all binding events on the surface including lipid
bilayer fusion and receptor reconstitution, thus adding
important features in comparison to exclusive ﬂuorescence
detection: i), ﬂuorescence labeling of several components
can be avoided, reducing signal cross talk and possible
effects on protein function; ii), surface concentrations are
directly determined and their changes are monitored, which
is extremely important in case of sensitive multicomponent
surface architectures; iii), straightforward calibration of
ﬂuorescence signals with respect to surface coverage. The
RIf transducer element—a silica layer on top of a glass
substrate—is fully transparent and does not quench surface-
proximal ﬂuorophores, unlike noble metal surfaces required
for detection by SPR, and therefore is ideally compatible
with TIRFS. At the same time, its silica surface is ideally
suited for preparing solid-supported ﬂuid lipid bilayers. RIf
detection is based on directional reﬂection, providing several
advantages over other detection techniques (Hanel and
Gauglitz, 2002): i), compared to evanescent ﬁeld interroga-
tion, background signals due to changes in the refractive
index or buffer properties are much lower; ii), strict mass
sensitivity independent on the distance from the surface or
changes in shear forces; iii), simple and rugged ﬁber-based
interrogation with no moving parts. Fluorescence excitation
and emission were kept independent of RIf illumination by
implementing monochromatic RIf detection in the near
infrared region. Thus, we realized a simple and rugged setup
for simultaneous mass sensitive and ﬂuorescence detection
without compromising the ﬂexibility of either technique.
Complete spectral separation of the two techniques proved
valuable as high-power illumination for optimum RIf de-
tection could be applied without photobleaching the
ﬂuorophores absorbing in the visible region. By further
optimizing the detection, the rms noise of the RIf signal of
currently 10 pg/mm
2 could be improved down to 1–2
pg/mm
2, which is comparable to spectral RIf detection
(Hanel and Gauglitz, 2002). No signiﬁcant cross talk be-
FIGURE 7 Interaction of 100 nM
AF488IFNa2 with
ifnar1-EC and ifnar2-EC coimmobilized onto supported
lipid bilayers at different absolute and relative amounts.
The signals detected by TIRFS (dotted line) and by RIf
(solid line) during sequential tethering of ifnar2-EC and
ifnar1-EC followed by injection of the ligand are shown in
panels A–D.( A) Ifnar2-EC (25 kDa) and ifnar1-EC (57
kDa) (12 fmol/mm
2 of both). (B) Ifnar2-EC and ifnar1-EC
(2 fmol/mm
2 of both). (C) Ifnar2-EC (2 fmol/mm
2)and
ifnar1-EC (10 fmol/mm
2). (D) Ifnar2-EC (8 fmol/mm
2)and
ifnar1-EC (5 fmol/mm
2). (E and F) Fluorescence traces of
association (E) and dissociation (F)o f
AF488IFNa2 shown
in panels A (black), B (green), C (red), and D (blue), in
comparison to the interaction with ifnar2-EC alone
(orange).
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citation with different excitation sources and different
excitation power was possible without compromising RIf
detection (data not shown). Vice versa, the performance of
the TIRFS setup was completely independent of RIf illu-
mination. Even at a low excitation power (2–3 mW/mm
2)
a detection limit of 10
7 ﬂuorophores/mm
2 (i.e., 10 ﬂuo-
rophores/mm
2) was reached, and thus ﬂuorescence detection
could be carried out without signiﬁcantly photobleaching the
ﬂurophores.
Ligand-induced receptor assembling
We have applied simultaneous TIRFS-RIf detection for mea-
suring ligand-receptor interactions within the plane of the
membrane. The extracellular domains of the two subunits of
the type I interferon receptor were tethered via C-terminal
histidine tags in an oriented fashion onto supported lipid
bilayers using chelator lipids (Dorn et al., 1998; Schmitt
et al., 1994). Here, we used bis-NTA chelator headgroups,
which bind decahistidine-tagged proteins very stably (Lata
and Piehler, 2005), ensuring that the interacting proteins
were tightly tethered to the membrane. Thus, oriented an-
choring and lateral diffusion of the receptor in the plasma
membrane was mimicked while the receptor surface concen-
trations could be varied in a straightforward manner. Homo-
geneous distribution of ifnar2-EC tethered on these bilayers,
and fast lateral diffusion with a diffusion coefﬁcient of
1 mm
2/s has been previously shown by laser scanning
microscopy (Lamken et al., 2004). This is comparable to the
local receptor mobility on the plasma membrane as de-
termined by single particle tracking (Ritchie et al., 2003).
The formation of a complete lipid bilayer and its integrity
during the experiments was monitored by RIf, thus ensuring
full experimental control. Furthermore, the amounts of
ifnar2-EC and ifnar1-EC tethered to the bilayers were
quantiﬁed in each binding experiment. Site-speciﬁcally ﬂuo-
rescence-labeled IFNa2-S136C was used to dissect and
study the interactions involved in ternary complex formation
by monitoring ligand binding simultaneously by TIRFS and
FIGURE 8 Ligand exchange in the ternary complex.
Ternary complex was formed with 2 fmol/mm
2 ifnar2-EC
and 10 fmol/mm
2 ifnar1-EC tethered on the lipid bilayer,
followed by an injection of 100 nM
AF488IFNa2. (A)
Decay of the ﬂuorescence signal in absence (solid line) and
in presence (dotted line)o f1 0mM unlabeled IFNa2. (B)
Fluorescence (dotted line) and interference (solid line)
signals during injection of 10 mM unlabeled IFNa2.
Additional binding of the nonlabeled IFNa2 during this
injection was detected by RIf.
FIGURE 9 Evaluation of ligand dissociation kinetics
from the ternary complex at different receptor surface
concentrations. (A) Correlation between saturation ligand
binding signals (ﬂuorescence) and molar surface concen-
tration of ifnar2-EC as determined from the RIf signal. (B)
Dissociation phase at a receptor surface concentration of 1
fmol/mm
2: ﬂuorescence signal correlated with the mass
loading (solid line) and ﬁt of Eq. 4 (dotted line). (C)
Normalized dissociation phase (solid line) at different
receptor surface concentrations (black, 12 fmol/mm
2; red,
8fmol/mm
2;blue,4fmol/mm
2;green,2fmol/mm
2;orange,
1 fmol/mm
2; brown, 0.3 fmol/mm
2) with ﬁt curves (dotted
line).(D)ResidualsfromthecurvesshowninpanelC(same
color coding as in C).
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very similar to the interaction properties previously de-
termined for wild-type IFNa2 (Lamken et al., 2004), we
furthermore succeeded to determine the rate constants of
the very transient interaction with ifnar1-EC by ﬂuorescence
detection. All results supported the previously proposed two-
step assembling mechanism of the ternary complex and a
dynamic equilibrium between binary and ternary complex on
the membrane. Furthermore, possible cooperative effects in
the ternary complex, which have been observed for other
cytokine-receptor complexes, could not be detected for the
IFNa2-ifnar interactions.
We used ligand dissociation kinetics for probing this
dynamic equilibrium between binary and ternary complex.
We assumed ligand association to ifnar2-EC as the ﬁrst step
(Fig. 2), thus simplifying the mathematical treatment
compared to the general model (Thompson and Axelrod,
1983). The possibility of i), readily varying the receptor
surface concentrations by reversible tethering, and ii),
quantifying absolute surface concentrations by RIf turned
out to be of key importance. Thus, we were able to precisely
parameterize the system. The ligand dissociation kinetics
was ﬁtted well by the model with a single parameter being
adjusted: the association rate constant kT
a of the interaction
between the IFNa2-ifnar2-EC complex and ifnar1-EC in
plane of the membrane. Despite this very constrained ﬁtting
procedure, this kT
a turned out to be independent on the
surface concentration of the receptor subunits. Even for the
IFNa2-mutant M148A, which dissociated from ifnar2-EC
nearly as fast as from ifnar1-EC, the ligand dissociation
kinetics was properly described by the model. Strikingly,
a very similar kT
a was obtained for this mutant, conﬁrming
that the IFNa2-ifnar1-EC interaction was probed by ligand
dissociation. In the case of the IFNa2-mutant R144A with
a similar ka toward ifnar2-EC and ifnar1-EC, however, the
model did not properly ﬁt the observed dissociation kinetics,
and a signiﬁcantly lower kT
a was obtained as compared to
IFNa2 wild type and IFNa2-M148A. These two mutants,
which bind ifnar2-EC with very similar afﬁnity,impressively
demonstrate the role of the association rate constants for the
assembling mechanism and the dynamics of the ternary com-
plex on the membrane.
Interaction in two and three dimensions
The interaction of IFNa2 with ifnar1-EC in solution and
on the surface can be compared based on these results:
the equilibrium dissociation constant of 36 mol/mm
2 as de-
termined for the interaction on the surface corresponds to a
KD of 5 mM (or 3000 mol/mm
3) with the ligand in solution.
At the concentrations corresponding to these respective KD,
the same numbers of association events per time unit take
place on the surface as in solution, assuming the same dis-
sociation rate constants. The average distance between the
molecules at these concentrations are ;200 nm on the mem-
brane and ;100 nm in solution. Under these conditions, the
probability of random collision between the two particles
should be 10–100-fold higher in solution than on the
membrane as estimated by the collision laws for diffusion in
three and two dimensions (Hardt, 1979) taking the different
diffusion coefﬁcients in solution (;100 mm
2/s, (Kreuz and
Levy, 1965) and on the membrane (1 mm
2/s) into account.
Collisions must, therefore, be 10–100 times more productive
when the proteins are tethered to the membrane. This sub-
stantially higher efﬁciency could be ascribed to a longer
TABLE 2 Surface association rate constants kT
a and surface
dissociation constants K T
D determined from the ﬁt of the
ligand dissociation kinetics from the ternary complex
IFNa2 ifnar1 [fmol/mm
2] kT
a [mm
2fmol
 1s
 1] KT
D [fmol/mm
2]
wt 12.0 19.2 0.076
7.8 16.8 0.047
4.7 17.7 0.040
3.8 16.6 0.063
2.2 14.8 0.087
1.0 15.5 0.085
0.3 14.7 0.069
Average 16 6 2 0.061 6 0.006
M148A 16.0 18.0 0.056
7.4 19.0 0.053
2.2 17.5 0.057
Average 18 6 1 0.056 6 0.004
R144A 8.5 8.2 0.12
3.9 8.5 0.12
1.6 9.8 0.10
Average 9 6 1 0.11 6 0.01
FIGURE 10 Simulation of ligand association and ter-
nary complex formation kinetics based on the experimental
rate constants of the interaction with ifnar1-EC on the
membrane (ligand concentration of 100 nM). For compar-
ison, all curves were normalized to the equilibrium signal.
(A) Comparison of the ligand association kinetics (black)
and the ternary complex formation (gray) at different
receptor surface concentrations (left, 10 fmol/mm
2; right,1
fmol/mm
2). (B) Comparison of the ligand association
kinetics (black) and the ternary complex formation (gray)
at different stabilities of the ligand interaction with ifnar2-
EC (left, 0.01 s
 1; right,1s
 1).
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the membrane (Gutfreund, 1995), suggesting that a decrease
in collision rate on the membrane is essentially compensated
by an increase in successful collisions. Furthermore, pre-
orientation of the membrane-tethered proteins should also
contribute to higher encounter efﬁciency.
Receptor recruitment on the plasma membrane
Our data also implicate functional consequences, as the sur-
face equilibrium and rate constants determine the formation
and the lifetime of the ternary signaling complex. The
apparent ligand dissociation rate constant (and also the
apparent equilibrium dissociation constant) can be used for
assessing the equilibrium on the cellular plasma membrane.
Thus, 10–20% free binary complex can be estimated for
IFNa2 by comparing our results with published cellular
binding data (Cutrone and Langer, 1997). Indeed, very
similar numbers were concluded from cellular binding data
for the IL-4-receptor (Whitty et al., 1998), where the binding
afﬁnities are well comparable to the IFNa2-ifnar interaction
(Letzelter et al., 1998). A surface equilibrium constant of
36 mol/mm
2, however, is not sufﬁcient for such effective
recruitment in case that the typically few 1000 receptors
are uniformly distributed on the total cell surface (;1–10
mol/mm
2). This suggests preorganization of the receptor
proteins at higher local concentration within membrane do-
mains, which have been shown to play an important role in
cytokine signaling (Sehgal, 2003; Takaoka et al., 2000). The
efficiency of ternary complex formation and its dynamics
could well be an important parameter determining the
responsiveness of different cell types. Differential respon-
siveness of different cells types toward different IFNs could
also be explained in terms of the efﬁciency of recruiting
ifnar1, because very different afﬁnities have been observed
for IFNa2 and IFNb (Lamken et al., 2004).
APPENDIX
The proposed assembling mechanism shown in Fig. 2 can be described by
the following set of differential equations:
d½T 
dt
¼ k
T
a½B ½R1  k
T
d½T 
d½B 
dt
¼  k
T
a½B ½R1 1k
T
d½T  k
B
d½B 1k
B
a ½R2 ½L ; (A1)
where [B] and [T] are the surface concentrations of the binary and the ternary
complex, respectively; [R1] and [R2] are the surface concentrations of free
FIGURE 11 Binary and ternary complex formation
analyzed for the IFNa2 mutants M148A and R144A. (A)
Dissociation of
OG488IFNa2-R144A (dotted line) and
AF488IFNa2-M148A (dashed line) from ifnar2-EC in
comparison to
AF488IFNa2( solid line) as detected by
TIRFS. (B) Dissociation of
OG488IFNa2-R144A (dotted
line) and
AF488IFNa2-M148A (dashed line) from ifnar2-
EC and ifnar1-EC (both 5–7 fmol/mm
2) in comparison to
AF488IFNa2( solid line) as detected by TIRFS. (C)
Normalized dissociation phases for
AF488IFNa2-M148A
at different receptor surface concentrations (red, 16 fmol/
mm
2; blue, 7.4 fmol/mm
2; orange, 2.2 fmol/mm
2) with ﬁt
curves (dotted line). (D) Residuals from the curves shown
in panel C (same color coding). (E) Normalized dissoci-
ation phases for
OG488IFNa2-R144A at different receptor
surface concentrations (red, 8.5 fmol/mm
2; blue, 3.9 fmol/
mm
2; orange, 1.6 fmol/mm
2) with ﬁt curves (dotted line).
(F) Residuals from the curves shown in panel E (same
color coding).
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Biophysical Journal 88(6) 4289–4302ifnar1-EC and ifnar2-EC, respectively; [L] is the (volume) concentration of
the free ligand; kB
a and kB
d are the association and the dissociation rate
constant of ifnar2-EC-IFNa2 complex formation; kT
a and kT
d are the surface
association and dissociation rate constants of the interaction of ifnar1-EC
with the ifnar2-EC-IFNa2 complex on the surface. The total surface-bound
ligand is monitored, i.e., the sum of both complexes [S]:
½S ¼½ T 1½B : (A2)
The total amount of ifnar2-EC on the membrane [R2]0 is given by the sum of
the amount of free ifnar2-EC, the binary complex and the ternary complex:
½R2 0 ¼½ R2 1½B 1½T : (A3)
The total amount of ifnar1-EC [R1]0, is given by the sum of the amounts of
free ifnar1-EC and the ternary complex.
½R1 0 ¼½ R1 1½T : (A4)
[R1] and [R2] from Eqs. A2 and A3 are inserted into Eq. A1:
d½T 
dt
¼ k
T
a 3 ½B  3 ð½R1 0  ½ T Þ   k
T
d 3 ½T 
d½B 
dt
¼  k
T
a 3 ½B  3 ð½R1 0  ½ T Þ1k
T
d 3 ½T 
  k
B
d 3 ½B 1k
B
a 3 ð½R2 0  ½ T  ½ B Þ 3 ½L 
½S ¼½ T 1½B : (A5)
During dissociation ligand concentration equals 0, ½L ¼0 and Eq. A5 can
be simpliﬁed to
d½T 
dt
¼ k
T
a 3 ½B  3 ð½R1 0  ½ T Þ   k
T
d 3 ½T 
d½B 
dt
¼  k
T
a 3 ½B  3 ð½R1 0  ½ T Þ1k
T
d 3 ½T  k
B
d 3 ½B 
½S ¼½ T 1½B : (A6)
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Ligand-induced cross-linking of the type I interferon (IFN) receptor
subunits ifnar1 and ifnar2 induces a pleiotrophic cellular response. Several
studies have suggested differential signal activation by ﬂexible recruitment
of the accessory receptor subunit ifnar1. We have characterized the roles of
the four Ig-like sub-domains (SDs) of the extracellular domain of ifnar1
(ifnar1-EC) for ligand recognition and receptor assembling. Various sub-
fragments of ifnar1-EC were expressed in insect cells and puriﬁed to
homogeneity. Solid phase binding assays with the ligands IFNa2 and IFNb
revealed that all three N-terminal SDs were required and sufﬁcient for
ligand binding, and that IFNa2 and IFNb compete for this binding site.
Cellular binding assays with different fragments, however, highlighted the
key role of the membrane-proximal SD for the formation of an in situ IFN–
receptor complex. Even substitution with the corresponding SD from
homologous cytokine receptors did not restore high-afﬁnity ligand
binding. Receptor assembling analysis on supported lipid bilayers
in vitro revealed that the membrane-proximal SD controls appropriate
orientation of the receptor on the membrane, which is required for efﬁcient
association of ifnar1 into the ternary complex.
q 2005 Elsevier Ltd. All rights reserved.
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Introduction
Type I interferons (IFNs) elicit a potent,
pleiotrophic antiviral, antiproliferative and
immunmodulatory response as an innate ﬁrst-line
defense against viral infection. All human type I
IFNs (12 IFNa subtypes and several allelic variants,
1 IFNb,1 IFN3, 1 IFNk and 1 IFNu
1) exert activity
through binding to the same receptor components,
ifnar1 and ifnar2.
2 It appears, however, that the
function of these different IFNs is not fully
redundant, but that differential signaling by differ-
ent IFNs can be observed.
3–9 In particular between
the IFNa subtypes and IFNb, substantial differences
have been observed on the level of receptor
phosphorylation
3 and effector recruitment,
10 as
well as on the level of gene induction.
11 As no
further receptor component has yet been identiﬁed,
these differences need to be explained through the
mode of interaction of IFNs with the extracellular
domains of ifnar1 (ifnar1-EC) and ifnar2 (ifnar2-
EC). The high-afﬁnity interactions between the
ifnar2-EC and different IFNs have been investigated
in detail,
9,12–14 and a model for the complex
between IFNa2 and ifnar2-EC, based on double
mutant cycle analysis, has been reported.
15,16
However, the structural differences which have
been identiﬁed for the interaction of ifnar2-EC with
IFNa2 and IFNb are only minute,
13–15 and therefore
cannot explain their functional differences.
The interaction between ifnar1 and IFN has been
reported to be of much lower afﬁnity, and its
contribution towards complex formation is less
well characterized. Cellular binding and activity
0022-2836/$ - see front matter q 2005 Elsevier Ltd. All rights reserved.
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doi:10.1016/j.jmb.2005.05.008 J. Mol. Biol. (2005) 350, 476–488assays are limited by the fact that the properties of
cell surface receptor such as afﬁnity and
competition are dominated by the (high-afﬁnity)
interaction with ifnar2. Sequence alignment has
predicted that ifnar1-EC is composed offour Ig-like
domains,
17 suggesting two potential cytokine
binding modules, but so far only 1:1:1 complex
stoichiometries have been detected both in vivo
18
and in vitro.
19,20 Time-resolved binding assays have
detected very transient binding of IFNa2 to ifnar1-
EC with a dissociation constant KD of 5 mM, while
for IFNb a considerably lower KD value of 50 nM
was determined.
20 Furthermore, no contacts
between ifnar1-EC and ifnar2-EC stabilizing the
ternary complex have been detected.
20 The binding
site for IFNs was mapped to the Ig-like domains 2
and 3 by using neutralizing antibodies against
ifnar1-EC.
21 These studies also indicated differen-
tial recognition of IFNa2 and IFNb by ifnar1. The
important role of domains 2 and 3 for ligand
binding was conﬁrmed by direct in vivo binding
assays with bovine ifnar1, which binds human
IFNas with high afﬁnity.
22 Several residues on these
two domains critical for binding IFNa2 have been
identiﬁed.
23,24 These results indicated that the
ligand-binding site of ifnar1 does not correspond
to a classical cytokine binding module and a more
complex architecture of the functional complex.
Cellular binding assays, however, could neither
clearly deﬁne which of the Ig-like domains of
ifnar1-EC form the binding site for different IFNs,
nor resolve the role of different ligand–receptor
stoichiometries. Therefore, more detailed character-
ization of the interaction of ifnar1 with different
IFNs is crucial for a better understanding of
differential receptor recruitment.
We have used subfragments of ifnar1-EC contain-
ing different Ig-like domains for conﬁning the
binding site for type I IFNs. The proteins were
expressed, puriﬁed and characterized in detail.
Binding of IFNa2 and IFNb was studied in vitro
by solid phase detection; namely, reﬂectance inter-
ference (RIf) and total internal reﬂection ﬂuor-
escence spectroscopy (TIRFS) in different assay
formats. Furthermore, ternary complex assembly
was investigated for different ifnar1 constructs in
living cells, and by ligand dissociation measure-
ments in vitro on supported lipid bilayers.
Results
Expression and puriﬁcation of ifnar1-EC and its
subfragments
For identiﬁcation of the Ig domains required for
ligand binding, ifnar1-EC with a C-terminal deca-
histidine-tag (SD1234-H10) and with N and
C-terminal decahistidine-tag (SD1234-DT), as well
as the subfragments H10-SD123, SD234-H10, H10-
SD12 and SD34-H10 (Figure 1(a)) were expressed in
Sf9 insect cells. All proteins were secreted into the
medium and efﬁciently puriﬁed by immobilized
metal afﬁnity chromatography (IMAC). In the
subsequent size exclusion chromatography (SEC)
all proteins eluted within a single protein peak,
while only minor quantities of higher molecular
mass aggregates were observed. An SDS-PAGE and
the SEC chromatograms of the puriﬁed proteins
(both carried out under non-reducing conditions)
are shown in Figure 1. In all cases, homogeneity
was O95% as judged by SDS-PAGE (Figure 1(b))
and analytical SEC (Figure 1(c)). For all species the
yield of puriﬁed protein was 0.5–2 mg from 200 ml
of cell culture. The proteins, stored at physiological
pH and ionic strength, were stable (monomeric) for
several weeks at 4 8C. Upon shock-freezing in liquid
nitrogen and thawing, more than 90% of the
monomeric protein was retained for all species as
determined by analytical SEC.
All ifnar1-EC fragments were glycosylated and
properly folded
Yields, stability and monomeric nature of the
subfragments under non-reducing conditions
Figure 1. Puriﬁcation of ifnar1-EC and the sub-
fragments. (a) Schematic of the ifnar1-EC fragments
used for localizing the IFN binding site, and their
attachment to surfaces via N and C-terminal H10-tags.
(b) SDS-PAGE of the puriﬁed subfragments after puriﬁ-
cation by immobilized metal afﬁnity chromatography and
size-exclusion chromatography. (c) Analytical SEC of the
puriﬁed subfragments on a Superdex 200 HR10/30
column. (d) SDS-PAGE of the puriﬁed subfragments
after deglycosylation with PNGaseF. (e) Analytical SEC of
the puriﬁed subfragments after deglycosylation with
PNGaseF under native conditions.
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corroborated by a more detailed protein-
biochemical analysis. Since the proteins were
expressed and secreted in eukaryotic cells, glycosyl-
ation of some of the overall nine potential glycosyl-
ation sites of ifnar1-EC was expected (Table 1).
Accordingly, the apparent molecular mass observed
in SDS-PAGE was substantially higher than the
expected mass for all proteins (Table 1): for SD1234-
H10 and SD1234-DT a single, yet broadened band
corresponding to a molecular mass of approxi-
mately 57 kDa was observed in SDS-PAGE
(Figure 1(b)) compared to 49 kDa expected for the
polypeptide chain. For the subfragments, similar
shifts as well as band broadening and even multiple
bands were observed (Figure 1(b)). To conﬁrm
glycosylation the proteins were deglycosylated in
analytical amounts using PNGaseF. The SDS-PAGE
analysis of deglycosylated SD1234-H10, SD1234-DT
and their subfragments is shown in Figure 1(d). For
all proteins the apparent molecular mass shifted
to the expected mass (Figure 1(d) and Table 1).
A similar, yet less pronounced effect was observed
in analytical SEC (Figure 1(e)). The rather broad,
asymmetric peaks observed for the glycosylated
proteins (Figure 1(c)) became more sharp and
symmetric, and slightly shifted towards higher
elution volumes after deglycosylation
(Figure 1(e)). No signiﬁcant differences were
observed in the elution volumes of SD1234-H10
and SD1234-DT. In contrast H10-SD123 eluted with
substantially higher apparent molecular mass than
SD234-H10, despite the very similar molecular
mass observed in SDS-PAGE (Figure 1(d)). This
difference suggests a different spatial arrangement
or a different ﬂexibility of the three Ig-like domains
in these two proteins. Also between H10-SD12 and
SD34-H10, a small, but reproducible and signiﬁcant
shift was observed, indicating different organiz-
ation of the Ig-like domains within these two
potential CBMs. Under non-reducing conditions
the band of the different ifnar1-EC species was
shifted to a lower molecular mass compared to the
reduced proteins (data not shown) indicating
internal disulﬁde bridge formation. The anticipated
secondary structure of mainly b-sheet (70–84%) was
furthermore conﬁrmed for all subfragments by
circular dichroism spectroscopy (Table 1) corrobor-
ating appropriate folding of the protein.
The three N-terminal domains of ifnar1-EC are
required for IFN binding
For all the following binding experiments the
glycosylated proteins were used because they were
more stable than the deglycosylated ones. We
probed the interaction of IFNa2 and IFNb with
the immobilized subfragments by solid phase
detection. The proteins were immobilized on a
polymer brush via their H10-tags using high-afﬁnity
multivalent chelator head groups providing
oriented and homogeneous attachment.
25 Both
ifnar1-EC and ifnar2-EC fully retained their ligand
binding activity on these surfaces and non-speciﬁc
binding of IFNa2 and IFNb to these surfaces was
shown to be negligible upon blocking excess
binding sites with histidine-tagged maltose-binding
protein.
20,25 For ifnar1-EC (SD1234-H10) KD values
of 5 mM and 50 nM were found for the interaction
with IFNa2 and IFNb, respectively, while a 1:1
stoichiometry was indicated by the relative ampli-
tudes.
20 Virtually the same equilibrium dissociation
constants were obtained for IFNa2 and IFNb in
complex with tag-less ifnar2-EC, implying that the
interactions of IFNs with ifnar1-EC and ifnar2-EC
are non-cooperative.
20 In order to exclude that the
additional N-terminal decahistidine-tag of SD1234-
DT affected the interaction with IFNs, ligand
binding assays with SD1234-DT tethered onto
surfaces through both histidine-tags (Figure 1(a))
were carried out. The reduced surface binding
capacity observed for SD1234-DT compared to
SD1234-H10, as well as imidazole-induced dis-
sociation experiments (data not shown) conﬁrmed
that indeed both histidine-tags were involved in
tethering the protein to the surface. Binding of
IFNa2 and IFNb to immobilized SD1234-DT is
shown in Figure 2. The KD value of the interaction
with IFNa2 was determined from the equilibrium
response, while the rate constants of the interaction
Table 1. Properties of the ifnar1-EC fragments used for deﬁning the IFN binding site
Name SD1234-H10 SD1234-DT H10-SD12 SD34-H10 H10-SD123 SD234-H10
Sequence
a K1-K409 K1-K409 K1-N207 E199-K409 K1-N311 P95-K409
H10-tag
b CC , NN C N C
Total no. of aa 424 436 224 226 326 325
Glycos. sites
c 995475
MM (expected) (kDa) 49.0 50.6 25.8 26.2 37.9 37.4
MM (found)
d (kDa) 57.3 – 31.1 29.4 45.3 42.2
MM (deglyc.)
e (kDa) 49 50 29 30 40 39
b-Sheet/a-helix/RC
f 84/2/14 78/2/20 70/4/26 77/01/22 76/3/21 75/2/23
a First and last amino acid (aa) according to the predicted mature sequence of ifnar1.
b Terminus, to which the decahistidine-tag was fused.
c Potential glycosylation sites as predicted by the NetNGlyc 1.0 server.
d Mean mass determined by MALDI-MS.
e Estimated from SDS-PAGE.
f As determined by circular dichroism spectroscopy.
478 Functional Cartography of the Ectodomain of ifnar1with IFNb were determined by ﬁtting exponential
functions to association and dissociation phase of
the binding curves. Furthermore, the kd value of the
dissociation of IFNa2 from immobilized SD1234-DT
was determined by total internal reﬂection ﬂuor-
escence spectroscopy. IFNa2-S136C site-speciﬁcally
labeled with the ﬂuorescence dye Alexa Fluor 488
(
AF488IFNa2) was used, which was shown to
interact with ifnar2-EC and ifnar1-EC as wild-type
IFNa2.
26 All equilibrium dissociation constants and
rate constants obtained for IFNa2 and IFNb (Table
2) were in agreement with the values observed for
SD1234-H10.
In the same manner, binding of IFNa2 and IFNb
was assessed for the subfragments. Up to concen-
trations of 10 mM IFNa2 and 200 nM IFNb,n o
speciﬁc binding was detectable for H10-SD12 and
SD34-H10, as well as SD234-H10 (Figure 3(a)–(c)).
Thus, the KD values of these subfragments were
O100 mMf o rI F N a2a n dO2 mMf o rI F N b.I n
contrast, uncompromised binding of both IFNs
was observed for H10-SD123 (Figure 3(a)–(c)). The
interaction constants determined from these curves
were very similar to the values observed for
SD1234-H10 (Table 2). Furthermore, H10-SD12
and SD34-H10 were co-immobilized in stoichio-
metric amounts onto solid-supported, ﬂuid lipid
bilayers in order to allow simultaneous interaction
with the ligand (Figure 3(d)). Still, neither for IFNa2
(Figure 3(e)) nor for IFNb (Figure 3(f)) was
signiﬁcant binding detectable, indicating that the
linkage between H10-SD12 and SD34-H10 is
required for the formation of an intact binding
site. In order to conﬁrm that loss of binding
activity was not due to denaturation of the protein
during immobilization on the surface we devised
another assay to assess binding. Ifnar2-EC was
immobilized on the surface and followed by
Figure 2. (a) and (b) Binding of
(a) 1 mM IFNa2 and (b) 100 nM
IFNb to SD1234-DT immobilized
on a polymer brush surface as
detected by RIfS (the bar marks
the injection period). SD1234-DT
was site-speciﬁcally tethered to the
surface through interaction of its
histidine-tags with covalently
attached multivalent chelator
head groups. (c) Dissociation of
AF488IFNa2 (200 nM) from SD1234-
DT (—) as detected by TIRFS in
comparison to the same experiment
carried out with SD1234-H10 (/).
(d) Dissociation of IFNb (100 nM)
from SD1234-DT (—) in compari-
son to the same experiment carried
out with SD1234-H10 (/).
Table 2. Afﬁnities and rate constants of the interaction with IFNa2 and IFNb determined for different ifnar1-EC
constructs
Ifnar1 IFNa2 IFNb
IFNa2
(L30A)/
ifnar2-EC
a
Fragment ka (M
K1 s
K1)
b kd (s
K1) KD (mM)
c ka (M
K1s
K1) kd (s
K1) KD (nM)
d kd (s
K1)
SD1234-H10 w2!10
5 1.0G0.3 w5( 3 G2)!10
5 0.015G0.005 50G20 w0.0001
(0.015G0.003)
SD1234-DT w2!10
5 1.0G0.3 w6( 3 G2)!10
5 0.015G0.005 50G20 w0.0001
(0.017G0.004)
H10-SD123 w2!10
5 1.3G0.4 w8( 3 G2)!10
5 0.020G0.006 70G20 w0.0002
(0.025G0.003)
a Ifnar1-EC constructs co-immobilized with ifnar2-EC on ﬂuid lipid bilayers at high surface concentrations (20–40 fmol/mm
2).
b Calculated from kd and KD.
c Determined from equilibrium response.
d Calculated from ka and kd..
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ifnar2-EC (Figure 4(b)). Subsequently, binding of
SD1234-H10 and the subfragments to ifnar2-EC-
bound IFNb was studied (Figure 4(b)). In Figure
4(c) binding of the subfragments is compared with
binding of SD1234-H10. Again,speciﬁc binding was
only detectable for the subfragment H10-SD123. All
these experiments conﬁrmed that the N-terminal
Ig-like domains 1, 2 and 3 on a single polypeptide
chain were required for the formation of an intact
binding site for IFNa2 and IFNb.
IFNa2 and IFNb bind competitively to ifnar1-EC
Since the analysis of different subfragments did
not indicate different binding domains in ifnar1-EC
Figure 3. Binding of IFNa2 and IFNb to the different subfragments immobilized on the transducer surface.
(a) Response during injection of 1 mM IFNa2 to SD1234-H10, H10-SD123, H10-SD234, H10-SD12, SD34-H10 in
comparison (color coding as shown in the inset). Signals were normalized to the molar surface concentration of the
immobilized protein. (b) Response during injection of 1 mM( /) and 10 mM (—) IFNa2 onto H10-SD123 and SD234-H10
in comparison. (c) Response during injection of 50 nM IFNb onto SD1234-H10,H10-SD123, SD234-H10,H10-SD12, SD34-
H10 in comparison (same color coding as in (a)). (d) Co-immobilization of H10-SD12 (I) and SD34-H10 (II) on solid-
supported lipid bilayers. (e) Response during injection of 1 mM IFNa2 onto H10-SD12 and SD34-H10 co-immobilized
(/) on solid-supported lipid bilayers in comparison to SD1234-H10 (—). (f) The same experiment as shown in (e) carried
out with 50 nM IFNb.
Figure 4. Binding of ifnar1-EC
species to the complex of immobi-
lized ifnar2-EC and IFNb.
(a) Schematic of the sandwich
assay: after immobilization of
ifnar2-EC excess chelators are
blocked with MBP-H10 (not
shown); then, IFNb binds irre-
versibly to ifnar2-EC, followed by
binding of the respective ifnar1-EC
variant. (b) Typical binding of
IFNb (I) to immobilized ifnar2-
EC, followed by an injection of
50 nM H10-SD12 (II) and of 50 nM
SD1234-H10 (III). (c) Binding
curves for SD1234-H10 and the
subfragments in comparison
(50 nM each; the color coding is
shown in the inset).
480 Functional Cartography of the Ectodomain of ifnar1for both IFNa2 and IFNb, we investigated whether
these two IFNs actually bind competitively to an
overlapping epitope. Binding of
AF488IFNa2 was
monitored in real-time by simultaneous TIRFS-RIf
detection, which combines label-free detection with
ﬂuorescence detection.
26 Both the ﬂuorescence and
the mass-sensitive signal monitored in real-time
during a typical experiment are shown in
Figure 5(a): after immobilization of ifnar1-EC, ﬁrst
1 mM
AF488IFNa2 was injected, followed by an
injection of 1 mM
AF488IFNa2 mixed with 100 nM
unlabeled IFNb. Subsequently, only 100 nM IFNb
was injected for comparison. The ﬂuorescence
signals during the ﬁrst two injections are compared
in Figure 5(b). Fast, transient binding of IFNa2 was
detectable in the ﬂuorescence channel with a similar
characteristic as observed for unlabeled IFNa2, as
shown in Figure 3(a). The sensitivity of Rif
detection is too low to detect binding at this
IFNa2 concentration, because of the rather low
surface concentration of SD1234-H10 used for these
measurements. When IFNa2 was injected together
with IFNb a decay of the ﬂuorescence signal after
the initial fast rise was observed (Figure 5(a) and
(b)). This transient binding of IFNa2 during injec-
tion may be ascribed to labeled IFNa2b e i n g
exchanged for unlabeled IFNb, which binds more
stably to ifnar1-EC. IFNa2 binds much faster than
IFNb because of its higher concentration in the
mixture and the similar association rate constants of
IFNa2 and IFNb.
26 Binding of IFNb with its typical
association and dissociation characteristics was
simultaneously detectable on the RIf-channel
(Figure 5(a)). For the injection of IFNb without
IFNa2 a very similar binding curve was detected for
IFNb on the Rif channel while no signal was
detectable on the ﬂuorescence channel. More
detailed analysis of the binding curves at different
concentrations conﬁrmed that the rate constants of
the interaction did not change, corroborating
competitive binding of IFNa2 and IFNb to ifnar1-
EC. The same experiment was carried out with H10-
SD123 immobilized on the surface. A comparison of
the curves for 1 mM IFNa2 in the presence and
absence of 100 nM IFNb is shown in Figure 5(c).
Very similar shapes of the curves as for ifnar1-EC
were obtained, conﬁrming that IFNa2 and IFNb
bind to an overlapping epitope formed by the three
N-terminal Ig-like domains of ifnar1-EC.
Ternary complex formation on supported lipid
bilayers
The direct interaction assays revealed that the
binding afﬁnity towards IFNa2 and IFNb decreased
by a factor of more than 20 in cases H10-SD12,
SD34-H10 and SD234-H10, while nearly full bind-
ing afﬁnity was maintained for H10-SD123. Owing
to the already low afﬁnity of IFNs towards ifnar1-
EC, the residual binding afﬁnity could not be
established by these assays. Furthermore, the effects
of subdomain deletion on ternary complex for-
mation remained unclear. We therefore investigated
ligand binding to ifnar2-EC co-immobilized with
ifnar1-EC or its subfragments onto a solid-
supported, ﬂuid lipid bilayer (Figure 6(a)). It was
shown that with stoichiometric amounts of ifnar2-
EC and SD1234-H10 at high surface concentrations
(w25–50 fmol/mm
2) IFNa2 binds at least 100 times
stronger than to ifnar2-EC alone.
20 The course of a
Figure 5. Competition of IFNa2
and IFNb for the ifnar1-EC binding
site. (a) Interference signal (—) and
ﬂuorescence signal (/)d u r i n g
injection of
AF488IFNa2( 1 mM)
alone (I), mixed with 100 nM IFNb
(II) and injection of IFNb alone
(III) on immobilized SD1234-H10.
(b) Overlay of the ﬂuorescence
signals of injections I (—) and II
(/). (c) Overlay of the ﬂuorescence
signals of injections I (—) and II
(/)f o rt h es a m ee x p e r i m e n t
carried out with immobilized
H10-SD123.
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shown in Figure 6(b). After tethering ifnar2-EC and
ifnar1-H10 in stoichiometric amounts, diffusion-
controlled association of IFNa2 was observed and
no signiﬁcant dissociation from the ternary complex
(Figure 6(c)). The dissociation curves of IFNa2f r o m
ifnar2-EC co-immobilized with different ifnar1-EC
variants is compared in Figure 6(d). In the case of
SD1234-DT, the ligand dissociation kinetics were
indistinguishable from the kinetics observed for
SD1234-H10 (Figure 6(d)), suggesting that the
formation of the ternary complex was not affected
by the additional tethering through the N-terminal
His-tag. For the subdomains H10-SD12, SD34-H10
(data not shown) and SD234-H10 (Figure 6(d)) no
signiﬁcant difference in the dissociation kinetics
was observed compared to the dissociation from
ifnar2-EC alone. Also upon co-immobilization of
H10-SD12 and SD34-H10 with ifnar2-EC, no change
in the dissociation kinetics was observed
(Figure 6(d)). This binding assay is even more
sensitive to low afﬁnities, since the ligand is
captured by the high-afﬁnity interaction with
ifnar2-EC, and a subtle lateral interaction on the
surface would be reﬂected by a decrease in the
dissociation rate constant. From these assays, a loss
of afﬁnity by more than two orders of magnitude
can be concluded for the subfragments H10-SD12,
SD34-H10 and SD234-H10. In contrast, a strong
decrease in the apparent kd value was observed for
SD123 co-immobilized with ifnar2-EC (Figure 6(d)),
almost as strong as for ifnar1-EC. A kd value of
0.0002 s
K1 was estimated by an exponential ﬁt, i.e.
two orders of magnitude slower than the dis-
sociation from ifnar2-EC alone. The stability of the
ternary complex formed upon co-immobilization
with ifnar2-EC was compared in more detail for the
variants SD1234-H10, SD1234-DT and H10-SD123
applying the IFNa2 mutant L30A, which binds
w500 times weaker to ifnar2-EC (kdw5s
K1). The
Figure 6. IFNa2 binding to ifnar2 co-immobilized with different ifnar1 subfragments onto solid-supported lipid
bilayers. (a) Schematic of the assay: ifnar2-EC and ifnar1-EC were sequentially tethered onto the supported lipid bilayer
in a stoichiometric ratio, followed by injection of the ligand. (b) Binding of IFNa2 at high, stoichiometric receptor surface
concentrations of ifnar2-EC and SD1234-H10 as detected by RIfS. (c) IFNa2 binding and dissociation as shown in (b).
(d) Dissociation kinetics for SD1234-H10 (black), SD1234-DT (magenta), H10-SD123 (blue), SD234-H10 (green) and H10-
SD12/SD34-H10 (red) co-immobilized with ifnar2-EC (/) in comparison to the dissociation from ifnar2-EC alone.
(e) Dissociation of IFNa2-L30A from SD1234-H10 (black) and H10-SD123 (blue) co-immobilized with ifnar2-EC. The
dotted lines are the mono-exponential ﬁts of these curves.
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was indistinguishable from the curve obtained for
SD1234-H10(Figure6(e))withakdvalueof0.015 s
K1.
In the case of H10-SD123, slightly faster dissociation
was observed (kdZ0.025 s
K1). Thus, only small
differences in ternary complex stability were
observed for H10-SD123 compared to SD1234-H10
at these high receptor surface concentrations,
conﬁrming that ternary complex formation was
possible without SD4.
No high-afﬁnity binding of IFNa2 to ifnar1
variants without SD4 in vivo
In cells ifnar1 has been shown to increase the
apparent binding afﬁnity by tenfold to 20-fold
compared to ifnar2 alone,
18,27 which is ascribed to
the formation of the ternary signaling complex. In
order to study the effect of sub-domain deletion on
ternary complex formation in vivo, ligand binding
was analyzed in HEK293T cells overexpressing
ifnar2 with different constructs of ifnar1-EC fused
to the ifnar1 transmembrane and cytoplasmic
domains (TMCD). The binding of IFNa2a n d
ifnar1 surface expression was quantiﬁed by ﬂuor-
escence-assisted cell sorting (FACS) (Figure 7).
Ifnar1 and the fragments were overexpressed by
one to two orders of magnitude higher than
endogenous ifnar1 without signiﬁcantly affecting
the expression level of overexpressed ifnar2 (Figure
7(a)). The amount of ligand bound to the cell surface
receptor was quantiﬁed by FACS using
AF488IFNa2.
The amount of receptors presented at the cell
surface was determined by FACS using monoclonal
antibodies. A linear increase in ligand binding was
observed with increasing cell surface concentration
of wild-type ifnar1. As expected, for SD234-TMCD
no increase in ligand binding was detectable, but
also for SD123-TMCD no high-afﬁnity ligand bind-
ing was observed (Figure 7(b)). In order to exclude
that steric hindrance due to direct linkage of SD3 to
the plasma membrane was responsible for this
effect, two constructs were made, where SD4 of
ifnar1 was substituted by the corresponding
domains from two other class II cytokine receptors:
the IL10 receptor 2 chain (SD123IL10R2D2-TMDC)
and the interferon l receptor (SD123LRD2-TMDC).
However, high-afﬁnity ligand binding could
not be recovered with these receptor proteins
(Figure 7(b)) suggesting that SD4 has an important
function for the assembling of the ternary complex
in vivo.
Orientation of ifnar1 affects ternary complex
assembling
In order to better understand this role of SD4, we
studied ternary complex assembly with several
ifnar1-EC fragments and variants in more detail
in vitro. SD123LRD2 with a C-terminal H10-tag
(SD123LRD2-H10), as well as SD1234 with an
N-terminal H10-tag (H10-SD1234) and SD123 with
a C-terminal H10-tag (SD123-H10) (Figure 8(a))
were expressed in Sf9 insect cells and puriﬁed to
homogeneity. As expected from the previous
analysis, direct binding of IFNa2 and IFNb was
unaltered compared to SD1234-H10 for these
proteins (data not shown). Ternary complex
assembling was studied by TIRFS-RIf detection
with
AF488IFNa2 at receptor surface concentrations
of w3 fmol/mm
2 of the ifnar1-EC construct. This
surface concentration is representative for the cell
surface receptor density,
20 and more than one order
of magnitude lower than the receptor surface
concentrations used in the ternary complex for-
mation assays described above. A comparison of
ligand dissociation curves for different fragments is
shown in Figure 8(b). For SD1234-H10, signiﬁcantly
faster ligand dissociation was observed compared
to the curve shown in Figure 6(b), as expected for
less efﬁcient kinetic stabilization at these lower
receptor surface concentrations.
20,26 Under the
same conditions, substantially faster dissociation
was observed for SD123LRD2-H10 than for SD1234-
H10, in agreement with the low afﬁnity observed for
this variant on the cell surface. The dissociation
kinetics, however, was still four to ﬁve times slower
than from ifnar2-EC alone, indicating that the
ternary complex still assembled, yet with a much
lower efﬁciency. In order to test the role of
orientation on surface afﬁnity, we investigated
ligand dissociation from ternary complexes formed
Figure 7. Cell surface binding of
IFNa2 on HEK293T cells over-
expressing ifnar2 and different
amounts of ifnar1. HEK293T cells
were co-transfected with plasmids
encoding EGFP, ifnar2 and ifnar1.
The EGFP positive population was
analyzed in FACS for (a) the cell
surface expression level of ifnar1
and ifnar2 and (b) for speciﬁc
binding of
AF488IFNa2. The binding
of
AF488IFNa2 is expressed relative
to the binding level measured on
cells transfected with EGFP and
ifnar2 alone (open circles).
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under the same conditions (i.e. receptor surface
concentrations). Strikingly, also for H10-SD1234,
substantially faster ligand dissociation from the
ternary complex was observed than for SD1234-
H10. For both H10-SD123 and SD123-H10 ligand
dissociation from the ternary complex was similarly
fast as observed for SD123LRD2-H10. However, by
increasing the receptor surface concentration, the
decrease in ligand binding afﬁnity could be com-
pensated (Figure 8(c)). Interestingly, tethering
ifnar1-EC through both the N and C terminus
onto the membrane (SD1234-DT) had only a minor
effect on ligand dissociation (Figure 8(d)). Taken
together, these results indicate that SD4 and its
anchoring to the lipid bilayer plays a key role for the
efﬁciency of ifnar1 recruitment into the ternary
complex without being responsible for ligand
recognition.
Discussion
Characterization of the binding site of human
ifnar1 in vivo has been hampered by the extremely
low afﬁnity towards its ligands: the high-afﬁnity
interaction with ifnar2 dominates binding to the
cellular receptor, while binding to ifnar1 alone is too
transient to be detectable. Thus, structure–function
studies of IFN recognition by ifnar1-EC in vivo were
performed either in the presence of ifnar2-EC,
21,24
or with bovine ifnar1, which binds human IFNas
with much higher afﬁnity.
22,23 We analyzed for the
ﬁrst time ligand binding to different subfragments
of human ifnar1-EC in vitro in order to dissect
contributions towards ligand recognition and tern-
ary complex assembly. The architecture of ifnar1-EC
with its four Ig-like domains suggests potentially
two cytokine binding modules. By direct ligand
binding assays we could clearly show that these
potenial CBMs, SD12 and SD34, separately do
not interact with IFNa2 or with IFNb.E v e nw h e n
co-immobilized on a ﬂuid support, which allowed
lateral rearrangements, the binding site was not
restored. Hence, the covalent linkage between SD2
and SD3 is absolutely critical for ligand binding.
Out of the two subfragments containing three Ig-
like domains (i.e. with an intact linkage between
SD2 and SD3) SD123 retained nearly full ligand-
binding activity while no ligand binding was
detectable for SD234. Interestingly, SD123 and
SD234 also appeared to be different in their
apparent molecular size in SEC, indicating an
asymmetric architecture of the four Ig-like domains
of ifnar1 and not simply two, linked symmetric
CBMs. No differences in terms of subdomains
required for ligand recognition were found for
IFNa2 and IFNb, which have been suggested to
bind to different epitopes on ifnar1.
21 By direct
competition experiments we could show that the
binding sites of IFNa2a n dI F N b a r ea tl e a s t
overlapping, if not congruent.
SD4 does not seem to play a substantial role for
ligand recognition, and is also not required for
ternary complex formation with ifnar2-EC. In cells,
however, no high-afﬁnity ligand-binding site was
observed in the absence of SD4 or when it was
exchanged by a corresponding domain of homo-
logous cytokine receptors. More detailed analysis of
these constructs in vitro indicated that ternary
complex formation is still possible, but recruitment
efﬁciency is substantially impaired if SD4 is absent
or exchanged. Strikingly, the orientation of ifnar1-
EC was shown to play a key role for stable
complex formation on supported lipid bilayers, as
tethering of ifnar1-EC only at the N-terminal
domain signiﬁcantly decreased the stability of
the ternary complex. We have recently shown that
Figure 8. (a) Schematic of the
constructs SD123LRD2-H10, H10-
SD1234 and H10-SD123 and their
attachment to the lipid bilayer.
( b )D i s s o c i a t i o no fI F N a2 from
ifnar2-EC co-immobilized with
different constructs of ifnar1-EC
on lipid bilayers (receptor surface
concentration w3f m o l / m m
2).
( c )D i s s o c i a t i o no fI F N a2f r o m
ifnar2-EC co-immobilized with
H10-SD123 (red) and SD123LRD2-
H10 (blue) at different surface
concentrations (continuous line:
w7 fmol/mm
2; dotted line:
w3 fmol/mm
2). (d) Dissociation
of IFNa2f r o mi f n a r 2 - E Cc o -
immobilized with SD1234-H10
(blue), H10-SD1234 (red), and
SD1234-DT (black) on supported
lipid bilayers (receptor surface
concentration w4 fmol/mm
2).
484 Functional Cartography of the Ectodomain of ifnar1IFN-induced receptor assembling occurs in two
s t e p sa sd e p i c t e di nFigure 9, and that the
equilibrium dissociation constant of the ifnar1/
IFNa2 interaction at the surface (K2) governs kinetic
stabilization of the ifnar2/IFNa2 complex.
20,26 The
decrease of ligand binding stability observed for
N-terminally attached or impaired ifnar1 constructs
reﬂects a decrease in K2. We ascribe this drop in
surface binding afﬁnity to a decrease in the surface
association rate constant k2; recently, we have
shown that this association rate on the membrane
is enhanced by tenfold to 100-fold in terms of
successful collisions compared to the interaction in
solution,
26 which can be ascribed to pre-orientation
of the interaction sites. Non-optimal orientation of
the ligand binding site of ifnar1 on the membrane
probably reduces the rate of productive collisions,
and thus reduces the surface association rate
constant and the surface afﬁnity constant. While
this effect was clearly detectable by mimicking
membrane anchoring of the receptors in vitro,i t
could contribute even stronger in the case of the
probably much more rigidly oriented trans-
membrane proteins on the cell surface. This could
explain the complete loss of a high-afﬁnity binding
observed for the chimeric ifnar1 constructs in living
cells. Strikingly, these effects only play a role if K2
limits ternary complex formation (i.e. at low
receptor surface concentrations). This is very likely
to be the case for the IFNa2–ifnarcomplex
20 and has
been shown to be the case for the IL4 receptor
in vivo.
28 We suggest that SD4 plays a key role for
properly orientating the binding site of ifnar1 at
SD123 on the membrane for highly efﬁcient
collision with the ifnar2–IFNa2 complex. Appro-
priate orientation apparently is ﬁnely adjusted for
different members of the class II cytokine receptor
family, as exchange of homologous domains
abolished high-afﬁnity ligand binding. For some
cytokine receptors orientation of the extracellular
domains have been shown to be critical for signal
activation.
29,30 We have provided evidence that an
appropriate orientation of the interaction sites on
the membrane is crucial for efﬁcient receptor
assembling. This insight is particularly important
for the de novo design of cytokine-like molecules for
therapeutic application.
Materials and Methods
Protein expression and puriﬁcation
IFNa2 and ifnar2-EC were expressed in Escherichia coli,
refolded from inclusion bodies and puriﬁed by anion-
exchange and size-exclusion chromatography as
described.
31 The IFNa2 mutant S136C was site-speciﬁ-
cally labeled with Alexa Fluor 488 (AF488) maleimide
(Molecular Probes), and was further puriﬁed by desalting
and a ﬁnal step of anion-exchange chromatography.
Ifnar1-EC and its subfragments and variants
(Figure 10(a)) were expressed in insect cells using the
b a c u l o v i r u ss y s t e m .T h eg e n eo fm a t u r ei f n a r 1 - E C
(GenBank accession number NM_000629; amino acids
from KNL until TSK) with an additional stretch of
nucleotides coding for a C-terminal decahistidine-tag
(SD1234-H10) was cloned into the transfer vector
pAcGP67B (BD Biosciences) via the BamHI and PstI
restriction sites. An additional N-terminal extension
ADLGS is expected from the cleavage site of the gp67
secretion sequence in the vector. SD1234-DTwas obtained
by inserting a linker coding for an H10-tag at the N
terminus of SD1234-H10 into the BamHI site, resulting in
a total N-terminal extension of ADLGSH10RS. This linker
was designed so that only the N-terminal BamHI site
was retained. The subfragments were subcloned based
on this SD1234-DT construct. Baculoviruses were
obtained by co-transfection with linearized baculoviral
DNA (BaculoGold, BD Biosciences) into Sf9 cells.
For protein expression, fresh Sf9 cell cultures (200 ml)
were infected with the respective baculovirus. The
supernatant was harvested three to four days after
infection, adjusted to TBS (20 mM Tris (pH 8.0), 200 mM
sodium chloride) and thoroughly dialyzed against the
same buffer. After centrifugation, the supernatant was
applied to a 5 ml chelating Sepharose column (HiTrap
chelating; Amersham Biosciences) loaded with Zn
2C.
After washing with TBS, the proteins were eluted with
a gradient from 0 mM to 500 mM imidazole in TBS.
Pooled fractions were further puriﬁed by size-exclusion
chromatography in TBS (Superdex 200-16/60; Amersham
Biosciences).
Figure 9. Kinetically controlled two-step receptor assembling mechanism, and the role of the appropriate orientation
of ifnar1-EC. Recruitment of ifnar1 into the ternary complex depends on the (surface) afﬁnity constant K2 and the
receptor surface concentration. Reduced complex stability without SD4 anchored to the membrane suggests that K2
depends on the orientation of the receptor.
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Proteins were deglycosylated at room temperature on
an analytical scale using PNGaseF (New England Biolabs)
according to the manufacturer’s instructions at room
temperature. Analytical size-exclusion chromatography
was carried out with a Superdex 200 HR10/30 column
(Amersham Biosciences) with TBS as the running buffer.
Typically, 500 mlo fa2mM protein solution was injected.
For circular dichroism spectroscopy, proteins at 20 mM–
40 mM concentration were extensively dialyzed against
20 mM phosphate (pH 8), 150 mM sodium ﬂuoride.
Circular dichroism spectra were recorded at 22 8Co na
Jasco J-810 circular dichroism spectrometer equipped
with a Jasco PTC-423S Peltier temperature control system
using quartz cuvettes with 0.2 mm path lengths. The
secondary structure composition was calculated using the
estimation software Jasco Spectra Manager version
1.53.00.
In vitro binding assays by solid phase detection
Label-free binding assays by reﬂectometric interference
spectroscopy (RIfS) were carried out as described
20,32
using a home-built set-up.
33 Simultaneous total internal
reﬂection ﬂuorescence spectroscopy (TIRFS) and reﬂect-
ance interference (RIf) detection were carried out as
described.
26 All measurements were carried out in HBS
(20 mM Hepes (pH 7.5), 150 mM NaCl). For monitoring
the interaction with IFNa2 and IFNb, ifnar1-EC and its
derivatives were immobilized onto PEG-modiﬁed
surfaces using multivalent chelators for stable immobil-
ization as described.
20,25 Excess coordination sites were
blocked with decahistidine-tagged maltose-binding pro-
tein (MBP-H10) to avoid non-speciﬁc binding. Ternary
complex formation was measured with ifnar2-H10 and
the ifnar1-EC proteins tethered onto supported lipid
bilayers via chelator lipids as described.
20,26 Ternary
complex assembly at high receptor surface concentrations
was probed by RIfS using IFNa2 as a ligand. Ternary
complex assembly at low receptor surface concentrations
was probed by TIRFS using
AF488IFNa2 as a ligand.
Construction of plasmids encoding transmembrane
ifnar1 variants
Ifnar1 cDNA (GenBank accession number NM_000629)
was inserted into an expression vector after the SRa
Figure 10. (a) Sequence of ifnar1-EC and the different subfragments, which were expressed and puriﬁed. The arrows
indicate the three proline-rich regions of the transition between two Ig-like domains. (b) Sequence alignment of SD4 of
ifnar1-EC with LRD2 and IL10R2D2.
486 Functional Cartography of the Ectodomain of ifnar1promoter. The deletion or substitution of subdomains
(SD) was carried out with a PCR-based site-directed
mutagenesis kit ExSite (Stratagene). Ifnar1 deletion
mutants SD123-TMCD and SD234-TMCD lack amino
acid residues P307 to S408 or K1 to P104, respectively.
Substitution mutant SD123-LRD2-TMCD was derived
from the deletion mutant SD123-TMCD by insertion of
the amino acid sequence P127 to N226 from the human
IFN-l receptor (IL28R1; GenBank accession number
AAN28266), at the site of the SD4 in ifnar1 wild-type
(Figure 10(b)). Amino acids P115 to V218 from the human
IL10R2 (GenBank accession number AAP7216) were
inserted at the same position in mutant SD123-
IL10R2D2 (Figure 10(b)). Numbering of IFN-l receptor
and IL10R2 includes the leader peptide.
Cell cultures and transfection
HEK293Tcells were cultured in DMEM with 10% (v/v)
fetal calf serum (FCS) and transfected by the use of
Lipofectamine (Invitrogen). The total amount of trans-
fected DNA (1.22 mg/500,000 cells in 9.6 cm
2)w a s
maintained constant with the empty expression vector.
EGFP and ifnar2 expression plasmids were transfected at
1/50 and 1/12, respectively, of the total DNA. In order to
get different ifnar1 expression levels, the ifnar1 plasmids
were co-transfected at 1/1.1 to 1/120 of the total DNA.
FACS assays
Receptor levels at the cell surface and ligand binding
was measured by ﬂuorescence-assisted cell sorting
(FACS). Cells were detached with PBS 0.5 mM EDTA
48 hours after transfection and collected in the same
buffer containing 3% FCS. Cells were incubated at 6 8Ci n
5n M
AF488IFNa2 with or without a 30 times molar excess
of unconjugated IFNa2. After 90 minutes cells were
pelleted by centrifugation and ﬁxed with 4% (v/v)
paraformaldehyde (Becton Dickinson). Ampliﬁcation
was achieved by the binding of rabbit anti-Alexa IgG
(Molecular Probes), followed bybiotinylated donkey anti-
rabbit (Jackson ImmunoResearch) and streptavidin-
allophycocyanin conjugate (SAv-APC) (Pharmingen).
Detached cells were incubated with monoclonal antibody
(mAb) EA12
34 for quantiﬁcation of ifnar1 or with mAb D5
for quantiﬁcation of ifnar2 (both D5 and EA12 were a
generous gift of from Dr L. Runkel). The signal was
ampliﬁed with biotinylated rat anti-mouse IgG (Jackson
ImmunoResearch) and SAv-APC. Fluorescence was
measured in a FacsCalibur dual laser FACS system (BD
Biosciences). EGFP ﬂuorescence was captured in FL1 and
APC ﬂuorescence in FL4. Cells were gated for single cells
by FCS and SSC and for high expression of EGFP. Results
are expressed as the mean APC ﬂuorescence of gated
cells.
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Ligand-induced receptor oligomerization has been shown to be 
a general principle for signal propagation across the plasma 
membrane common to many cell surface receptors.
1 Reduction in 
dimensionality upon ligand binding onto the membrane has been 
proposed to have important physicochemical consequences on 
receptor recruitment and signaling efficiency.
2-4 Therefore, 
elucidation of the biophysical mechanisms governing the 
dynamics of ligand-receptor complexes on membranes is a 
prerequisite for understanding and for systematic manipulation of 
signal activation. Owing to a lack of suitable experimental tools, 
however, the 2-dimensional interaction kinetics of ligand-receptor 
complexes with appropriately mimicked biophysical constraints 
including membrane anchoring and membrane fluidity has hardly 
been studied quantitatively. Here, we describe an in vitro 
approach for determining a 2-dimensional dissociation rate 
constant of a cytokine-receptor complex. 
Chelator lipids incorporated into lipid bilayers have been 
shown to be powerful tools for tethering histidine-tagged proteins 
onto solid-supported membranes in an oriented and reversible 
fashion.
5 A drawback of the traditional chelator lipids based on a 
single nitrilotriacetic acid (NTA) moiety, however, is its low 
intrinsic affinity towards the oligohistidine-tag, leading to 
transient and ill-defined attachment.
6,7 Measurement of 2-
dimensional interactions kinetics between membrane-anchored 
proteins requires stable tethering of a receptor ectodomain by a 
single histidine-tag, and therefore tethering through traditional 
chelator lipids is not appropriate. 
Recently, we have reported molecularly stable tethering by 
multivalent chelator head groups.
8 Here, we have synthesized a 
lipid-analogue based on a chelator head group comprising two 
NTA moieties (bis-NTA), which binds histidine tagged proteins 
with multivalent interactions (Figure 1a). High mobility in the 
membrane was ensured by conjugating bis-NTA to a saturated 
and an unsaturated alkyl chain (octadec-9-enyl-octadecylamine). 
This bis-NTA lipid was incorporated into silica-supported, fluid 
lipid bilayers (Figure 1b). Thus, interactions at the bilayer surface 
can be studied by surface-sensitive detection while maintaining 
lateral mobility of proteins attached to the bis-NTA head group. 
This experimental approach was employed to explore the 
dynamics of ligand-induced ternary complex formation of the 
type I interferon (IFN) receptor. The extracellular domains of the 
receptor subunits ifnar1 and ifnar2 fused to a C-terminal 
decahistidine-tag (ifnar1-H10 and ifnar2-H10, respectively) were 
tethered onto solid-supported membranes (Figure 1b), and 
complex formation upon binding of the ligand IFNα2 was 
monitored in real time by fluorescence and mass-sensitive 
detection. The dynamics of the ternary complex in plane of the 
membrane was probed by a pulse-chase approach based on 
fluorescence resonance energy transfer (FRET) between IFNα2 
and ifnar2-H10 (Figure 1c,d). 
The interaction of IFNα2 with the two receptor subunits has 
been studied in detail earlier, and a two-step assembling 
mechanism was established.
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Figure  1  The chemical structure and schematic representation of bis-
NTA lipid (a), which binds histidine-tagged proteins by multivalent 
interaction. b) Silica-supported lipid bilayers doped with bis-NTA lipid 
were used for stable and controllable tethering of ifnar2-H10 (blue) and 
ifnar1-H10 (green), and ternary complex formation was induced by 
binding of IFNα2 (orange). c) Structure of ifnar2-EC (blue) in complex 
with IFNα2 (red) and a model of ifnar1-EC (green). The residues mutated 
for labeling are colored in orange (ifnar2-EC) and green (IFNα2). d) 
Principle of surface kinetics measurements by FRET (top view onto the 
membrane): Donor fluorescence from ifnar2-H10 (blue) is quenched upon 
ternary complex formation with acceptor-labeled IFNα2 (orange) and 
unlabeled ifnar1-H10 (green). Upon pulse-chasing the ternary complex by 
tethering rapidly an excess of unlabeled ifnar2-H10 to the membrane, 
donor-labeled ifnar2-H10 is competed out of the complex, leading to a 
recovery of the donor fluorescence. 
Here, ligand interaction with ifnar2-H10 was monitored by 
FRET using simultaneous total-internal reflection fluorescence 
spectroscopy and reflectance interference (TIRFS-RIf) detection.
9 
The interaction of IFNα2 S136C site-specifically labeled with 
Cy3 (
Cy3IFNα2) with membrane-tethered ifnar2-H10 S35C site-
specifically labeled with Alexa Fluor 488 (
AF488ifnar2-H10) is 
shown in Figure 2a. Ligand binding was detected by a drop in the 
donor fluorescence signal due to FRET from 
AF488ifnar2-H10 to  
bound 
Cy3IFNα2. During ligand dissociation, the fluorescence 
signal recovered, confirming ligand-specific fluorescence 
quenching. As the interaction between IFNα2 and ifnar2-H10 at 
surfaces was shown to be strongly biased by mass transport 
limitation,
9 ligand dissociation unbiased by rebinding was 
measured by pulse-chasing the receptor-ligand complex with 
1 µM non-labeled IFNα2 in solution, and by tethering an excess 
of non-labeled ifnar2-H10 to the surface (Figure 2b). Similar 
dissociation kinetics with a kd of 0.05 ±0.005 s
-1 was observed.  
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Figure  2 Surface kinetics measurements by FRET. a) Donor 
fluorescence detected by TIRFS (upper panel) and mass signal detected by 
RIf (lower panel) for tethering of 
AF488ifnar2-H10 (60  nM) onto lipid 
bilayer followed by binding of 
Cy3IFNα2 (100  nM). b) Dissociation of 
Cy3IFNα2 from 
AF488ifnar2-H10 upon chasing with IFNα2 (black) and upon 
a pulse-chase injection of ifnar2-H10 (red) as monitored by FRET (top 
panel: normalized fluorescence curves; bottom curves: mass deposition as 
detected by RIf). For comparison, the dissociation of 
Cy3IFNα2 from 
ifnar2-H10 upon chasing with IFNα2 as detected by direct excitation of 
Cy3 is shown. c) Interaction of 
Cy3IFNα2 with 
AF488ifnar2-H10 and ifnar1-
H10 tethered in stoichiometric amounts onto the lipid bilayer as detected 
by donor quenching. d) Binding of 
Cy3IFNα2 (100 nM) to 
AF488ifnar2-H10 
and ifnar1-H10 tethered in stoichiometric amounts onto the lipid bilayer 
followed by a pulse chase injection of ifnar2-H10. e) Binding of 
Cy3IFNα2 
(detected by direct excitation of Cy3) to ifnar2-H10 and ifnar1-H10 
tethered in stoichiometric amounts followed by a pulse chase injection of 
ifnar2-H10. f) Comparison of the exchange kinetics as detected by the 
pulse-chase experiment shown in d) (red) with the dissociation of 
Cy3IFNα2 from 
AF488ifnar2-H10 alone as shown in b) (blue) and the 
dissociation of 
Cy3IFNα2 from the ternary complex as shown in e) (black). 
Based on the FRET between 
Cy3IFNα2 and 
AF488ifnar2-H10, the 
formation and the dynamics of the ternary complex with ifnar1-
H10 tethered onto the bilayer were studied. Ifnar1-H10 binds 
IFNα2 with a very low affinity (~5  µM) and a kd of ~1  s
-1.
9 
Previous extensive binding studies have shown that the 
interaction of IFNα2 with ifnar1-H10 is independent on the 
interaction with ifnar2.
10 After sequentially tethering 
AF488ifnar2-
H10 and ifnar1-H10 onto the lipid bilayer in a 1:1 molar ratio, 
Cy3IFNα2 was injected, and the interaction with 
AF488ifnar2-H10 
was monitored by FRET (Figure 2c). Dissociation of the ligand 
was very slow compared to the interaction with ifnar2-H10 alone, 
which can be ascribed to the formation of a ternary complex by 
simultaneous interaction of IFNα2 with ifnar2-H10 and ifnar1-
H10. This ternary complex, however, is in dynamic equilibrium 
with the binary complexes of IFNα2 with each of the receptor 
subunits. In order to probe the surface kinetics of the interaction 
with ifnar2-H10, the ternary complex was pulse-chased by 
tethering a 10-fold excess of non-labeled ifnar2-H10 over 
AF488ifnar2-H10 onto the surface within ~10 s (Figure 2d). Under 
these conditions, the rise in fluorescence intensity indicated 
AF488ifnar2-H10 dissociation from 
Cy3IFNα2. No ligand, however, 
dissociated from the surface under these conditions as confirmed 
in a control experiment with direct excitation of Cy3 (Figure 2e). 
Thus, the change in fluorescence was solely due to exchange of 
OG488ifnar2-H10 in the ternary complex by unlabeled ifnar2-H10, 
confirming the dynamic nature of the ternary complex. The 
kinetics monitored by donor fluorescence recovery therefore 
represents the dissociation kinetics of the 
AF488ifnar2/
Cy3IFNα2 
complex in plane of the membrane. Strikingly, significantly 
slower dissociation was observed under these conditions with a kd 
of  0.012 ± 0.003 s
-1 (Figure 2f). The reasons for the slower 
dissociation could be slower diffusion of the proteins in the 
membrane, the reduced degree of freedom affecting the reaction 
coordinate or cooperative interaction with ifnar1-H10. Further 
studies are required to resolve this issue decisively. 
The substantial effect of protein tethering to the membrane on 
the dissociation kinetics, however, highlights the key importance 
of mimicking the properties of the membrane for studying ligand-
receptor dynamics. Here, we have succeeded to directly 
determine the dissociation rate constant of an important cytokine-
receptor complex in plane of the membrane. The novel, high-
affinity bis-NTA lipid provided the key prerequisites of such an 
endeavor: stable tethering of the proteins to the membrane in an 
oriented manner, and the possibility to rapidly change the 
receptor surface concentration. In combination with powerful 
surface-sensitive techniques for controlling and probing 
interaction this provides means for experimentally addressing the 
role of lateral interaction at the membrane in signaling processes. 
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Abstract. Ligand-induced cross-linking of cell surface receptors is a basic paradigm of signal activation by many 
transmembrane receptors. After ligand binding, the receptor complexes formed on the membrane are dynamically maintained 
by 2-dimensional protein-protein interactions on the membrane. The biophysical principles governing the dynamics of such 
interactions have not been understood, mainly because measurement of lateral interactions on membranes so far has not 
been experimentally addressed. Here, we describe a generic approach for measuring 2-dimensional dissociation rate 
constants  in vitro using a novel high-affinity chelator lipid for reconstituting a ternary cytokine-receptor complex on solid-
supported membranes. While monitoring the interaction between the ligand and one of the receptor subunits on the membrane 
by fluorescence resonance energy transfer, the equilibrium on the surface was perturbed by rapidly tethering a large excess of 
the unlabeled receptor subunit. Exchange of labeled by un-labeled protein in the ternary complex was detected as a recovery 
of the donor quenching. Since the dissociation of the ligand-receptor complex in plane of the membrane was the rate-limiting 
step under these conditions, the 2-dimensional rate constant of this process was determined. Strikingly, the 2-dimensional 
dissociation was much slower than ligand dissociation into solution, suggesting that membrane tethering significantly affects 
the dissociation process. This result highlights the importance of studying ligand-receptor complexes tethered to membranes 
for understanding the principles governing signal activation by ligand-induced receptor assembling. Paper V   
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Abstract 
Ligand-receptor interactions within the plane of the plasma membrane play a pivotal role for 
transmembrane signaling. The biophysical principles of protein-protein interactions on lipid 
bilayers, though, have hardly been experimentally addressed. We have dissected the 
interactions involved in ternary complex formation by ligand-induced cross-linking of the 
subunits of the type I interferon (IFN) receptor ifnar1 and ifnar2 in vitro. The extracellular 
domains ifnar1-EC and ifnar2-EC were tethered in an oriented manner on solid-supported 
lipid bilayers. The interactions of IFNα2 and several mutants, which exhibit different 
association and dissociation rate constants towards ifnar1-EC and ifnar2-EC, were monitored 
by simultaneous label-free detection and surface-sensitive fluorescence spectroscopy. Surface 
dissociation rate constants were determined by measuring ligand exchange kinetics, and by 
measuring receptor exchange on the surface by fluorescence resonance energy transfer. 
Strikingly, approximately 3-times lower dissociation rate constants were observed for both 
receptor subunits compared to the dissociation in solution. Based on these directly 
determined surface dissociation rate constants, the surface association rate constants were 
assessed by probing ligand dissociation at different relative surface concentrations of the 
receptor subunits. In contrast to the interaction in solution, the association rate constants 
depended on the orientation of the receptor components. Furthermore, the large differences in 
association kinetics observed in solution were not detectable on the surface. Based on these 
results, the key roles of orientation and lateral diffusion on the kinetics of protein interactions 
in plane of the membrane are discussed.   3 
  
Introduction 
Protein-protein interactions within the plane of cellular membranes play a key role for many 
biological processes and in particular for transmembrane signaling. These lateral interactions 
are not static and are typically triggered or stabilized by interactions with further interaction 
partners such as ligands, effectors and binding proteins from the matrices adjacent to the lipid 
bilayers. A prominent example is the ligand-induced cross-linking of receptor tyrosine 
kinases (1,2) and cytokine receptors (3), where 2-dimensional interaction between receptor 
subunits have been recognized to be important for regulating signaling (4-7). The 
fundamental importance of such coupled interactions for cell-surface receptor activation has 
stimulated numerous theoretical studies (8-13). The underlying concept of these models is the 
reduction in dimensionality upon ligand binding to a membrane anchored receptor (14). The 
binding of ligands to individual surface receptors can be determined by standard techniques, 
and rate constants and equilibrium constants are measured in the same units as for interaction 
in solution. In the second step, however, lateral interactions take place in the plane of the 
membrane, i.e. in two instead of three space dimensions. For several reasons, the kinetic 
parameters of these interactions cannot be readily deduced from the rate constants of the 
same interaction in solution: (i) Anchoring of the proteins into the membrane reduces the 
translational and rotational freedom, and results in a preferred orientation of the interaction 
partners to each other along the normal of the surface. Hence, the reaction diagram and the 
reaction coordinate of the interaction are different from the interaction in solution. (ii) Lateral 
and rotational diffusion of the membrane-anchored protein is much slower than in solution, 
while the dynamics of the amino acid side chains mediating the interaction between the 
proteins are not affected. The consequences of these constraints have been subject of 
numerous speculations and theoretical consideration, but to date only very few semi-
quantitative (4) or quantitative (15,16) experimental approaches towards characterizing 2-
dimensional interactions on membranes have been reported. 
Recently, we have reported an experimental approach for reconstituting and analyzing 
membrane-anchored proteins on solid-supported lipid bilayers. The extracellular receptor 
domains of the type I interferon (IFN) receptor subunits ifnar1 (ifnar1-EC) and ifnar2 (ifnar2-
EC) were tethered in an oriented manner onto solid-supported lipid bilayers providing well-
defined and homogeneous diffusion kinetics. The interaction of the membrane-anchored 
receptor subunits with the ligand IFNα2 was studied by using simultaneous surface-sensitive 
fluorescence and interference detection (17). This approach enables to monitor and vary the 
concentrations of the receptor subunits on the lipid bilayer, and the absolute surface 
concentrations can be quantified. A rigorous analysis of all possible interactions between the 
three partners established ternary complex formation by independent interaction of ifnar1 and 
ifnar2 with the ligand IFNα2 (17,18). A general mechanism describing the two possible 
pathways of ternary complex formation and dissociation is depicted in Figure 1. Altogether, 4 
separate interactions have to be considered: two of them (described by K1 and K4) involve 
ligand binding from solution to the surface receptor subunits. The affinity of IFNα2 towards 
ifnar2-EC (K1: 5 nM) is about three orders of magnitude higher than the affinity towards 
ifnar1-EC (K4: ~5µM) (18). In contrast, the interactions of the binary complexes on the 
surface with the second receptor subunits (described by K2 and K3) are 2-dimensional 
interactions. Despite its inherent 3-body complexity, several striking features make this 
interaction a particularly suitable system for studying surface interactions: First, the receptor 
subunits interact independent from each other with the ligand, and do not interact with each 
other as proposed for other cytokine receptors. Second, only a heterodimeric ternary complex 
was detectably involving ifnar2-EC, ifnar1-EC and IFNα2 in a 1:1:1 stoichiometry. Thus, the 
surface interaction is triggered by a ligand binding from solution and the equilibria K2 and K3   4 
  
between binary and ternary complex on the surface K2 and K3 can be probed by the 
dissociation kinetics of the ligand from the surface (17). Since receptor surface 
concentrations can be absolutely quantified in the reconstituted system, this provides the 
means for determining the equilibrium dissociation constants of these 2-dimensional 
interactions. 
Because ligand binding to ifnar2-EC (k1) is at least 10-times faster than to ifnar1-EC (k4), 
pathway 1 has been assumed to be substantially favored both for formation and for the 
dissociation of the ternary complex at stoichiometric surface concentrations of the receptor 
subunits. For an IFNα2 mutant with reduced k1, however, pathway 2 has been proposed to 
considerably contribute, which may hold true also for other members of the type I IFN family 
(17). Here, we have employed the features of this system to explore the biophysical principles 
governing protein interactions in plane of biological membranes. By using different chasing 
and pulse-chasing assays, as well as IFN-mutants with different affinities and different 
association and dissociation rate constants of the interaction with ifnar1-EC and ifnar2-EC, 
each of the 2-dimensional rate constants of the two interaction pathway depicted in Figure 1 
were determined. Furthermore, the role of electrostatic rate enhancement and the relative 
orientation of the receptor subunits on the surface association rate constants were 
investigated. Based on these data, we compare the determinants of protein interaction kinetics 
in 3 and 2 dimensions. 
Materials and Methods 
Protein expression and purification 
IFNα2, IFNα2 HEQ, ifnar2-EC with a C-terminal decahistidine-tag (ifnar2-H10), ifnar2-H10 
I47A and tag-less ifnar2-EC (ifnar2-tl) were expressed in Escherichia coli, refolded from 
inclusion bodies and purified by anion-exchange and size-exclusion chromatography as 
described (19). For site-specific labeling, an additional cysteine was introduced by the 
mutations S136C (IFNα2) and S35C (ifnar2-H10). These proteins were expressed, refolded 
and purified as the wild-type proteins. After size exclusion chromatography, these proteins 
were incubated with a 3-fold excess of Alexa Fluor 488 (AF488) maleimide or Oregon Green 
488 (OG488) maleimide as FRET donors, and Alexa Fluor 568 (AF568) maleimide as an 
FRET acceptor (all from Molecular Probes, Eugene, OR). After the labeling reaction, the 
proteins were further purified by anion exchange chromatography. Binding experiments 
confirmed that the interaction properties of both proteins were not affected by mutagenesis or 
labeling. Ifnar1-EC with a C-terminal decahistidine tag (Ifnar1-H10) and with a N-terminal 
decahistidine tag (H10-ifnar1) were expressed in Sf9 insect cells, and purified from the 
supernatant by immobilized metal affinity chromatography followed by size exclusion 
chromatography as described earlier (20). 
Simultaneous fluorescence interference detection 
Two dimensional interactions were detected with a home-built set-up for simultaneous 
reflectance interferometry (RIf) and total internal reflection fluorescence spectroscopy 
(TIRFS) detection as described previously in more detail (17). An argon ion laser was used 
for fluorescence excitation at 488 nm at an excitation power of 2–3 µW focused onto an area 
of 1 mm² in order to minimize photo-bleaching. Fluorescence was collected by an optical 
fiber and detected by a photomultiplier tube through bandpass filters. FRET measurements 
with donor and acceptor fluorescence detection were carried out by changing the emission 
filters by means of a filter wheel. Mass deposition onto the surface was monitored 
simultaneously by RIf detection at 800 nm. Both TIRFS and RIf were acquired with a time 
resolution of 1.2-1.5 s. Sample handling was carried out in a flow-through format using a   5 
  
syringe pump as described (21). With this system, flow rates between 1 and 500µl/s can be 
employed. Sample handling and data acquisition were controlled with software written in 
LabVIEW (National Instruments). 
Lipid bilayer assembling, receptor reconstitution and binding assays 
The transducer surface was incubated for 30 min in a freshly prepared mixture of two parts 
30% (v/v) hydrogen peroxide and three parts concentrated sulfuric acid. After extensive 
washing with water, the transducer was dried in a nitrogen stream and mounted immediately 
into the flow cell. Solid supported lipid bilayers were prepared by fusion of small unilamelar 
vesicles (SUVs) obtained by probe sonication. Synthetic stearoyl-oleoyl phosphatidylcholine 
(SOPC, Avanti Polar Lipids, Alabaster, AL) lipids were doped with 5 mol% lipid containing 
bis-NTA chelator head (17). The unsaturated alkyl chain of both matrix and chelator lipid 
prevented phase segregation and ensured bilayer fluidity. 
All binding studies were carried out with 20 mM HEPES, pH 7.5, and 150 mM NaCl as the 
running buffer. Solid-supported lipid bilayers were obtained by injecting SUVs at a lipid 
concentration of 250  µM on the surface of the transducer. Protein immobilization and 
binding assays were in principle carried out as described earlier (18). For tethering the 
histidine-tagged proteins to the supported membranes, the chelator head groups were loaded 
with Ni
2+ ions by injecting 10 mM nickel(II)chloride in the running buffer for 150 s and 
conditioned by a 150 s injection of 200 mM imidazole. Depending on the targeted surface 
concentrations, the his-tagged proteins were sequentially injected at concentrations between 
2 nM and 1 µM for 20–60 s. The ligand was then injected at a concentration of 50 nM for 
150-300 s with a flow rate of 1 µl/s, followed by a buffer wash with 10 µl/s or injection of 
2 µM ifnar2-tl, 1 µM IFNα2 or 1 µM IFNα2 HEQ at a flow rate of 1µl/s for 300-450 s. For 
pulse-chase experiments 1µM ifnar2-H10 was injected for 20 s, followed by a buffer wash 
with a flow rate of 10µl/s. After a set of ligand binding experiments, all attached proteins 
were removed by a 150 s pulse of 200 mM imidazole, and the subsequent binding assays 
were carried out on the same lipid bilayer. 
Data evaluation 
Binding curves were analyzed using Origin (Microcal Software, Northampton, MA) or 
Berkeley Madonna (UCB, Berkeley, CA) software packages. If necessary, RIf curves were 
corrected for a linear drift based on the signals before tethering the proteins and after 
regeneration with imidazole. Two different models were used to evaluate ligand dissociation 
curves. Dissociation rate constants were obtained by fitting a mono-exponential function: 
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2-dimensional association rate constants were determined by fitting a two step dissociation 
model describing one of the two pathways shown in Figure 1 as in principle described before 
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For determination of k3 (pathway 2), the following set of differential equations was fitted:   6 
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[R1]0 and [R2]0 were initial surface concentrations of ifnar1-EC and ifnar2-EC, respectively, 
which were determined from the RIf signals. [S] was the total surface concentration of the 
ligand, which was detected in a time-resolved manner by the TIRFS signal and converted into 
a absolute surface concentration using a calibration by RIf. The 2-dimensional dissociation 
rate constants k-2 and k-3, respectively, were determined independently by chasing 
experiments. The respective 2-dimensional association rate constant was the only parameter 
varied in the fitting procedure. 
Simulations 
Ligand dissociation kinetics through both pathways was numerically simulated using the 
following set of differential equations: 
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with the initial conditions:  0 ] 1 [ , 0 ] 2 [ , fmol/mm   2 ] [ 0 0
2
0 = = = = = = t t t B B T . For the total surface 
concentrations of the receptor subunits, 2 or 22 fmol/mm² were assumed. 
The populations of pathway 1 and pathway 2 were simulated according to the equations 
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Results 
The interaction kinetics of ifnar2-EC and ifnar1-EC with IFNα2 has been previously studied 
in detail, and numerous mutants with different interaction rate constants have been described 
(18,22-25). Here, we used several mutants of IFNα2 and ifnar2-EC, as well as different 
variants of ifnar1-EC. The rate constants of the mutants applied for further characterization of 
the 2-dimensional interaction involved in ternary complex formation were verified by ligand 
binding assays with the site-specifically fluorescence labeled IFNα2 species using TIRFS 
detection (Table 1). 
Pathways of receptor assembling and dissociation 
IFN-induced two-step assembling and dissociation of the ternary complex with ifnar1-EC and 
ifnar2-EC can occur by two different pathways (Figure 1). For the interaction of IFNα2 with 
ifnar2-EC and ifnar1-EC at stoichiometric concentration, pathway 1 has been considered to 
determine both complex formation and dissociation, because of the faster association rate 
constant k1 compared to k4 (17). This holds obviously true for the complex formation, since 
ligand binding from solution is the rate-limiting step of the assembling process (17), which is 
~10-fold faster to ifnar2-EC than to ifnar1-EC. Dissociation of the ternary complex, however, 
is determined by the 2-dimensional rate constants k2,  k-2,  k3 and k-3, which have been 
assumed to scale relatively as the corresponding rate constants in solution. This assumption 
was qualitatively tested by rapidly changing the receptor surface concentration after 
formation of a stoichiometric ternary complex (Figure 2). Ifnar1-EC and ifnar2-EC carrying a 
C-terminal decahistidine-tag (ifnar1-H10 and ifnar2-H10) were site-specifically tethered in 
stoichiometric concentrations onto silica-supported lipid bilayers doped with bis-NTA lipids. 
The dissociation kinetics of fluorescence-labeled IFNα2 (
AF488IFNα2) was monitored before 
and after tethering additional ifnar1-H10 onto the membrane (Figure 2B, C). As expected, 
slower ligand dissociation kinetics was observed upon loading additional ifnar1-H10, 
indicating a shift of the equilibrium K2 towards the ternary complex (cf. Figure 1). 
Surprisingly, however, a similar effect was observed when the ifnar2-H10 surface 
concentration was rapidly increased under the same conditions (Figure 2D, E). Since only 
pathway 2 depends on the surface concentration of ifnar2, this result indicates that this 
pathway is significantly involved in the dissociation of the ternary complex. Properly 
describing the receptor dynamics therefore requires dissection of all four 2-dimensional rate 
constants involved in ternary complex formation. 
2-dimensional dissociation kinetics measured by FRET 
The dissociation rate constant of the 2-dimensional interaction between ifnar2-H10 and the 
IFNα2 complexed by ifnar1-H10 was directly measured using a pulse chase approach, which 
is schematically depicted in Figure 3A. After ternary complex formation of 
AF568IFNα2 with 
AF488ifnar2-H10 and ifnar1-H10, a substantial excess of unlabeled ifnar2-H10 was rapidly 
tethered onto the membrane, and the exchange of 
AF488ifnar2-H10 from ternary complex with 
unlabeled ifnar2-H10 was monitored by the decaying FRET between 
AF568IFNα2 and 
AF488ifnar2-H10. A typical experiment is shown in Figure 3B. Donor fluorescence from 
AF488ifnar2-H10 was quenched upon ternary complex formation with acceptor-labeled 
AF568IFNα2, which was accompanied by an increase in sensitized fluorescence. During 
rinsing, slow recovery of the donor fluorescence and likewise and decay of the acceptor 
fluorescence due to ligand dissociation was observed. Upon pulse-chasing the ternary 
complex by rapidly tethering an excess of unlabeled ifnar2-H10 onto the membrane, much 
faster recovery of the donor fluorescence and decay of the acceptor fluorescence where   8 
  
observed. Under these conditions, ligand dissociation was hardly detectable (Figure 3C and 
Figure 2D), confirming that indeed the kinetics of the exchange of 
AF488ifnar2-H10 against 
unlabelled ifnar2-H10 on the surface was monitored by FRET. The normalized traces for 
donor and acceptor fluorescence were in excellent agreement (Figure 3C). The rate constant 
of this exchange is determined by the 2-dimensional dissociation rate constant of the ifnar2-
H10/IFNα2 complex k-3, which is the rate-limiting step in this process. The rate constants 
obtained by a mono-exponential fit to the two FRET signals were in good agreement and an 
average  k-3  of  0.007 ± 0.001 s
-1 was determined from multiple experiments at different 
receptor surface concentrations. Strikingly, k-3 is ~3-times lower than the k-1 of 0.02 s
-1 for the 
dissociation of IFNα2 from ifnar2-H10 into solution (cf. Figure 3C and Table 1). Extensive 
ligand binding studies with the soluble receptors domains have excluded cooperative binding 
of the receptor subunits to IFNα2. Thus, the difference between k-1 and k-3 results from 
anchoring the complex onto the membrane. 
Determination of 2-dimensional rate constants by ligand chasing 
In order to confirm this effect on the dissociation kinetics, the 2-dimensional dissociation rate 
constants were assessed by ligand chasing experiments. The principle of this assay is depicted 
in Figure 4A. Here, a high excess of ifnar1-EC compared to ifnar2-H10 was tethered onto the 
membrane, and the ternary complex was formed by injecting 
AF488IFNα2. The excess of 
ifnar1-H10 remained free due to the low affinity of wild-type IFNα2 to ifnar1-H10 and its 
fast dissociation from ifnar1-H10 (kd: ~1 s
-1). By injection of 1 µM unlabeled IFNα2 HEQ, 
which binds to ifnar1-H10 with 20-fold higher affinity (25), these free ifnar1-EC molecules 
are rapidly saturated with ligand. The labeled ligand in the ternary complex is first exchanged 
against unlabeled IFNα2 HEQ by 2-dimensional dissociation of the ifnar2-H10/IFNα2 
interaction, followed by dissociation from excess ifnar1-H10 into solution (cf. Figure 4A). 
Because of the fast dissociation of labeled IFNα2 from excess ifnar1-H10 into solution, the 
rate-limiting step of this exchange process is the dissociation of the ifnar1-H10/IFNα2 
complex from ifnar2-H10, which is again the 2-dimensional dissociation rate constant k-3. A 
typical course of such an experiment is shown in Figure 4B. After tethering the receptor 
subunits in appropriate surface concentrations, 
AF488IFNα2 was injected and spontaneous 
dissociation was monitored. Fast dissociation from excess ifnar1-H10 within a few seconds 
was followed by very slow dissociation (comparable to the ligand dissociation kinetics in 
Figure 2A after loading excess of ifnar1-H10). The same injection of 
AF488IFNα2 was 
repeated, but ligand dissociation was monitored in presence of tag-less ifnar2-EC (ifnar2-tl) 
in order to suppress mass-transport dependent rebinding (26,27), which has to be considered 
at these receptor surface concentrations. After the third injection of 
AF488IFNα2, unlabeled 
IFNα2 HEQ was injected and the exchange kinetics was monitored. Rapid saturation of the 
excess ifnar1-H10 by binding of IFNα2 HEQ was verified by the RIf signal. The normalized 
dissociation curves are compared in Figure 4C with the ligand dissociation from ifnar2-H10 
into solution. Again, substantially slower 2-dimensional dissociation of ifnar2-H10 from 
IFNα2 bound to ifnar1-H10 was observed compared to the 3-dimensional dissociation. A rate 
constant k-3 of (0.0044±0.001) 
s-1 was obtained, which is in good agreement with the value 
obtained by pulse-chasing with ifnar2-H10. 
From the spontaneous ligand dissociation kinetics, the 2-dimensional association rate 
constant was determined, assuming that dissociation through pathway 1 can be neglected at 
this high excess of ifnar1-EC. Since spontaneous dissociation was indeed biased by rebinding 
(Figure 4C), the dissociation curve in presence of 2  µM ifnar2-tl was used. A 2-step 
dissociation model (equation 3) was fitted taking into account the appropriate 2- and 3-
dimensional rate constants k-3 and k-4, respectively, as well as the surface concentration of   9 
  
ifnar2-H10 as quantified from the RIf signal. A 2-dimensional association rate constant k3 of 
3.3×10
16 mm
2mol
-1s
-1 was obtained from the fit. Thus, a 2-dimensional equilibrium 
dissociation constant (K3) of 0.004  fmol/mm² or 2.3  molecules/µm² was obtained for the 
IFNα2/ifnar2 interaction. 
The same experiment was carried out with the ifnar2-H10 mutant I47A, which binds IFNα2 
with ten-fold lower affinity, but with the same association rate constant. Much faster 
spontaneous ligand dissociation from the ternary complex was observed at similar receptor 
surface concentrations used for wt ifnar2-H10 (Figure 4D). Upon chasing with IFNα2 HEQ, 
the labeled ligand was exchanged within a few 10 seconds. Comparison of 2- and 3-
dimensional dissociation kinetics (Figure 4E), however, again yielded a ~2-fold lower rate 
constant for the interaction in plane of the membrane (k-3 = 0.11s
-1) compared to the 
dissociation of the ligand from the surface (k-1 = 0.2s
-1). In contrast, the 2-dimensional 
association rate constant k-3 obtained from fitting the spontaneous dissociation kinetics with a 
2-step dissociation model (Equation 3) was 2.8×10
16 mm
2mol
-1s
-1, i.e. very similar to the k3 
obtained for the interaction of IFNα2 with wild-type ifnar2-H10 interaction. These consistent 
results confirmed that the surface dissociation kinetics is affected by tethering the receptor 
subunits to the membrane, and the robustness of the experimental approach to determine 2-
dimensional rate constants. 
The 2-dimensional interaction involved in pathway 2 was furthermore characterized by 
applying the IFNα2 mutant R144A (data not shown), which binds ifnar2-H10 with a 10-fold 
lower association rate constant than wild-type IFNα2 (cf. Table 1). Again, ~3-times slower 
dissociation in plane of the membrane (k-3 = 0.012s
-1) was observed compared to the 
dissociation from the surface (k-1 = 0.044s
-1). More importantly, however, a slower 2-
dimensional association rate constant (k3 = 9.1×10
15 mm
2mol
-1s
-1) was obtained, which was 
~3-fold slower than the 2-dimensional association rate constant of wild-type IFNα2. Thus, the 
10-fold difference of the ka in solution was not maintained on the membrane surface, 
suggesting that the slower diffusion on the membrane may affect association kinetics. 
The 2-dimensional rate constants of pathway 1 
In order to determine the 2-dimensional rate constants of the interaction between ifnar1-H10 
and IFNα2 in the ternary complex we studied the ligand dissociation pathway 1 by a similar 
set of experiments. In order to ensure that 2-dimensional dissociation is rate limiting, ifnar2-
H10 I47A was used in combination with IFNα2 HEQ, which dissociates from ifnar1-EC with 
a rate constant of 0.05 s
-1. The ligand chasing experiment were carried out at an excess of 
ifnar2-H10 I47A, and wild-type IFNα2 was used for chasing (Figure 5A). A typical 
experiment is shown Figure 5B: After formation of the ternary complex with 
AF488IFNα2 
HEQ, spontaneous dissociation was monitored in presence of 2  µM ifnar2-tl to suppress 
rebinding of the ligand. After a second injection of 
AF488IFNα2 HEQ, ligand exchange in 
presence of unlabeled wild-type IFNα2 was monitored. In Figure 5C, the dissociation kinetics 
in plane of the membrane is compared with the dissociation from the surface. Again, 
significantly lower dissociation rate constant was obtained for 2-dimensional dissociation (k-
2: 0.026s
-1) was observed compared to the dissociation into solution (k-4: 0.047s
-1). Based on 
this 2-dimensional dissociation rate constant, the spontaneous ligand dissociation kinetics 
was fitted by a 2-step model (Equation 2). A 2-dimensional association rate constant of 
1.3×10
16 mm
2mol
-1s
-1 was obtained for the interaction of IFNα2 HEQ with ifnar1-H10 (k2). 
These measurements were also carried out with different combinations of wild-type and 
mutant IFNα2 and ifnar2-H10. All results are summarized in Table 2. In all combinations, 
similar values of ~1×10
16 mm
2mol
-1s
-1 were obtained for k2, very similar to the k3 obtained for 
IFNα2 R144A. Interestingly, also the 3-dimensional association rate constants k1 and k4 are   10 
  
very similar for this mutant (cf. Table 1). Furthermore, a ~2.5-fold lower k-2 compared to k2 
was confirmed for all combinations, confirming the decrease in the dissociation rate constant 
by tethering the complex onto the surface. Based on these consistent observations, we 
estimated a k-2 of 0.4 s
-1 for wild-type IFNα2. 
The role of orientation in 2-dimensional interactions 
Orientation and flexibility of membrane-anchored proteins have been suggested to be key 
parameters in the kinetics of 2-dimensional interactions on membranes. In order to study the 
role of orientation on ternary complex formation, we tethered ifnar1-EC through an N-
terminal decahistidine tag (H10-ifnar1) onto the membrane. For this protein, very similar rate 
constants as for ifnar1-H10 were obtained by conventional ligand binding assays (Table 1). 
The 2-dimensional rate constants were determined using ligand chasing experiments as 
described above. The results are summarized in Table 2. No significant effect on the surface 
dissociation rate constants k-2 and k-3 was observed upon changing the orientation of ifnar1-
EC. The effect on the 2-dimensional association rate constants, however, was substantial: for 
k2 (pathway 1), a ~3-fold decrease was observed compared to the rate constant obtained with 
ifnar1-H10. For k3 (pathway 2), the effect was even stronger with a ~5-fold decrease 
compared to the rate constant obtained with ifnar1-H10. Thus, we could demonstrate the key 
role of receptor orientation on surface association kinetics and affinity by mimicking oriented 
attachment to the membrane in vitro. 
Population of the dissociation pathways 
Based on the experimentally determined rate constants, the population of the two dissociation 
pathways was compared at experimentally relevant receptor surface concentrations by 
numerically simulating ligand dissociation (Equation 4 and 5). The ligand dissociation curves 
for both pathways together and individually are compared for the wild-type proteins and two 
mutants in Figure 6. At stoichiometric concentration of the receptor subunits, pathway 1 is 
clearly dominant in case of the wt proteins (Figure 6A), and also for ifnar2-I47A (Figure 6B). 
However, a substantial contribution of pathway 2 to ligand dissociation is observed, which is 
in line with the only ~3-fold higher 2-dimensional association rate k3 compared to k2. For 
IFNα2 R144A (k3 ≈ k2), both pathways are similarly populated at stoichiometric receptor 
concentrations, confirming the key role of the relative surface 2-dimensional association rate 
constants on the dissociation pathway. At 10-fold excess of ifnar2 or ifnar1, only pathway 1 
or pathway 2, respectively, is responsible for ligand dissociation. 
Discussion 
Cellular signaling by cytokine receptors is initiated by ligand-mediated cross-linking of two 
or more receptor subunits. Thus, the 2-dimensional interactions between the ligand and its 
cognate receptor subunits determine the dynamics of the receptor complex on the plasma 
membrane, which has been proposed to play a critical role for signaling and its regulation . 
Here, we have for the first time parameterized the rate constants of a ternary cytokine-
receptor complex on model membranes. By exchange experiments based on chasing the 
ternary complex with additional receptor or ligand, we succeeded to reliably determine the 2-
dimensional dissociation rate constants. The two possible pathways were studied separately 
by using excess concentrations of one of the receptor subunits. Based on several mutants and 
variants of the interacting proteins, the effect of different rate constants and protein 
orientation on the complex dynamics was studied. Thus, we have identified several critical 
features of 2-dimensional interactions on membrans, which cannot be readily concluded from 
solution binding assays. The first surprising observation was that the dissociation rate 
constants were generally 2-3-fold lower for the interaction in plane of the membrane   11 
  
compared to the interaction in solution. This difference was not due to cooperative binding of 
the receptor subunits, which was confirmed by extensive ligand binding studies. Surface 
anchoring limits the degree of freedom, which may affect the reaction coordinate, but the 
dissociation kinetics in plane of the membrane was hardly significantly affected by the 
orientation of ifnar1-EC. The environment of the interaction interface is not affected by 
membrane anchoring, but the separation of the interaction partners by lateral diffusion, is 
~100-fold slower on the membrane than in solution, which may account for the slower 
dissociation. Furthermore, more efficient rebinding of the membrane-anchored proteins prior 
to full dissociation may be caused by reducing rotational freedom. The first explanation 
implies that the dynamics of ligand-receptor complexes may depend on the diffusion 
properties of the receptor in the membrane, which are known to be locally rather variable due 
to the microdomain structure of the plasma membrane. By partitioning of receptor complexes 
in microdomains with low fluidity such as caveolae, which has been reported for several 
tyrosine kinases and cytokine receptors (28,29) including ifnar (30), the stability of 
oligomeric complexes would be substantially enhanced. This could be a simple mechanism 
for increasing receptor recruitment efficiency at low receptor surface concentration. However, 
more detailed analysis of the dependence of the 2-dimensional kd on membrane fluidity would 
be required, as well as confirmation for other ligand-receptor complexes. 
Assessment of the association rate constants in plane of the membrane and towards the 
receptor subunits revealed further striking features of interactions on membranes. More than 
10-fold faster association of IFNα2 with ifnar2 compared to ifnar1-EC suggested that 
pathway 1 dominates both formation and dissociation of the ternary complex. On the 
membrane, though, a less than 3-fold difference in the 2-dimensional association rate 
constants was observed. For the IFNα2 mutant R144A, which binds to ifnar2-EC with a 10-
fold lower association rate constant than wild-type IFNα2, similar 2-dimensional association 
rate constants were obtained for both pathways. It was shown earlier that the association 
kinetics of IFNα2 to ifnar2 is accelerated by electrostatic attraction (19). Electrostatic 
association rate enhancement has been explained by a stabilization of the encounter complex 
and by steering of the proteins into appropriate orientations (31-34). Our results suggest that 
this electrostatic rate enhancement is not as effective on the membrane. This could be 
ascribed to changed electrostatic properties by tethering the interacting proteins onto the 
membrane. Another reason could be that the association kinetics is limited by the slower 
diffusion on the membrane. While electrostatic steering did not seem to be as important as in 
solution, receptor orientation was shown to strongly affect the 2-dimensional association rate 
constants. Interestingly, even more similar values were observed for both k2 and k3 upon 
tethering ifnar1-EC through the N-terminus. Compared to the rate constants obtained with 
ifnar1-EC tethered in its natural orientation both k2 and k3 were substantially decreased. 
Orientation has been proposed to play a key role for 2-dimensional interactions on 
membranes (35); the strong effect, though, is somewhat surprising because tethering through 
the histidine tag to the membrane is expected to provide substantial flexibility, which should 
counteract pre-orientation. Furthermore, ifnar1-EC comprising four Ig-like domains is 
probably rather flexible in itself. However, our results suggest that steering of association by 
oriented anchoring in the membrane is more critical for 2-dimensional association kinetics 
than electrostatic steering. We have shown here that membrane anchoring through histidines 
can in principle mimic some determinant of ligand-receptor interaction on membranes. The 
importance of lateral diffusion kinetics, orientation and flexibility underscore the importance 
of assessing transmembrane proteins interactions under conditions, which mimic the 
properties of membrane anchoring even more appropriately.    12 
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Tables 
Table 1  Parameters of the individual interactions between IFNα2 and the receptor subunits. 
IFNα2
  Ifnar2-H10 Ifnar2-H10  I47A  Ifnar1-H10/H10-ifnar1 
  ka (k1) 
[M
-1s
-1] 
kd (k-1) 
[s
-1] 
KD (K1) 
nM 
ka (k1) 
[M
-1s
-1] 
kd (k-1) 
[s
-1] 
KD (K1) 
nM 
ka (k4) 
[M
-1s
-1] 
kd (k-4) 
[s
-1] 
KD (K1) 
nM 
wt 3×10
6 0.02  7  3×10
6 0.2  70  2×10
5 1 5000 
R144A 3×10
5 0.044  150  3×10
5 0.5  1700  2×10
5 1 5000 
HEQ 3×10
6 0.02  7  3×10
6 0.2  70  2×10
5 0.05  250 
In brackets, the identifier of the constants as introduced in Figure 1 are given. All IFNα2 
species were site-specifically fluorescence labeled with OG488 or AF488 by incorporating the 
additional mutation S136C. 
 
Table 2 2-dimensional interaction rate constants determined for different combinations of 
receptor and ligand variants 
  Pathway 1  Pathway 2 
Ifnar2-H10/IFNα2/ 
ifnar1-EC 
k2 
[mm²fmol
-1s
-1] 
k-2 
[s
-1] 
K2 
[fmol/mm²] 
k3 
[mm²fmol
-1s
-1] 
k-3 
[s
-1] 
K3 
[fmol/mm²] 
I47A/wt/C-term 
a  16.5 ± 3.3  ~0.4 
c  0.024  28.2 ± 5.1  0.11 ± 0.02  0.004 
I47A/R144A/C-term 
a  9.6±2.0 ~0.4 
c 0.042  11.3±2.2  0.2±0.02  0.018 
wt/R144A/C-term 
a  9.1 ± 1.8  ~0.4 
c 0.044 9.1±2.0  0.012±0.001  0.0013 
wt/wt/C-term 
a       33±5.5  0.0044±0.001  0.00013 
wt/HEQ/C-term 
a         0.004  
I47A/HEQ/C-term 
a 13.1±2.8  0.026±0.002  0.002       
wt/wt/N-term 
b       5.2±1.2  0.007±0.002  0.0014 
I47A/wt/N-term 
b  4.0 ± 0.8 
~0.4
c 0.100  5.0±1.0  0.070±0.005  0.014 
I47A/HEQ/N-term 
b  4.0 ± 0.9  0.033±0.004  0.008       
a ifnar1-EC tethered to the membrane by a C-terminal H10-tag. 
b ifnar1-EC tethered to the 
membrane by a N-terminal H10-tag; 
c estimated by comparison with IFNα2 HEQ.   15 
  
Legends to figures 
Figure 1 Schematic of the dynamic equilibria of solution and surface interactions involved in 
the 2-step formation and dissociation of the ternary IFN-receptor complex on a 
membrane (details in the text). 
Figure 2 Relevance of the two possible dissociation pathways of the ternary complex. (A) 
Schematic of the experiments: ternary complex on fluid lipid membrane was formed 
by sequential tethering of ifnar2-H10 (1) and ifnar1-H10 (2) in stoichiometric 
amounts, followed by binding 
AF488IFNα2 to form the ternary complex (3). After the 
second injection of 
AF488IFNα2, additional ifnar1-H10 (top) or ifnar2-H10 (bottom) 
was rapidly tethered onto the membrane, and dissociation was monitored (4). (B) 
Course of a typical experiment as monitored by simultaneous TIRFS (top) and RIf 
(bottom) detection with addition loading of ifnar1-H10. (C) Overlay of ligand 
dissociation curves with (red) and without (black) free ifnar1-H10 on the 
membrane. (D) Course of a typical experiment as monitored by simultaneous TIRFS 
(top) and RIf (bottom) detection with addition loading of ifnar2-H10. (E) Overlay of 
ligand dissociation curves with (red) and without (black) free ifnar2-H10 on the 
membrane. 
Figure  3  Monitoring 2-dimensional dissociation kinetics by pulse-chasing the ternary 
complex. (A) Principle of surface dissociation rate constant determination as 
detected by FRET: The ternary complex on fluid lipid membrane is formed by 
sequential injection of 
AF488ifnar2-H10 (1), ifnar1-H10 (2) and 
AF568IFNα2 (3). 
Equilibrium is then perturbed by rapidly tethering an excess of non-labeled ifnar2-
H10 onto the membrane (4), which exchanges the labeled ifnar2-H10 in the ternary 
complex (5). (B) Course of a typical experiment monitoring donor fluorescence 
(green) and acceptor (red trace) fluorescence by TIRFS and the mass loading by RIf 
(black). (C) Comparison of the surface dissociation rates from donor (green) and 
acceptor (red) channels with the dissociation of 
AF568IFNα2 from ifnar2-H10 alone 
(blue). A control experiment carried out the same way, but with unlabeled ifnar2-
H10 in (1) and with direct excitation of 
AF568IFNα2 confirmed negligible ligand 
dissociation from the surface (black). The residuals from monoexponential curve fits 
are shown in the bottom. 
 
Figure 4 Determination of 2-dimensional dissociation rate constants by ligand chasing. (A) 
Schematic of the assay: Ternary complex on fluid lipid membrane was formed by 
sequential injection of ifnar2-H10 (1), a large excess of ifnar1-H10 (2) and 
AF488IFNα2 (3). The excess of ifnar1 was then loaded with an unlabeled competitor 
(4), which binds ifnar1 with high affinity (IFNα2 HEQ) and exchanged the labeled 
ligand in the ternary complex (5). (B) Typical experiment carried out with the wild-
type proteins as detected by TIRFS (green) and by RIf (black). After the second 
injection of 
AF488IFNα2, 2 µM ifnar2-tl was injected to eliminate rebinding. After 
the third injection of 
AF488IFNα2, 1 µM unlabeled IFNα2 HEQ was injected. (C) 
Overlay of the normalized 
AF488IFNα2 dissociation curves from B: spontaneous 
dissociation during washing with buffer (black) and with 2µM ifnar2-tl (red), as 
well as dissociation while chasing with IFNα2 HEQ (green). Dissociation from   16 
  
ifnar2-H10 alone is shown for comparison (blue). The residuals from the curve fits 
are shown in the bottom. (D) Same experiment as in B carried out with ifnar2-H10 
I47A. (E) Overlay of the dissociation curves from D (same color coding as in C) 
with comparison of 
AF488IFNα2 dissociation from ifnar2-H10 I47A alone (blue). The 
residuals from the curve fits are shown in the bottom. 
Figure 5 Determination of 2-dimensional rate constants for pathway 1. (A) Schematic of the 
assay: ternary complex on fluid lipid membrane was formed by sequential injection 
of ifnar1-H10 (1), excess ifnar2-H10 I47A (2) and 
AF488IFNα2 HEQ (3). Upon 
loading the excess binding sites of ifnar2-H10 with unlabeled IFNα2 (4), labeled 
IFNα2 in the ternary complex was exchanged (5). (B) Course of a typical 
experiment as detected by TIRFS (green) and RIf (black). During spontaneous 
ligand dissociation, 2 µM ifnar2-tl was maintained in the background in order to 
eliminate rebinding. After the second injection of 
AF488IFNα2 HEQ 1 µM unlabeled 
IFNα2-wild-type was injected. (C) Overlay of the normalized dissociation curves: 
spontaneous dissociation from the ternary complex (red) and ligand exchange 
kinetics washing with 1µM IFNα2 HEQ (green). Dissociation from Ifnar1-H10 
alone is shown for comparison (blue). The residuals from the curve fits are shown in 
the bottom. 
 
Figure  6  Population of the dissociation pathways under different conditions. Ligand 
dissociation was numerically simulated based on the experimentally determined 2- 
and 3-dimensional rate constants for the following species of ifnar2/IFNα2/ifnar1: 
wt/wt/wt (A); I47A/wt/wt (B); wt/R144A/wt (C). In all cases, 2 fmol/mm² of both 
ifnar2 and ifnar1 were assumed to form ternary complex under three different 
condition: no excess of either of the receptor subunits (top panel), with an excess of 
20  fmol/mm² ifnar1 (middle panel), and with an excess of 20  fmol/mm² ifnar2 
(bottom panel).   17 
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